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The objectives of this thesis research were to determine the molecular 
mechanisms by which dietary fatty acids (FA) regulate lipogenic gene expression and 
milk fat synthesis.  Principal component and multivariate analyses were conducted to 
establish the relationship between milk fat and FA concentrations in lactating cows 
fed milk fat depressing (MFD) diets. This analysis showed that in addition to the 
established inhibitory effect of t10c12 CLA, t7-18:1 and t7c9-CLA isomers might  be 
involved in MFD. Lactating mice were used to test the effects of several individual 
trans-18:1 isomers and t10c12-CLA on milk fat synthesis, lipogenic genes in liver 
and mammary tissues.  Both MFD and extensive conversion of t7-18:1 to t7c9-CLA 
in mammary and liver tissues were shown in mice fed the t7-18:1. As expected, 
t10c12-CLA feeding caused MFD and reduced the expression of lipogenic 
transcription factor (TF) SREBP-1C. Potential roles of the TF ChREBP, PPARG, and 
INSIG1 were also established.  
  
 A subsequent study aimed to establish whether these mechanisms operated 
in lactating dairy cows. Compared with uninfused controls and a t10c12 CLA 
negative control, post-ruminal infusion of butterfat which contains all fatty acids in 
the same proportion to those found in milk fat to a mixture of fats containing only the 
long chain fatty acids were examined.  Milk fat content, milk yield and mammary 
lipogenic gene expression were increased by butterfat but not by the long chain fatty 
acid mixture.  This suggested that rates of short and medium chain fatty acid 
synthesis might be limiting for milk fat production.  Unlike the results from the 
mouse study, SREPB-1C expression was not altered by FA treatments including 
t10c12-CLA.      
 The effects of individual FA effects and a PPARγ-specific agonist 
(Rosiglitazone) on mRNA expression via qPCR of 19 genes with roles in de novo 
synthesis, FA uptake and transport, desaturation, triacylglycerol synthesis, 
transcriptional regulation, and nuclear receptor signaling in a MACT cell culture 
system were examined. The FA regulated mammary lipogenic gene expression to 
different extents. PPAR-γ activation of de novo lipogenesis coupled with exogenous 
FA availability might play a role in regulating milk fat synthesis.  These experiments 
demonstrate the role of FA in regulating mammary lipogenic pathways, highlighting 
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Chapter 1: INTRODUCTION 
The current milk component pricing system (MCP) was introduced by the 
Federal Milk Marketing Administration in 2000. Accordingly, there has been a shift 
in the producer payment from the historic system based on the volume of milk 
(adjusted for fat content) to one based primarily on the amounts of milk fat and 
protein produced. The MCP system provides a powerful economic incentive for dairy 
producers to produce high value milk components, namely fat and protein while there 
is little or no incentive to produce components directly associated with milk volume 
(lactose and minerals) that have little or no value (Erdman, 2008). Milk component 
yields are driven by both milk volume and component concentration. The dairy cow’s 
diet has not been shown to consistently affect milk lactose and mineral content 
(Sutton, 1989). Compared to milk fat responses, only modest effects of diet on milk 
protein concentration have been reported (Sutton, 1989). Milk fat is the milk 
component most easily manipulated by diet (Sutton, 1989). Reports in the literature 
have shown that milk fat percentage and yield can be reduced up to 46% (Piperova et 
al., 2000; Peterson et al., 2003) by milk fat-depressing diets containing high levels of 
grain and polyunsaturated fatty acids (PUFA).  
  It has been demonstrated that conjugated linoleic acid (CLA) and trans-18:1 
fatty acids (FA) arising from incomplete rumen biohydrogenation of dietary PUFA 
can markedly alter milk fat synthesis. Numerous studies have shown that 
concentrations of trans-18:1 FA or CLA can be increased in milk by dietary means 
(Griinari et al., 1998, Piperova et al., 2000, Peterson et al., 2003) or abomasal 
infusion of trans-18:1 FA or CLA mixture (Gaynor et al., 1994; Romo et al., 1996; 
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Chouinard et al., 1999) and this results in reduction of milk fat concentration.  
Examination of the isomer profile of trans-18:1 FA (Griinari et al., 1998) and CLA 
(Griinari and Bauman., 1999) indicated that increases in ruminally-derived trans-10-
containing 18:1 and 18:2 isomers in milk were more closely associated with milk fat 
depression (MFD) than the general increase in total trans-18:1 FA or CLA.   
Abomasal infusion of partially hydrogenated vegetable oil (PHVO) (Gaynor et al., 
1994; Romo et al 1996), or diets supplemented with Ca-salts of trans-18:1 both 
containing isomers from t6 to t16 (Piperova et al., 2004) can cause MFD.  However, 
when individual trans-18:1 isomers, including t9-, (Rindzig and Schultz, 1974), t11- 
and t12- (Griinari et al., 2000) were post-ruminally infused, milk fat was not affected. 
Although high concentration of t10-18:1 are typically observed in milk fat of lactating 
cows fed MFD diets  (Piperova et al.,2000; Peterson et al., 2003; Loor et al., 2004), 
abomasal infusion (40 g/d) t10-18:1  was not effective in reducing milk fat percentage 
in lactating cows ( Lock et al., 2007).  Baumgard et al. (2000) provided convincing 
evidence that abomasal infusion of t10c12 CLA inhibits milk fat synthesis.  In an 
earlier study, Chouinard et al. (1999) observed MFD in lactating cows abomasally 
infused with a CLA mixture lacking t10c12 CLA.   
Feeding experiments have also shown that the concentration of t10c12 CLA in 
milk does not always account for the degree of MFD (Peterson et al., 2003) and that 
reduction in milk fat concentration can occur without increases in t10c12 CLA in 
milk (Piperova et al., 2004; Loor et al., 2005a). The t8c10 CLA and c11t13 CLA 
isomers, usually present in lower concentrations in commercial CLA mixtures, were 
examined by Perfield et al. (2004) and they found no effect of these isomers on milk 
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fat synthesis.  These collective results suggest that there must be other 
biohydrogenation intermediates besides t10c12 CLA that are involved in MFD.   
The mechanisms causing MFD are not well understood. The classical dietary-
induced MFD is characterized by a predominant decreases in the short (SCFA) and 
medium chain fatty acids (MCFA) of milk fat by decreasing de novo FA synthesis 
(Bauman and Griinari, 2003). Similar effects on de novo FA synthesis were observed 
when milk fat yield was reduced by t10c12-CLA (Loor and Herbein, 1998).  Feeding 
a MFD diet (Piperova et al., 2000; Peterson et al., 2004) to lactating dairy cows, or 
feeding t10c12-CLA to rats (Ringesis et al., 2004) and mice (Lin et al., 2004) lead to 
decrease in mRNA abundance and enzymatic activity of several mammary lipogenic 
enzymes. Transcriptome profiling of lactating mammary glands of mice demonstrated 
that substantial regulation of lipid synthesis occurred at the level of mRNA 
expression and implicated the transcription factor SREBP-1c as one of the regulators 
(Rudolph et al., 2006).  Studies with MAC-T cells (Peterson et al., 2004) and 
lactating dairy cows (Harvatine and Bauman, 2006) have shown that the effect of 
t10c12-CLA on fat synthesis could be regulated via the SREBP-1c which may act as 
a global regulator of milk fat synthesis. However, SREBP-1c knock out mice exhibit 
50% lower rate of FA synthesis without fully suppressing lipogenic gene expression 
(Liang et al., 2002). This suggested that other transcription regulators may be 
involved in FA synthesis. Studies with cultured primary hepatocytes (Dentin et al., 
2004) and SREBP-1c knock out mice (Lizuki et al., 2004) have reported a role of  
carbohydrate response element binding protein (ChREBP) in the coordinated control 
of glucose metabolism, FA synthesis, and TAG synthesis in liver. 
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Recently, Bionaz and Loor (2008) demonstrated that PPARγ nuclear receptor 
was up-regulated by more than three-fold at the onset of lactation and this was 
maintained throughout lactation in dairy cows.  Simultaneous increases in expression 
of genes related to FA uptake, transport, synthesis and desaturation (Bionaz and Loor, 
2008) were also observed, suggesting that part of the long chain fatty acids (LCFA) 
effects could be mediated through PPARγ.   
 
Understanding the mechanism by which FA regulate milk fat synthesis would 
enable us to develop feeding strategies that can alter milk fat yield depending on the 
needs of the dairy industry. The present study was based on the premise that: “Fatty 
acids regulate milk fat synthesis by altering lipogenic gene expression in the 
mammary gland” and my hypothesis was: “Fatty acids affect mammary gene 
expression by altering multiple transcription regulators.”  
 
 
Specific Study Objectives: 
1. To determine the relationship between milk FA and diet-induced MFD 
employing principal component and multivariate analyses as a means to 
potentially identify individual FA effects. 
2. To determine the effects of several individual trans-18:1 isomers and t10c12-
CLA on fat synthesis, and expression of lipogenic genes and transcription 
regulators in mammary and liver tissues of lactating mice.  
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3. To compare the effects of abomasal infusion of butterfat containing all FA 
present in milk, including the short and medium chain FA, with infusion of 
only the LCFA present in milk, on the milk FA composition, milk fat yield 
and mammary lipogenic gene expression in lactating dairy cows. 
4. To determine the effects of individual FA on mammary lipogenic gene 
expression and to ascertain the role of PPARγ in regulation of lipogenic genes. 
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Chapter 2: LITERATURE REVIEW 
Milk fat is the most variable component of the milk constituents (Sutton, 
1989). Milk fat content and composition varies with the animal breed/type, 
physiological and dietary conditions (Sutton et al., 1989; Schutz et al., 1990). 
Typically, milk fat consists of 97-98% triacylglycerols, the remaining percentages 
being phospholipids, esterified and unesterified sterols and other components 
associated with the milk fat globular membrane surrounding the milk fat droplets. 
Milk fat triacylglycerols of the cows consist of 19% short (C4 to C8), 19% medium 
(C10 to C14,) and 62% long chain (>C16) fatty acids (Jensen, 2002). The short and 
medium chain fatty acids and part of palmitic acid (C16) are synthesized de novo in 
the mammary gland. The long chain (>C16) fatty acids are derived from the uptake of 
circulating fatty acids that originate from either absorption of dietary lipids or 
mobilization of body fat (Dils, 1983). 
 
Biosynthesis of milk fat 
De novo milk fatty acid synthesis 
 The de novo FA synthesis involves the synthesis of acetyl CoA and malonyl 
CoA, and the step wise elongation of ‘primed’ malonyl CoA by the enzyme fatty acid 
synthetase. The process requires the provision of NADPH for the reductive steps in 
the pathway (Dils, 1983). 
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 Acetate and beta-hydroxybutyrate are the predominant precursors for 
mammary fatty acid synthesis in ruminants (Moore and Christie, 1979). Acetate and 
butyrate, the major volatile fatty acids produced in the rumen are absorbed into the 
portal circulation across the rumen wall. In the rumen wall, butyrate is extensively 
metabolized into beta-hydroxybutyrate while a small amount of acetate is 
metabolized before entering the blood circulation (Bergaman and Wolf, 1971). 
Considerable amounts of endogenous acetate from acetyl CoA are produced in the 
liver (Costa et al., 1976) and the lactating mammary gland (Annison and Linzell, 
1964). Beta-hydroxybutyrate contributes about 8% of the carbon in the total milk 
fatty acids (Palmquist et al., 1969). About 50% of the four-carbon atoms at the methyl 
terminal end of the de novo synthesized fatty acids arise from beta-hydroxybutyrate, 
while the remaining carbon atoms are derived from acetate (Palmquist et al., 1969). 
Beta-hydroxybutyrate is oxidized in the mitochondrian by the enzyme beta -
hydroxybutyrate dehydrogenase, producing acetyl CoA. However, the acetyl CoA 
produced in the mitochondria can not be used for lipogenesis which occurs in the 
cytosol (Bauman and Davis, 1974). Therefore, the contribution of butyrate to fatty 
acid synthesis is limited mostly to synthesis of the initial four carbons of the fatty acid 
carbon chain. 
In ruminants, glucose is not a precursor for fatty acid synthesis as the 
activities of the enzymes ATP citrate lyase and NADP malate dehydrogenase are 
extremely low in the mammary tissue (Bauman and Davis, 1974). Synthesis of fatty 
acids involves reductive steps requiring the reducing equivalents NADPH. In 
ruminant mammary gland, NADPH is produced predominantly by isocitrate cycle 
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involving NADP isocitrate dehydrogenase and to some extent by pentose phosphate 
pathway involving glucose-6-phosphate dehydrogenase and 6-phospho gluconate 
dehydrogenase (Bauman et al., 1970). About 50 % of NADPH produced in the 
ruminants is by the pentose phosphate pathway using glucose (Bauman et al., 1973). 
Synthesis of fatty acid chain 
Acetate taken up by the mammary cells is converted to acetyl CoA in the 
presence of the enzyme ‘Acetyl CoA Synthetase’. Acetate and beta-hydroxybutyrate 
can also be converted to acetyl CoA and butyryl CoA by Fatty Acid Thiokinases on 
the surface of the rough endoplasmic reticulum. 
Synthesis of malonyl CoA from acetyl CoA is the first ‘committed step’ in 
fatty acid synthesis and the reaction is catalyzed by the enzyme ‘Acetyl CoA 
Carboxylase (ACC) (Dils, 1983). This step is considered rate limiting for  fatty acid 
biosynthesis as the activity of ACC is lower than the activities of other enzymes 
involved in fatty acid synthesis (Ganguly, 1960). A high correlation between ACC 
and lipogenic activity vs. low correlation between lipogenic activity and other 
enzymes involved in fatty acid synthesis in the mammary tissue at different stages of 
lactation cycle indicates its importance in mammary lipogenesis (Mellenberger et al., 
1973). 
Acetyl CoA Carboxylase is an enzyme complex of two polypeptide subunits 
with molecular weight of 230kD. Each subunit contains catalytic domains of biotin 
carboxylase, transcarboxylase, biotin carboxyl carrier protein and the regulatory 
allosteric site (Wakil et al, 1983). ACC occurs both in catalytically inactive 
protomeric form and active polymeric form (Moore and Christie, 1979). The activity 
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of ACC is regulated by interconversion between these two forms. The active 
polymeric form is promoted by citrate while inactive polymeric form is promoted by 
malonyl CoA and other long chain fatty acids (Moore and Christie, 1979). Covalent 
modifications can also regulate ACC activity. Phosphorylation of ACC by cyclic 
AMP-dependent protein kinase lowers the specific activity, while dephosphorylation 
reverses it to high specific activity (Dils, 1983). The phosphorylation of ACC is 
accompanied by depolymerisation to its protomeric form (Lent et al., 1978). Citrate 
seems to have allosteric control over ACC through covalent modification as 
physiological concentrations of citrate have been shown to activate the 
dephosphorylated ACC (Witters et al., 1979). 
 
Elongation of fatty acid chain 
 The second step in the de novo fatty acid synthesis involves fatty acid 
synthetase (FAS), which catalyses elongation of acetyl/butyryl CoA to long chain 
fatty acids by malonyl CoA. FAS is the largest known multifunctional enzyme 
composed of two identical polypeptide subunits of molecular weight 263kD. Each 
peptide unit is a complex of seven enzyme units, including acetyl transacylase, 
malonyl transacylase, beta-ketoacyl synthetase, beta-ketoacyl reductase, dehydratase, 
enoyl reductase and thioesterase I, and an acyl carrier protein (ACP) site (mol wt. 
10kD) with it’s 4' phosphopantetheine group (Wakil et al., 1983). 
 The first step, referred to as the priming reaction, is catalyzed by acetyl 
transacylase, where acetyl CoA / butyryl CoA condenses on to a cystein residue of 
beta- ketoacylsynthetase. Though both acetyl CoA and butyryl CoA can be used as 
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the primers, butyryl CoA is the preferred primer in ruminants (Lin and Kumar, 1972). 
The priming reaction is followed by esterification of the 4' phosphopantetheine 
residue of the ACP by malonyl transacylase. The acetyl group is then transferred from 
the cystein residue to the ACP. A condensation reaction between acyl and malonyl 
groups of acetyl CoA and malonyl CoA form the acetoacetyl group bound to ACP. 
The acetoacetyl ACP undergoes reduction, dehydration, and reduction by the 
enzymes beta–ketoacyl reductase, dehydratase and enoyl reductase, respectively and 
give rise to butyryl ACP. The butyryl group transfers to the cysteine group of beta-
ketoacyl synthetase enzyme and the vacant 4' phosphopantetheine residue of the ACP 
is esterified by malonyl CoA. The butyryl group is transferred back to ACP and the 
process of condensation followed by other steps is repeated. Each cycle lengthens the 
fatty acyl ACP chain by the addition of two carbons at the carboxyl end of the fatty 
acid. Finally the chain elongation is terminated by reaction catalyzed by the enzyme 
thioesterase I.  
 The fatty acid termination process leading to the synthesis of the short- and 
medium-chain fatty acids in milk of ruminants are not completely elucidated 
(Bauman and Davis, 1974). However, based on  in vitro studies it is proposed that the 
pattern of fatty acids synthesized in the mammary tissue can be changed by altering 
the concentrations of acetyl CoA and malonyl CoA. Increasing the ratio of acetyl 
CoA:malonyl CoA increases the proportion of small- and medium-chain fatty acids, 
while a decrease in the ratio increases the proportion of the long-chain fatty acids 
(Bauman and Davis, 1974). Similarly, altering the levels of ACC and FAS can affect 
the pattern of milk fatty acids (Bauman and Davis, 1974). Increasing the amounts of 
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FAS relative to ACC resulted in higher short and medium milk fatty acids, while 
increased ACC reversed the pattern. The shifts in the pattern of milk fatty acids were 
attributed to the competitive nature of acetyl CoA and malonyl CoA to bind to ACP. 
The binding of acetyl CoA to ACP instead of malonyl CoA led to the termination of 
the growing fatty acyl chain (Bauman and Davis, 1974). 
 Due to rumen biohydrogenation, very small amounts of unsaturated long 
chain fatty acids are absorbed from the intestine in ruminants. Unsaturated long chain 
fatty acids with one double bond are produced in the mammary gland. The enzyme 
fatty acyl CoA desaturase can desaturate  myristic (C14:0), palmitic (C16:0), and 
stearic acid (C18:0) to the respective C14:1, C16:1, and C18:1 monounsaturated fatty 
acids (Dils, 1983). 
 
Uptake of preformed blood lipids by the mammary gland 
The serum lipids of the lactating cow are predominantly present as high-
density lipoproteins (HDL) (92%), low-density lipoproteins (LDL) (7%) and very low 
density lipoprotein (VLDL) (1%) (Raphael et al., 1973). About 2% of the serum 
lipids are associated with chylomicrons (Wendlant and Davis, 1973). The serum 
VLDL of lactating cows contains 57% triacylglycerol, while LDL contains 12% 
triacylglycerol. Under normal conditions, about 90% of the fatty acids in plasma 
triacylglycerol or non esterified fatty acids (NEFA) consist of 16:0, 16:1, 18:0 and 
18:1 (Moore and Christie, 1979). Most esterified fatty acids taken up by the 
mammary gland are from chylomicrons and VLDL (Moore and Christie, 1979). The 
enzyme, lipoprotein lipase (LPL) bound to the capillary endothelial surface plays a 
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major role in this process (Moore and Christie, 1979). Triacylglycerols in the 
chylomicrons adhering to the luminal surface of the endothelium are hydrolyzed by 
LPL. It is presumed that LPL is involved in the attachment of chylomicrons to the 
endothelium, as LPL can adsorb chylomicrons as shown by in vitro studies (Moore 
and Christie, 1979). Hydrolysis of triacylglycerols by LPL is seen only in 
chylomicrons attached to the capillary endothelium and is initiated by the cleavage of 
an acyl ester bond in position sn-1. A part of the diacylglycerols may be further 
hydrolyzed at the luminal surface. The resulting monoacylglycerols and 
diacylglycerols are transported across the endothelial cells through microvesicles 
(Moore and Christie, 1979). Hydrolysis of the diacylglycerols continues in the 
microvesicles and the products are released at the sub endothelial space where the 
monoacylglycerols are hydrolyzed into free fatty acids and glycerol. The free fatty 
acids, monoacylglyceols and glycerol entering the mammary alveolar cell can be used 
for milk fat synthesis.  A part of the glycerol, the magnitude of which depends on the 
glycerokinase activity in the mammary tissue and the free fatty acids produced at the 
endothelial surface, also enters the blood flow (Moore and Christie, 1979). 
 
Synthesis of triacylglycerol 
 Fatty acids and sn2 monoacylglycerol/glycerol 3-phosphate are required for 
the biosynthesis of triacylglycerol. The fatty acids arise either from de novo synthesis 
or are derived from the circulating blood lipids (Moore and Christie, 1979). The fatty 
acids are activated to CoA thioester by ATP-dependent acyl CoA synthestases. 
Glycerol-3-phosphate originates either from triose phosphate through glycolysis or 
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through phosphorylation of glycerol originating from hydrolysis of triacylglycerol 
(Bauman and Davis, 1974). About 70% of the glyceride glycerol in the mammary 
gland of the cow is derived from glucose through glycolysis (Luick and Kleiber, 
1961). The remaining arises from the phosphorylation of free glycerol by the enzyme 
glycerokinase (Bauman and Davis, 1974). 
 The triacylglycerol biosynthesis in the mammary gland can occur through 
three different pathways - sn-glycerol 3-phosphate pathway, monoglyceride pathway 
and dihydroxyacetone pathway. Of the three, the sn-glycerol 3-phosphate pathway is 
the principal route for triacylglycerol synthesis in bovine mammary gland (Dils, 
1983). In the sn-glycerol 3-phosphate pathway, the glycerol 3-phosphate is acylated 
sequentially on positions sn1 and sn2 to form phosphatidic acid. The enzyme 
phosphatidate phosphatase hydrolyses the phosphate at the sn-3 position resulting in 
the formation of diacylglycerol. The diacylglycerol is acylated by specific 
acyltransferases to form triacylglycerol (Moore and Christie, 1979). The sn3 position 
is acylated last in the biosynthesis of triacylglycerol. 
The positional distribution of fatty acids on glyceride glycerol of milk fat in 
ruminants shows that the short chain fatty acids (C4-C6) are almost exclusively 
(95%) esterified to the sn-3 position. All of the C4:0, 93% of C6:0, and 63% of the 
C8:0 are esterified to sn-3 position (Jensen et al., 1991). The distributions of other 
fatty acids in the triacylglycerol appear to vary depending on the molecular weight of 
the triacylglycerol (Parodi, 1982). The C10:0, C12:0 and C14:0 fatty acids are 
predominantly found in the sn-2 position. Palmitate (C16:0) is almost equally 
distributed between the sn-1 and sn-2 positions. Oleate (C18:1) is preferentially 
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distributed in the sn-3 position in high molecular weight triacylglycerols and at  sn-1, 
in the low molecular weight triacylglycerol.  Stearate (C18:0) selectively esterifies at 
sn-1 position (Parodi, 1982). The concentration of palmitate increases at the position 
sn-2 with the increase in the molecular weight (Bauman and Davis, 1974). The 
unsaturated fatty acids are preferentially esterified at sn-3 position in higher 
molecular weight triacylglycerols. Though the exact mechanisms involved in the 
positioning of the fatty acids in milk fat triacylglycerol in ruminants is not clearly 
understood, specific mammary acyltransferases may be involved  (Parodi, 1982). 
    
Lipid metabolism in liver in relation to milk fat synthesis 
 In ruminants, liver does not play a major role in fatty acid synthesis and  de 
novo fatty acid synthesis is very low (Hanson and Ballard, 1967; Hood et al., 1980). 
Also, liver has low levels of LPL and hepatic triacylglycerol lipase (Emery et al., 
1992) and therefore takes up fatty acids mostly through endocytosis of 
triacylglycerols (Emery et al., 1992). The uptake of fatty acids depends on the plasma 
concentration of NEFA and the rate of blood flow to the liver (Bell, 1979). The 
uptake of NEFA could occur by a simple diffusion which is directly related to the 
concentration of NEFA in the blood or through facilitated transport by the liver-fatty 
acid binding protein (L-FABP), fatty acid translocase and fatty acid transporter 
protein (FTP) (Abumrad et al., 1998). 
 In liver, fatty acids may be stored as trigacylycerols, secreted in bile or as 
lipoproteins, or oxidized to carbon dioxide, acetic acid or ketone bodies (Emery et al., 
1992). Hepatic fatty acid oxidation in ruminants is regulated by the rumen 
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fermentation products acetate and propionate. Their conversion to malonyl CoA, 
inhibits carnithine acyl transferase enzyme, essential for the transport of fatty acids 
into mitochondria, for β oxidation (Jesse et al., 1986; Reid and Husbands, 1985). 
Propionate, when metabolized into glycerol, diverts the fatty acids to storage by 
esterification rather than oxidation (Jesse et al., 1986). 
 Due to increased fatty acid mobilization, there is an increased influx of NEFA 
into the liver during late gestation and early lactation.  Hypergluconemia 
accompanied by hypoinsulinemia can decrease liver concentrations of malonyl CoA 
leading to increased oxidation of fatty acids, producing ketone bodies (Zammit, 
1990). In ruminants, the release of triacylglycerol from the liver is slower than in 
monogastrics due to insufficient rates of apolipoprotein B synthesis (Grummer, 
1993). The slower rate of triacylglycerol release and more rapid rate of synthesis lead 
to the accumulation of triacylglycerol in the liver (Emery et al., 1992) in the transition 
period.  
 
Lipid metabolism in adipose tissue in relation to milk fat synthesis 
 In contrast to monogastrics where liver is an active site of fatty acid synthesis, 
adipose tissue is the major site of fatty acid synthesis in non-lactating ruminants. 
Specific metabolic alterations in lipid synthesis and mobilization occur during 
pregnancy and lactation. Adipose lipid synthesis is decreased during middle to late 
pregnancy, while  lipolysis is stimulated to meet the energy needs of the mammary 
gland during lactogenesis. In an in vitro study with bovine adipose tissue obtained at 
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different stages of pregnancy and lactation, McNamara and Hillers (1986b) observed 
a 95% decrease in lipogenesis and a 50% decrease in fatty acid esterification at one 
month postpartum compared to one month prepartum cows. Lipogenesis and 
esterification rebounded back to higher rates during mid-lactation (McNamara and 
Hillers, 1986a,b). Rates of lipogenesis and lipolysis in the adipose tissue depended on 
the production potential and the dietary energy level of the animal (McNamara, 
1991).  
 A decrease in adipose tissue lipogenesis reflects a decrease in FAS, fatty acid 
dehydrogenases and LPL enzyme activities (Smith and Walsh, 1988). A large 
decrease in LPL activity during early lactation was observed  in animals with a 
negative energy balance (Smith and Walsh, 1988, Chilliard, 1993) but not when the 
animals were in positive energy balance (McNamara et al., 1987).  
 Lipolysis in adipose tissue is regulated by hormone sensitive lipase (HSL), 
which catalyses the release of free fatty acids and glycerol from stored 
triacylglycerides. McNamara (1991) reported that the activity of HSL increased 
during lactation and was highest in the high production group fed low-energy diets 
and remained elevated even after the energy balance returned to a positive state. 
Glycerol can not be recycled by the adipose tissue; therefore, glycerol release and 
blood glycerol concentrations have been used as indirect indicators of HSL activity 
(McNamara, 1991). Rates of lipolysis depend on the amount of the enzyme and the 
proportion of its active form. Relative rate of release of individual fatty acids from 
adipose tissue during lipolysis is not necessarily associated with their relative 
proportion in adipose tissue triacylglycerols for reasons not yet clear (McNamara, 
 
 17
1991).  Smith and McNamara (1990) reported that the HSL activity peaked at 
approximately 60 days postpartum and then declined as the animals began to regain 
reserves. The HSL activity is regulated by changes in the balance of insulin and 
glucagons, catecholamines, adenosine and prostaglandin E isoforms in response to 
dietary energy supply in relation to the needs of the animal (McNamara, 1991).  
 In adipose tissue, lipolysis and fatty acid esterification proceed continuously. 
The balance of the two processes is determined by the energy states and by short and 
long term hormonal control (Vernon, 1980). During early and mid pregnancy, the 
animal is in positive energy balance and there is an increased esterification in the 
adipose tissue. During late pregnancy and early lactation the animal moves into a 
negative energy balance due to increased demand by the fetus and onset of lactation 
resulting in increased lipolysis (Vernon, 1980). Adipose tissue switches from a 
primarily anabolic state in early and mid pregnancy to a catabolic state in late 
pregnancy and early lactation (McNamara, 1991). The majority of these adaptations 
could be accounted for primarily by insulin and glucagon while sex steroids, growth 
hormone and prolactin are also important as they are involved in metabolism of 
pregnancy and lactation (McNamara, 1991). In addition, nor-epinephrine released 
from the sympathetic nervous system regulates lipolysis directly by activating HSL 
(McNamara, 1991). 
 
Dietary factors affecting milk fat synthesis and composition 
 Dietary factors have a profound influence on milk fat synthesis and 
composition by providing long-chain fatty acids or indirect supply of precursors for 
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milk fatty acid synthesis. Milk fat content and composition are affected by dietary 
factors including amounts, sources and fatty acid profiles of the diet, forage physical 
form and forage to concentrate ratio. 
 
Fatty acid profile of the diet 
 Generally, forages contain small amounts of fat (1-3%) containing primarily 
unsaturated fatty acids such as linoleic acid (C18:2; 13 g/100 g FA) and linolenic acid 
(C18:3; 60 g/100 g FA) (Christie, 1981). Supplemental oil seeds are sources of oleic 
(C18:1) and linoleic acids, while fish oil is the only source of eicosapentaenoic acid 
(C20:5) and docosahexaenoic acid (C22:6). 
 Fat supplements derived from cottonseed, soybean and sunflower seed have 
greater than 50% polyunsaturated fatty acids (PUFA) , whereas tallow, canola meal, 
sunflower and safflower are relatively high in monounsaturated fatty acids 
(Grummer, 1991). In addition to the fatty acid composition,  the form of 
supplemented fat affects milk fat percentage. Feeding free oil depressed milk fat 
yield, while fat supplemented as part of cottonseed and soybean seeds had no effect 
(Mohamed et al., 1988). In contrast, ground oil seeds seem to have more effect in 
decreasing milk fat compared to ungrounded oil seeds, possibly due to quicker release 
of oil in ground seeds due to loss of protection in the rumen (Grummer, 1991). 
Physical form of the forage 
 Quality and quantity of forage has an effect on the milk fat concentration. 
Woodford et al. (1986) reported a linear increase in milk fat percentage from 3.5 to 
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4.0% when forage was increased from 28 to 53% of diet dry matter. Depression of 
milk fat percentage was prevented when forage mean particle size was greater than 
0.64 cm possibly due to increased chewing time, leading to higher saliva production 
that helped to maintain rumen pH (Woodford et al., 1986).  
 
Forage to concentrate ratio 
 Reducing the forage to concentrate ratio in diets generally results in decreased 
milk fat percentage if the forage level falls below 50% of the total diet. The decrease 
in milk fat accelerates when the proportion of concentrate in the diet is more than 
60% and the depression in milk fat percentage can be as much as 50% of normal with 
diets containing more than 70% concentrate (Doreau et al., 1999). Sutton (1989) 
reported a decrease of 0.17 % in milk fat per 1% decrease in dietary ADF 
concentration in the dry matter. Earlier, Erdman (1988) reported an increase of .056% 
in milk fat for each percentage increase in ADF. 
 Replacing high-forage diet with low-forage diet decreased yields of all fatty 
acids with exception of C18:2(Gaynor et al., 1995;  Griinari et al., 1998).  The C6:0 
to C16:0 content of milk fat is typically reduced and proportions of C18:1 and C18:2 
are increased when low roughage diets are fed (Grummer, 1991). Gaynor et al. (1995) 
reported increases in the total trans 18:1 fatty acids and proportions of C18:1 and 
C18:2 in milk fat when the diet constituted 80% concentrate.  Similar results for total 
trans 18:1 were reported by Kalscheur et al. (1997) but other milk fatty acid did not 
vary significantly between cows fed  diets containing 40 or  75% concentrate. 
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Fat source and level of fat supplementation 
 Supplementation of vegetable oils, oilseeds and marine oils decreases the milk 
fat content, while there appears to be only a moderate effect when animal fat sources 
are fed (Chilliard et al., 2001). Meta-analysis of data from  studies with protected and 
unprotected tallow showed increased milk fat yield with protected tallow. This was 
mainly due to a substantial increase in stearic and oleic acids coupled with a decrease 
in medium-chain fatty acids (Chilliard et al., 2001). In the same study, using 
unprotected tallow caused similar changes in medium-chain fatty acids but smaller 
increases in the long-chain fatty acids (Chilliard et al, 2001). Use of animal-vegetable 
oil blends, calcium soaps, hydrogenated vegetable fat and saturated fatty acids as 
supplements decreases C8:0 to C15:0 fatty acids. Changes in C16:0, C18:0 and C18:1 
were dependent on C16:0 and C18:0 fatty acid contents of the respective supplements 
(Palmquist et al., 1993). In addition, interactions between fat source and forages in 
the basal diet may influence the animal response (Onetti and Grummer, 2004) 
possibly by their combined effect on rumen biohydrogenation. 
 The level of fat supplementation seems to have a direct effect on the milk fatty 
acid composition. Grummer (1991) reported an inverse relationship between level of  
fat supplementation and the proportion of C4: 0 to C14:0 milk fatty acids, synthesized 
de novo in the mammary gland. The decrease in short- and medium-chain fatty acids 





 Most ruminant diets contain at least of some amounts (2%) of unsaturated 
fatty acids, the composition of which depends on the type of feed ingredients. A 
forage-based diet would have linolenic acid as the predominant fatty acids while diets 
with oil seeds or oil supplements would have higher concentrations of oleic and 
linoleic acids. In the rumen, dietary lipids are hydrolysed to free fatty acids by 
microbial lipases and the unsaturated free fatty acids are biohydrogenated to saturated 
fatty acids by rumen microbes (Harfoot and Hazlewood, 1988). Rumen bacteria are 
predominantly involved in biohydrogenation and the process involves several steps 
(Fig 2.1). 
Figure 2.1.  Rumen biohydrogenation pathway  
 
(Harfoot and Hazlewood, 1997) 
 
The first step in biohydrogenation of both linoleic (18:2, c9, c12) and linolenic acid 
(18:3, c9, c12, c15) involves the isomerization of cis12 double bond to trans 11 
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double bond to form conjugated cis/trans double bond intermediates. Further 
reduction of the conjugated dienoic acids to monoenoic acids is accompanied with 
considerable double bond migration and formation of a variety of positional trans -
18:1 isomers. (Griinari and Bauman, 1999; Mosley et al., 2002). Trans 11-18:1 is the 
major end product in this first step of biohydrogenation. The second step of 
biohydrogenation involving hydrogenation of trans 11-18:1 to stearic acid occurs 
very slowly and is considered rate limiting in the complete biohydrogenation  
sequence of PUFA (Kemp and Lander, 1984). Both steps of biohydrogenation 
involve separate groups of rumen bacteria (Harfoot and Hazlewood, 1988).  
 Changes in ruminal pH can result in a shift in microbial populations and 
related . changes in the profile of biohydrogenation end products (Griinari and 
Bauman, 1999). Diets with low roughage and high concentrate and/or containing 
higher PUFA supplements reduce the pH in the rumen, affecting the ruminal 
microflora. The altered ruminal microflora affects the rumen biohydrogenation 
process, leading to increased accumulation of biohydrogenation intermediates, 
predominantly consisting of trans-18:1 isomers (Kalscheur et al., 1997). The pattern 
of trans-18:1 and CLA isomers formed during biohydrogenation, depends largely on 
the dietary profile of unsaturated fatty acids (Loor et al., 2002). Using modeling 
analysis, Harvantine and Allen (2006) reported that increasing dietary unsaturated 
fatty acids stimulated the extent of 18:2 and 18:3 biohydrogenation, but inhibited the 
extent of 18:1 and trans 18:1 fatty acid biohydrogenation, leading to accumulation of 
the latter in the rumen. 
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 In the rumen, the trans-18:1 fatty acids and the CLA isomers are adsorbed to 
ruminal digesta and pass to the duodenum, the site of nutrient absorption. About 80% 
of trans-18:1 fatty acids  in the duodenal flow enter the lymphatic system without any 
selective absorption of individual isomers (Bickerstaffe et al., 1972). The intestinal 
epithelium has small amounts of stearoyl-CoA desaturase activity which is evident 
from increased levels of cis-octadeca-9-enoate (18:1) in the lymph compared to the 
levels in the duodenum (Bickerstaffe et al., 1972). 
  Similarly, there appears to be no selectivity in the uptake of different trans-
18:1 fatty acids and CLA isomers by the mammary tissue. In the mammary tissue, 
some of the trans-18:1 fatty acids (especially trans-11) are further desaturated by the 
enzyme stearoyl-CoA desaturase to give rise to c9t11-CLA. Most of c9t11-CLA 
originates from desaturation of trans-11 18:1 fatty acid, making it the predominant 
CLA in cow’s milk fat. The contribution of endogenously synthesized CLA to milk 
fat is much greater than the CLA originating from the rumen (Piperova et al., 2002).  
 
Trans-18:1 fatty acids and CLA in milk fat depression  
 Experiments (Gaynor et al., 1994; Romo et al., 1996; Baumgard et al., 2000; 
Piperova et al., 2004) have shown the involvement of either trans-18:1 and/or CLA 
isomers in milk fat depression. Teter et al. (1990) reported decreased milk fat in 
lactating mice fed trans-18:1 fatty acids regardless of the level of a fat or essential 
fatty acid content in the diet. In dairy cows, abomasal infusion of fat mixture 
containing trans-18:1 fatty acid significantly reduced milk fat content (Gaynor et al., 
1994; Romo et al., 1996). The involvement of trans-18:1 fatty acids in MFD was 
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further investigated in  feeding studies with dairy cows fed high grain diets with or 
without buffers (Kalscheur et al., 1997). Milk fat depression was observed with 
increased trans-18:1 fatty acid flow to the duodenum and increased trans-18:1 fatty 
acids in milk fat, irrespective of the origin of the isomers - either from diet or from 
incomplete biohydrogenation of unsaturated fatty acids (Wonsil et al., 1994). Griinari 
et al., (1998) reported a close relationship between MFD and increased trans-10 18:1 
fatty acid in milk fat of dairy cows supplemented with different levels of concentrate 
with either corn oil or dry fat product. However, they did not find any correlation 
between total trans-18:1 fatty acids and fat percentage in milk. Feeding a MFD diet 
consisting of 70% concentrate and 5% soybean oil to lactating Holstein cows 
increased the total milk trans fatty acid content by seven fold predominantly due to an 
increase in trans-10 18:1 fatty acid (Piperova et al., 2000). A small increase in other 
trans-18:1 fatty acid isomers was also seen in addition to significant (P<0.01) 
increases in t10c12-CLA and t7c9-CLA (Piperova et al., 2000). 
  Loor et al. (2005a) reported a five-fold increase in trans-10 18:1 fatty acid in 
milk fat-depressed Holstein cows fed high-concentrate diets with or without linseed 
oil, confirming the possible role of this particular 18:1 fatty acid isomer in MFD. 
During MFD, trans-10 18:1 fatty acid replaces trans-11 18:1 fatty acid as the 
predominant trans FA (Griinari et al., 1998; Piperova et al., 2000). While these 
experiments suggest trans-10 18:1 isomer a potential inhibitor of fat synthesis, 
abomasal infusion of pure trans-10  18:1 does not support such an effect in lactating 
cows (Lock et al., 2007) . Further, an increase in milk concentrations of other trans-
18:1 isomers during  MFD suggests possible involvement of these isomers in MFD. 
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For example, Pretch et al. (2002) reported a significant increase in trans 6+7+8-, trans 
13+14-18:1 fatty acids in high-yielding Holstein Friesian cows supplemented with 
rumen-protected fatty acids. However, they did not report the changes in milk fat 
percentages in the study. Significant (P<0.001) negative correlation was seen between 
trans 6+7+8-, trans 9-, trans 10- and trans-11 18: 1 and milk fat percentage in 
Holstein cows fed dry ground corn grain or high-moisture corn (Bradford and Allen, 
2004). 
 Among the CLA isomers, the role of t10c12-CLA in MFD has been well 
established.  Using  abomasal infusion of purified t10c12-CLA in Holstein cows 
Baumgard et al. (2000) identified t10c12-CLA  as the isomer responsible for MFD.  
A curvilinear response was observed between levels of t10c12-CLA and MFD in 
abomasally-infused lactating animals (Peterson et al., 2002). Abomasal infusion of 
c9t11-CLA had no effect on milk fat in lactating Holstein cows (Baumgard et al., 
2000) suggesting that this major CLA isomer is not involved in MFD. Similarly, 
abomasal infusion of fat mixtures enriched in t8c10-CLA and c11t13-CLA failed to 
depress milk fat content in lactating cows (Perfield et al., 2004). Although t10c12-
CLA has been shown to directly depress milk fat, changes in concentrations of milk 
t10c12-CLA during diet-induced MFD have been insufficient to account for the 
reduction in milk fat content. Piperova et al. (2004) reported decreased milk fat in 
lactating dairy cows without increase in t10c12-CLA when the animals were fed Ca 
salts of trans 18:1 fatty acids and CLAs. Similarly, other studies (Bradford and Allen, 
2004; Loor et al. 2005a) reported the absence of any correlation between t10c12-CLA 
and milk fat content of diet-induced MFD.  These findings suggested possible 
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involvement of other fatty acid isomers in MFD. Recently, at least two other CLA 
isomers  t7c9-CLA (Piperova et al., 2002) and t9c11-CLA (Perfield et al., 2005) were 
shown to increase in milk fat during MFD and were strongly negatively correlated to 
milk fat content  These combined results  suggest that further studies are needed to 
determine the  fatty acid isomers involved in  MFD. 
 
Molecular mechanisms involved in milk fat depression 
 During MFD, the decrease in milk fat has been attributed predominantly to 
inhibition of de novo fatty acid synthesis. The decrease in short- (C4 to C8) and 
medium-chain (C10 to C16) fatty acids in milk fat could affect the formation of 
mammary triacylglycerol  synthesis and, in part, could explain the decrease in milk 
fat content (Loor and Herbein, 1998; Baumgard et al., 2002). Our previous 
experiments and studies by others have provided evidence that mRNA abundance and 
gene expression of key lipogenic enzymes were inhibited during dietary MFD 
(Piperova et al., 2000; Peterson et al., 2003). Similarly, addition of fish oil to dairy 
cow diets decreased the mRNA abundance of ACC, FAS and SCD in mammary tissue 
(Ahnadi et al., 2002). The reduction observed in mRNA abundance correlated with 
the degree of MFD (Ahnadi et al., 2002; Peterson et al., 2003). Peterson et al.(2003) 
reported that in addition to ACC and FAS, dietary-induced MFD down regulated the 
expression of GPAT, AGPAT, SCD and LPL in lactating mammary gland. Abomasal 
infusion of t10c12 CLA reduced mRNA abundance for lipogenic enzymes involved 
in de novo fatty acid synthesis, fatty acid uptake and transport, desaturation of fatty 
acids and triacylglycerol synthesis in the mammary tissue explants obtained from the 
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infused animals (Baumgard et al., 2002). In the bovine mammary cell line (MAC-T), 
mRNA abundance for ACC, FAS and SCD was decreased within 48 hrs of incubation 
with t10c12 CLA, but not with c9t11 CLA (Peterson et al., 2004). Similarly, ACC, 
FAS and SCD mRNA abundance was reduced by feeding t10c12 CLA, c9t11 CLA 
and t11-18:1 to lactating mice (Lin et al., 2004).  
 Each of these MFD studies suggests that the lipogenic enzymes are possibly 
regulated through a common pathway or mediator at the level of gene expression. The 
role of the transcription factors, sterol response element binding protein-1 (SREBP-1) 
and thyroid hormone response protein (THRSP) have been suggested (Peterson et al., 
2004; Harvatine and Bauman, 2006). However, Bionaz and Loor (2008) have 
questioned the proposal that SREBP1 is the central regulator of milk fat synthesis and 
have suggested a pivotal role for PPARγ and INSIG1.  
 
 Sterol response element binding protein (SREBP) 
 Sterol response element binding proteins (SREBPs) are the transcriptional 
factors associated with regulation of cholesterol and lipid metabolism. They activate 
the expression of at least 30 enzymes involved in the synthesis of cholesterol and 
lipids (Horton et al., 2003). There are three isoforms of SREBP- 1a, 1c and 2. The 
isoform SREBP-1a is involved in regulation of both fatty acid and cholesterol 
metabolism while SREBP-1c and SREBP-2 are involved in fatty acid metabolism and 
cholesterol metabolism, respectively. The isoform SREBP-1c is found predominantly 




 SREBP is a membrane-bound precursor protein found in endoplasmic 
reticulum with a molecular weight of 125kDa comprising 1150 amino acids present in 
three domains. The first, NH2 – terminal domain (~ 480 amino acids) contains a basic 
helix-loop-helix leucine zipper domain that functions as a transcription factor. The 
second domain (~80 amino acids), consists of two trans-membrane helices linked by 
a short (~31 amino acid) loop protruding into the lumen of the endoplasmic 
reticulum. The third domain (~590 amino acids), consists of the COOH- terminal 
segment (Brown and Goldstein, 1997). The positioning of the three domains gives a 
hairpin shape to the molecule with the first and the last domains extending into the 
cytosol. SREBP binds to SREBP cleavage activating protein (SCAP) at the third 
domain and is anchored to the endoplasmic reticulum membrane through INSIG 
proteins (Horton et al., 2002; Yang et al., 2002). SCAP contains a sterol sensory 
domain which senses the concentration of sterols in the cell. Whenever the sterol 
concentrations in the cells are low, the SREBP-SCAP complex is detached from 
INSIG proteins, and SCAP escorts it to golgi. It is sequentially cleaved by two 
proteases, site1 protease (S1P) and site 2 protease (S2P) to release a 68-kDa mature 
SREBP. The mature protein translocates to the nucleus and binds to sterol response 
elements (SRE) in the promoter region of the lipogenic genes, activating the 
transcription process. Additional recruitment of co-activator proteins is necessary for 
complete transcriptional activation by SREBP-1a and SREBP-2. However, no reports 
are available on the recruitment of co activator proteins by SREBP-1c (Edwards et 
al., 2000). Though, SREBP-1a and SREBP-1c have similar action on regulation of 
lipogenic genes, SREBP-1a is 5 to 12 times more potent than SREBP-1c in activating 
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the target genes, possibly due to differences in the acidic transcription activating 
domains at the NH2 – terminal domain ( Pai et al., 1998).  
 Dietary polyunsaturated fatty acids are known to decrease the production of 
fatty acids in the liver by down regulating genes encoding lipogenic enzymes and up 
regulating genes encoding proteins, and/or enzymes involved in fatty acid oxidation 
(Jump et al., 1994; Xu et al., 1999; Clarke, 2001). Feeding PUFA to mice decreased 
mature SREBP-1 while mRNA or the precursor SREBP bound to membranes were 
only slightly reduced, indicating that the effect of PUFA is mediated by a decrease in 
the mature form of SREBP-1 in liver (Yahagi et al., 1999). The decrease in mRNA 
levels of lipogenic genes corresponded to the pattern of suppression in mature 
SREBP-1. Dietary PUFA did not affect the lipogenic gene expression in transgenic 
mice in which high amounts of the mature form of SREBP-1 in the liver were over 
expressed. The transgenic mice had transgene-encoded amino acids 1-436 of human 
SREBP-1c under the control of the PEPCK promoter and the protein terminated 
before the transmembrane segment, which enabled it to enter the nucleus directly 
without a requirement of proteolysis and over expression of SREBP-1. This 
confirmed the role of mature SREBP-1 in the regulation of lipogenic genes (Yahagi et 
al., 1999). 
 Feeding fish oil to mice reduced precursor SREBP-1, precursor SREBP-2, 
SREBP-1c mRNA and mature SREBP-1 but did not alter SERBP-1a mRNA 
suggesting that the mature form was reduced due to down regulation of SREBP-1c 
mRNA (Kim et al., 1999). Hepatic (HepG2) cells treated with PUFA significantly 
decreased precursor SREBP-1 (Xu et al., 1999) and hepatic abundance of SREBP-1 
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mRNA (Mater et al., 1999; Xu et al., 1999) along with mature SREBP-1. Similarly, 
HEK-293 cells treated with different unsaturated fatty acids decreased mRNA levels 
of SREBP-1a and SREBP-1c in addition to the respective mature proteins (Hannah et 
al., 2001). Increases in chain length and degree of unsaturation increased the 
effectiveness of fatty acids to reduce  the mature SREBP-1 (Hannah et al., 2001). In 
the same study, production of SREBP-1a by a cDNA expressed from an independent 
promoter decreased mature SREBP-1a without changing the concentrations of 
mRNA. Also, when mature SREBP-1a was expressed from an independent promoter 
engineered to express the truncated form of SREBP-1a that enters the nucleus with 
out a requirement for proteolysis, fatty acids did not change the concentrations of 
mature SREBP1. The authors concluded that the fatty acids could down regulate 
mature SREBP by two mechanisms: one at the level of mRNA expression and the 
other at the proteolytic processing of the precursor protein. At the mRNA level, the 
regulation may occur either at transcriptional or post-transcriptional levels. The post-
transcriptional regulation, in addition to suppression of proteolytic cleavage of 
SREBP-1, occurs through accelerating the decay of mRNA as demonstrated in rat 
hepatocytes in monolayer culture (Xu et al., 2001). The transcriptional regulation of 
SREBP-1 mRNA involves two factors - a feed-forward regulation by mature SREBP-
1 and liver X- activated receptors (LXRs) (Horton et al., 2002). 
 LXRs are nuclear receptors activated by oxysterols, the intermediates of 
cholesterol synthesis, and form active heterodimers with RXRs (retinoid X receptors). 
LXR enhances transcription of SREBP-1c by binding to LXREs (LXR response 
elements) in the promoter region. PUFA antagonizes the activation of LXR by its 
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endogenous ligands (Ou et al., 2001) and inhibits the binding of LXR/RXR 
heterodimer to the LXREs in the SREBP-1c promoter (Yoshikawa et al., 2002) 
thereby reducing the activation of SREBP-1c expression. 
  The SREBP-1c promoter region in mouse has one putative nuclear factor Y 
(NF-Y) binding site, in addition to two LXR-response elements and one sterol 
regulatory element (SRE). The mature SREBP binds to SREs in the promoter region 
to activate the gene transcription and further requires the binding of NF-Y and/or SP-
1 binding in the nearby sites (Amemiya-Kudo et al., 2000). 
 These studies indicate the involvement of multiple steps in the regulation of 
lipogenic gene expression and confirm that the regulation occurs through altering the 
content of mature nuclear SREBP-1c. However, deletion of SREBP-1c resulted in 
~50% reduction in fatty acid synthesis and expression of lipogenic genes was not 
completely suppressed  in the SREBP-1c knockout mouse (Liang et al., 2002). This 
indicated the possible involvement of other transcriptional factors like ChREBP in 
regulation of lipogenic genes.A series of in vitro studies in primary culture 
hepatocytes has shown that glycolytic and lipogenic gene expression is synergistically 
regulated by SREBP-1c and ChREBP (Dentin et al., 2004).  
 
Carbohydrate response element-binding protein  
 The transcription factor, ChREBP is activated in response to high glucose 
concentrations in the liver and up regulates the lipogenic genes upon binding to 
glucose response elements (Uyeda et al., 2002). Studies with knockout mice for 
SREBP1c-/- have confirmed the role of ChREBP in coordinated control of glucose 
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metabolism, fatty acid synthesis and triacylglycerol synthesis (Lizuku et al., 2004). 
 ChREBP has a molecular weight of 94.6 kDa with 864 amino acids and 
contains several domains – nuclear localization signal (NLS) near the N-terminus, 
polypropylene domains, a basic helix-loop-helix leucine zipper (b/HLH/Zip), and a 
leucine-zipper-like domain. It also contains several potential phosphorylation sites for 
cAMP-dependent protein kinase (PKA) and AMP-activated protein kinase (AMPK) 
(Uyeda et al., 2002). 
 ChREBP is regulated reciprocally by the actions of glucose and cAMP 
(Kawaguchi et al., 2002). ChREBP is translocated into the nucleus by a high glucose 
concentration in the cell. The movement of ChREBP from cytosol to nucleus is 
regulated by dephosphorylation of the phosphor-Ser 196 site present closer to the 
NLS site. In the nucleus, the transcription factor binds to DNA upon 
dephoshphorylation of Ser 568 and Thr 666 residues. The dephosphorylation of the 
residues in both the cytosol and the nucleus is mediated by protein phosphatase 2A 
(PP2A) which is activated by xylulose 5-phosphate (X5P), a pentose phosphate 
pathway intermediate (Dentin et al., 2005a). On dephosphorylation of the residues, 
ChREBP interacts with another transcription factor Max-like protein X (Mlx), and 
forms a heterodimeric complex. This complex helps to recognize and bind to 
carbohydrate response elements (ChRE) that are glucose responsive (Stoeckman et 
al., 2004). 
 On the other hand, phosphorylation of the Ser and Thr residues of ChREBP by 
cAMP prevents nuclear translocation and DNA binding. Similarly, AMP activated 
protein kinase (AMPK) prevents DNA binding. This was confirmed by using 5-
 
 33
amino-imidazolecarboxamide ribotide, a specific activator of AMPK in the cell. In 
the same study, a large increase in AMPK activity was seen due to increased 
cytosolic AMP concentration in response to acetate, octanoate and palmitate in 
hepatocytes (Kawaguchi et al., 2002). Similarly, PUFA suppressed ChREBP activity 
by altering its translocation from cytosol to nucleus as a result of decreased xylulose-
5 phosphate concentration (Dentin et al., 2005b). 
 
Peroxisomal proliferator active receptors (PPARs) 
PPARs are members of the nuclear hormone receptor family which consists of 
three isoforms - PPARα, PPARβ and PPARγ, which  are activated upon binding to 
ligands such as fatty acids and fatty acid derivatives.  PPARs heterodimerize with 
retinoid-R-receptor (RXR) and modulate the expression of genes containing 
peroxisone proliferative response elements (PPRE) (Berger and Moller, 2002).  
PPARα is present mostly in liver and is involved in regulation of genes related to FA 
oxidation, while PPARγ is involved in lipogenesis and differentiation of cells in 
adipose tissue (Auwerex, 1999; Smith, 2002). Some of the PPARγ target genes in 
adipose include LPL, CD36, FABP, ACACA, FAS, SCD, ACSL and AGPAT (Way et 
al., 2001).  Although, the role of PPARγ in lipid metabolism in adipose is well 
established, its role in the mammary tissue is not completely explored (Wan et al., 
2007). Bionaz and Loor (2008) reported increased PPARγ expression with the onset 
of lactation in bovine mammary tissue. A simultaneous increase in genes related to 
FA uptake, transport, synthesis and desaturation (Bionaz and Loor, 2008) was also 
observed suggesting that part of the LCFA effects could be mediated through PPARγ.  
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PPARγ has been shown to be important in maintaining the quality of maternal milk 
(Wan et al., 2008). A targeted deletion of PPARγ in the mouse mammary gland led to 
increased oxidizing enzymes and the production of inflammatory lipids, which 
affected the health of the nursing pups (Wan et al., 2008). This suggests that PPARγ 
could play an important role in regulation of mammary lipid synthesis.  
Possible regulatory mechanism in the mammary gland 
 Relatively little work has been done on the molecular mechanisms involved in 
regulation of lipid synthesis in bovine mammary cells. Peterson et al.(2004) reported 
decreased abundance of the mature SREBP-1, whereas no reduction was observed for 
precursor SREBP-1 and mRNA of SREBP-1 in mammary cell lines treated with 
t10c12 CLA. Loor et al. (2005) measured the gene expression profiling in the 
mammary gland of cows fed a MFD diet using  a bovine oligonucleotide microarray. 
While eighteen genes associated with fatty acid metabolism were down regulated, the 
expression of SREBP-1 was not altered (Loor et al., 2005c). However, Harvatine and 
Bauman (2006) suggested a role of  SREBP-1 and THRSP in regulation of milk fat 
synthesis in lactating dairy cows. Nevertheless, in a comprehensive study  on gene 
networks driving milk fat synthesis during lactation in dairy cows, Bionaz and Loor 
(2008) suggested an important role for PPARγ and INSIG1 in regulation of milk fat 
synthesis.  
The results from earlier studies suggest that the regulation of lipogenic genes 
in the mammary gland might occur as a result of changes in transcriptional regulators 
(Havativen and Bauman, 2006; Bionaz and Loor, 2008). MFD induced either by 
altering the diets or by infusion has generally decreased milk fat content by 25 to 
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50%. These dietary interventions were not able to reduce milk fat beyond a certain 
point or completely eliminate the milk fat content. This suggests that, in addition to 
SREBP-1c, mammary lipogenic genes could be regulated by another major 
transcription factor, possibly ChREBP or PPARγ. To my knowledge, the role of 
ChREBP in regulation of milk fat synthesis has not been reported any where in the 
literature.  
 Based on the previous literature review, it is hypothesized that the depression 
in milk fat synthesis due to increased concentrations of trans-18:1 and/or CLA 
isomers in milk could be mediated through their action on the expression of 
transcriptional regulators. In addition to the established role of SREBP1 and THRSP, 
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 The objective of this study was to assess the relationship between individual 
milk fatty acids and diet induced milk fat depression using principal component 
(PCA) and multivariate analysis (MA).  Cow treatment observations (n=63) from 3 
published feeding experiments with lactating dairy cows (Piperova et al., 2000; 
Piperova et al., 2002; and Piperova et al., 2004) were used in the analyses.  In the 
PCA, principal component loading plots 1 (PC1) and 2 (PC2) described 55.9% of the 
total variation in milk FA and fat concentrations. Saturated FA (14:0, 16:0, and 17:0) 
and milk fat percentage showed negative loading for PC1. Trans-18:1 isomers 
(t6+7+8 to t15), t7c9 CLA, and t10c12 CLA showed positive (opposite) loading 
suggesting a negative relationship between these isomers and milk fat percentage.  
Cis11t13 CLA and c9t11 CLA were associated with the PC2 axes (neutral), 
indicating that they were not associated with MFD.  Multivariate analysis with milk 
fat percentage as dependent variable and individual PC1 positive loading variables 
showed a break point relationship for t6+7+8-, t9-, t10-, and t13+14 -18:1 and a linear 
relationship for t11-, t12-, t15-18:1, t10c12 CLA and t7c9 CLA.  Subsequent MA was 
conducted on 41 treatment means from 12 independent experiments from the 
literature where concentrations of t6+7+8-, t9-, t10-, and t11-18:1, and c9t11, and 
t10c12 CLA were reported.  Significant negative effects of t9-18:1, t10-18:1, and 
t10c12 CLA, on milk fat percentage were observed. In this study, the PCA and MA 
analysis showed that among trans-18:1 isomers, t10-18:1 was most negatively 
correlated to milk fat percentage.  However, the threshold concentration related to 
maximum MFD indicated that the relative potency was greatest for t6+7+8- and least 
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for t10-18:1. These results suggested that t6+7+8-18:1 might be more important than 
t10-18:1 in MFD.  Principal component analysis also showed that t10c12, and t7c9 
CLA were the isomers most negatively correlated to milk fat percentage, implying a 
possible role of t7c9 CLA in MFD. Additional experiments are needed to establish 
whether t7-18:1 is involved in MFD or that its effects are mediated via the 
endogenously synthesized t7c9 CLA.  





  It has been demonstrated that conjugated linoleic acid (CLA) and trans-18:1 
fatty acids (FA) arising from incomplete rumen biohydrogenation of dietary poly-
unsatureated FA (PUFA) can markedly alter milk fat synthesis. Numerous studies 
have shown that concentrations of trans-18:1 FA or CLA can be increased in milk via 
dietary means (Griinari et al., 1998; Piperova et al., 2000; Peterson et al., 2003) or 
abomasal infusion (Gaynor et al., 1994; Romo et al., 1996; Chouinard et al., 1999) 
and can cause  reduction of milk fat concentration.  Examination of the isomer profile 
of trans-18:1 FA (Griinari et al., 1998) and CLA (Griinari and Bauman. 1999) 
indicated that an increase in ruminally-derived trans-10-containing 18:1 and 18:2 
isomers in milk was more closely associated with milk fat depression (MFD) than the 
general increase in total trans-18:1 FA or CLA.   It was demonstrated that abomasal 
infusion of partially hydrogenated vegetable oil (PHVO) (Gaynor et al., 1994; Romo 
et al., 1996), or diets supplemented with Ca-salts of trans-18:1 both containing 
isomers from t6 to t16 (Piperova et al., 2004) can cause MFD.  However, when 
individual trans-18:1 isomers, including t9-, (Rindzig and Schultz, 1974), t11-, t12- 
(Griinari et al., 2000) were post-ruminally infused, milk fat was not affected. 
Although high concentrations of t10-18:1 are typically observed in milk fat of 
lactating cows fed MFD diets (Piperova et al.,2000; Peterson et al., 2003; Loor et al., 
2004), abomasal infusion of 40 g/d t10-18:1  was not effective in reducing milk fat 
percentage in lactating cows (Lock et al., 2007).  Baumgard et al. (2000) provided 
convincing evidence that abomasal infusion of t10c12 CLA inhibits milk fat 
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synthesis.  Nevertheless, in an earlier study, Chouinard et al.(1999) observed MFD in 
lactating cows abomasally infused with a CLA mixture lacking t10c12 CLA.   
Feeding experiments have also shown that concentration of t10c12 CLA in 
milk does not always account for the degree of MFD (Peterson et al., 2003) and that 
reduction in milk fat concentration can occur without increases in t10c12 CLA in 
milk (Piperova et al., 2004; Loor et al., 2005a). The t8c10 CLA and c11t13 CLA 
isomers usually present in lower concentrations in commercial CLA mixtures were 
examined by Perfield et al. (2004). They found no effect of these isomers on milk fat 
synthesis.  These collective results suggest that there must be other biohydrogenation 
intermediates besides t10c12 CLA involved with MFD.   
Multivariate analysis (MA) can be applied to visualize the 
multidimensionality of the data to identify underlying variables that may contribute to 
dietary MFD.  Principal component analysis (PCA) is a multivariate technique that 
reduces the dimensionality of data by transforming a number of related variables into 
a set of uncorrelated variables, while retaining as much variation as possible.  The 
transformed new variables, referred to as principal components (PC) are the linear 
combinations of the original variables.  The first PC (PC1) accounts for the maximum 
variability while the remaining PC (PC2, PC3…PCn, n= number of variables) 
account for the remaining variability in the data.  Each PC is independent and 
orthogonal to the other.  Generally, only the first few PC describe the majority of total 
variation in the data as indicated by the Eigen values (Jolliffe, 2002; Kent and Coker, 
1992).   As a means to potentially identify individual FA effects, the objective of this 
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study was to assess the relationship between milk FA and diet induced MFD using 
PCA and MA analysis.  
 
MATERIALS AND METHODS 
Experimental Design and Diets   
 Individual cow within treatment observations (n=63)  from 3 published 
feeding experiments (Piperova et al., 2000;  Piperova et al.,  2002, and Piperova et al., 
2004) with lactating dairy cows conducted at the University of Maryland were used in 
this analysis.  The studies were comprised of diets with different forage to concentrate 
ratios (with or without vegetable oil or buffer addition) and diets supplemented with 
Ca- salts of trans 18:1 fatty acids or CLA.  Diets were formulated to meet the NRC 
(2001) requirements for milk production at 40 kg/d and 3.5% fat.  Details of the 
experiments used in the study are presented in Table 3.1.  In each experiment, cows 
were housed in individual stalls and fed individually.  Forage and concentrate dry 
matter (DM) was measured weekly, and the TMR was adjusted accordingly to 
maintain constant forage to concentrate ratio on a DM basis during the experiment.  
Milk production was recorded at each milking.  At the end of each experimental 






The FA composition of milk samples and Ca-tFA and Ca-CLA supplements 
was determined using FA methyl esters (FAME) prepared by mild trans-esterification 
with 0.04 M H2SO4 in methanol, at room temperature, using GLC conditions 
previously described (Piperova et al., 2000).  Trans-18:1 concentration in milk and 
isomer distribution were determined by a combination of preparative Ag+-thin layer 
chromatography and GLC analysis (Piperova et al., 2000). Argentation-high 
performance liquid chromatography was used to determine CLA isomer distribution 
patterns (Piperova et al., 2000). 
Statistical Analysis 
Relationships between milk FA were evaluated from PCA loading plots, 
based on the correlation matrix, using XLSTAT software (XLSTAT- Pro 7.5.2 for 
windows, Addinsoft, New York, NY).  Relationships between individual milk FA 
concentrations (% of total FAME) and fat percentage on individual cow treatment 
observations were analyzed using NLmixed procedure (SAS, 2000) with a break 
point or simple linear regression model analysis depending on the best fit for each 
individual FA. FA were analyzed only if they were present in all experiments. Data 
for short chain FA were available only in one of the three experiments used and were 
not included in the analysis.   
 The break point analysis used the following model: 
Y= b0 +( b1  * X) + En   
 If X ≤ break point, then: 
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Y=b2+ En  
Where: 
Y= Milk fat% 
b0  &  b2 = Intercept values for Regression Lines 1 and 2 respectively. 
b1 = Slope of Regression Line 1. 
En= Experimental effect. 
The break point in this analysis is the concentration of FA where regression Lines 1 
and Line 2 intercept. 
Subsequent MA were conducted on treatment means (n = 41) from 12 
independently published experiments (Donovan et al., 2000; Loor et al., 2002; 
Peterson et al., 2002b; AbuGhazaleh et al., 2003; 2004; Peterson et al., 2003; 
Shingfield et al., 2003; Loor et al., 2003; 2005a, 2005b; Loor and Herbein, 2003; 
Selberg et al., 2004) that reported concentrations of t6+7+8-, t9-, t10-, t11-18:1 and, 
c9t11 and t10c12 CLA isomers in milk of lactating cows. 
 
RESULTS  
 Correlation coefficients between the variables are presented in Table 3.2.  The 
14:0, 16:0, 17:0 and 18:0 saturated FA were positively correlated (P < 0.001; P < 
0.001; P < 0.03; and P < 0.02, respectively) to milk fat percentage.  Conversely, 14:0, 
16:0 and 17:0 FA were negatively correlated to trans-18:1 and CLA isomers, with the 
exception of c9t11 CLA, c11t13 CLA , t16-18:1 and t15-18:1(for 17:0). The 18:0 FA 
was associated negatively to trans-18:1, t6+7+8-, t10-18:1 FA and t10c12 CLA.  
Total trans-18:1 and individual trans-18:1 isomers (except t16-18:1) were negatively 
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correlated to milk fat concentration (P < 0.001).  The t7c9 CLA, and t10c12 CLA 
isomers were significantly (P < 0.001) negatively correlated to milk fat concentration, 
contributing to the negative correlation observed for the total CLA.  Linoleic acid and 
non-conjugated 18:2 isomers (18:2i) were negatively correlated to milk fat and were 
positively correlated to CLA and trans-18:1 isomers with the exception of c9t11 
CLA, c11t13 CLA and t16-18:1.  Among the CLA, t7c9 CLA and t10c12 CLA 
isomers were highly correlated (r = 0.831; P < 0.001) to each other and both were 
positively correlated (P < 0.001) to trans-18:1 isomers (t6+7+8 to t-15).  Cis9t11 
CLA was positively correlated to t7c9 CLA (r = 0.365, P < 0.03), t11-18:1  (r = 
0.236, P < 0.06) and t12-18:1 (r = 0.355, P < 0.01), while c11t13 CLA was positively 
correlated to 16:0 (r = 0.18).  Trans-18:1 isomers, with the exception of t-16,  were 
highly correlated (P < 0.001) to each other and to t7c9 CLA and t10c12 CLA. 
 In the PCA, the PC1 and PC2 described 55.93% of the total variation in milk 
FA and fat concentration across the three experiments (Table 3.3).  Principal 
Components 1 and 2 had Eigen vectors of 10.12 and 4.42 describing 38.9% and 17% 
of the total variance, respectively.  Eigen vectors are the coefficients of loadings that 
explain whether all variables in the data are described by the PCA.  The Eigen vectors 
for PC1 and PC2 (Table 3.4) showed that except  for 18:3, all other FA were 
described by either PC1 or PC2, or by both. 
 The position of individual FA in the loading plot defined their relationship to 
milk fat percentage (Figure 3.1).  Four clusters of FA were identified on the loading 
plot:  Cluster 1, consisting of 14:0, 16:0, and 17:0 was positively correlated to milk 
fat (P < 0.05, Table 3.3); Cluster 2, consisting of trans-18:1 isomers (t6+7+8 to t15), 
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total CLA, t7c9, and t10c12 CLA loaded opposite to milk fat percentage, showed a 
strong negative correlation (Table 3.2); Cluster 3, including 15:0 and 16:1; and 
Cluster 4, consisting of 18:0, c18:1, t16-18:1, and c9t11, c11t13 CLA, were both 
associated with the PC2 neutral axis, suggesting no relationship, either positive or 
negative, with milk fat percentage. Finally, linolenic acid (18:3), positioned close to 
the origin of the plot, was not related to any of the PC. 
 To further elucidate the relative importance of each CLA isomer to MFD, 
individual CLA isomers were subtracted from the total CLA concentration to 
determine their effects on the position of the remaining CLA on the loading plot 
(Figures not included). Total CLA, t10c12 and t7c9 CLA isomers were inversely 
correlated to milk fat percentage emphasizing their involvement in MFD (Figure 3.1, 
Table 3.2).  Subtraction of either t7c9 CLA or t10c12 CLA from total CLA did not 
change the position of the remaining CLA isomers relative to the PC1 axis (Figure 
not included).  However, when both t7c9 CLA and t10c12 CLA isomers were 
subtracted from total CLA, the remaining CLA isomers were positioned closer to the 
neutral PC2 axis (Figure 3.2).  The c9t11 CLA and c11t13 CLA were not associated 
with changes in milk fat percentage. Due to the positive correlation between all trans-
18:1 isomers, subtractions of individual isomers from total trans-18:1 did not change 
their position on the loading plot (Figure not included). 
 Multivariate analysis on PC1 positively-loaded variables, showed a break 
point relationship for t6+7+8-, t9-, t10- and t13+14-18:1 FA and a linear relationship 
for t11-, t12- t15-18:1, t10c12 CLA and t7c9 CLA with milk fat percentage (Figure 
3.3, Panels 1.A to 9.A).  Subsequent MA of the independently gathered literature 
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means showed a break point relationship only for t10-18:1, and a linear relationship 
between t6+7+8-, t9-, t11-18:1 and t10c12 CLA, and milk fat percentage (Figure 3.3, 
Panels 1.B, 2.B, 3.B, 4.B and 8.B).  
 
DISCUSSION 
The PCA analysis and results from the correlation matrix confirmed previous 
reports (Bradford and Allen, 2004; Loor et al., 2005a) that trans-18:1 and CLA 
isomers were negatively correlated to milk fat percentage. Although, the results 
showed negative correlation of C18:2 to milk fat percentage, there is no evidence that 
18:2 that escaps rumen biohydrogenation is directly involved in MFD. Studies 
(Gaynor et al., 1994; Romo et al., 1996) in lactating cows post-ruminally infused with 
fat mixtures containing similar amounts of C18:2 showed MFD only when the 
infusion mixture contained trans-18:1 FA. However, there is uncertainty as to the 
potential for individual trans-18:1 isomers to reduce milk fat concentration (Offer et 
al., 1999).  Earlier experiments (Newbold et al., 1998) have found that change in milk 
fat concentration was related negatively to the change in t10-18:1 of milk  but was not 
related to changes in t9- and t11-18:1. Offer et al. (1999) reported significant negative 
correlations between concentration of fat in milk and proportions of t9-, t10- and t11-
18:1 of milk FA.  Loor et al. (2005a) reported that total trans-18:1, t6+7+8-, t9-, t11-, 
and t12-18:1 were negatively correlated to concentrations of de novo FA in milk from 
lactating cows fed low- or high-concentrate diets with or without linseed oil.  
Increased concentration of t6+7+8-18:1 in milk, was observed by others (Griinari. et 
al., 1998; Piperova et al., 2000, Peterson et al., 2003) in cows fed MFD diets.  
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Previously, Precht et al. (2002) suggested that t6+7+8-18:1 might be a key isomer in 
dietary MFD. 
In the current study, trans-10-18:1 had the greatest negative correlation with 
milk fat percentage (r = 0.633; P < 0.01; Table 3) among all trans-18:1 isomers.   
Griinari et al. (1998) first suggested that the degree of MFD may be related to the 
proportions of individual trans-18:1 isomers in milk fat and noted that t10-18:1 
replaced t11-18:1 as the predominant trans-18:1 isomer in milk during MFD.  High 
t10-18:1 concentration was consistently observed in lactating cows during dietary 
MFD (Piperova et al., 2000; Peterson et al., 2003; Loor et al., 2004).  However, 
during dietary-induced MFD, both t10-18:1 and t10c12 CLA increased 
simultaneously, making it difficult to determine if t10-18:1 had an effect on milk fat 
synthesis that was independent of t10c12 CLA effects.  Shingfield et al. (2006) 
showed that 0.74 of the variation in milk fat concentration of lactating cows fed corn 
silage-based diets supplemented with fish and sunflower oil was due to changes in 
milk t10-18:1 concentration.  However, they did not suggest that t10-18:1 was the 
causative factor for the decrease in milk fat concentration.  Rather, it was concluded 
that high concentration of t10-18:1 could be an indicator of rumen conditions 
favorable for MFD to occur.  Furthermore, Lock et al.(2007) recently reported that 
abomasal infusion of 43g/d t10-18:1 for 3 d did not reduce milk fat synthesis in dairy 
cows. 
 Break point analysis was used in this study, as a means to determine the 
threshold concentration of the respective FA isomer associated with maximum MFD 
(Figure 3.3).  The underlying assumption was that there is a limit to the degree of 
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MFD regardless of the amount of inhibitory rumen biohydrogenation products taken 
up by the mammary gland.  Indeed, titration studies with t10c12 CLA (Baumgard et 
al., 2001) and CLA mixtures (Chouinard et al., 1999) suggested a maximal milk fat 
depression of about 50% compared to the controls.   
 In this study, the relationship between individual isomers (t6+7+8- to t15-
18:1, t7c9 CLA and t10c12) and milk fat percentage (Figure 3.3; 1.A-9.A) displayed 
similar patterns. There was a cluster of data points, especially at low isomer 
concentrations, where milk fat was variable in relation to isomer concentration. As 
isomer concentration increased, a linear decrease in milk fat was observed until 
concentrations of trans-18:1 or CLA reached the break point threshold level.  As milk 
trans-18:1 or CLA isomer concentrations increased beyond the break point, no further 
depression in milk fat concentration was apparent regardless of isomer concentration.  
Using this approach, maximal reduction in milk fat percentage was observed at 0.69, 
0.86, 2.37 and 1.94% (% of FAME) for t6+7+8-, t9-, t10- and t13+14-18:1, 
respectively (Figure 3.3).  If these isomers caused MFD, then their estimated relative 
potencies would be greatest for t6+t7+t8- and least for t10-18:1. However, the 
potencies could be related to the preferential synthesis of these trans-18:1 FA in the 
rumen during MFD. 
 Individual (Figure 3.3, Panel 3A) and literature-derived (Figure 3.3, Panel 
3.B) data for t10-18:1 were consistent where the threshold concentrations were 
similar, 2.37% and 2.52%, respectively.  Further, there was greater variation in milk 
fat responses with t10-18:1 concentration less than 1.3%.  Recently, Lock et al.(2007) 
reported no change in milk fat with post-ruminal infusion of 43g/d t10-18:1 for 3 d in 
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lactating cows.  However, milk t10-18:1 was only 1.11%, well below the suggested 
threshold concentration and also within the concentration range where milk fat 
responses are variable and would be more difficult to detect.  Applying the 0.6 
percentage unit increase in milk t10-18:1 observed by Lock et al.(2007) to equations 
shown in Figure 3.3, Panels 3.A and 3.B, the expected decline in fat percentage 
would have been 0.4 - 0.5 percentage units.  Inconsistent milk fat responses that have 
been observed at low t10-18:1 concentration could be an alternative conclusion 
versus a total lack of response to t10-18:1 suggested by Lock et al. (2007).  
 Post-ruminal infusion studies with increasing amounts of t10c12 CLA 
(Baumgard et al., 2000; Baumgard et al., 2001; Peterson et al., 2002a) showed a 
curvilinear decline in milk fat, eventually approaching a plateau at maximum MFD. 
Using literature data obtained from experiments with dietary-induced MFD, it was 
showed that the relationships between t6+7+8-, t9-, t11-18:1 and t10c12 CLA and 
milk fat percentage were linear only.  However, maximal t10c12 CLA concentration 
was much lower than that observed in post-ruminal infusion studies.  Therefore, a 
possible reason for the lack of a defined break point for t10c12 CLA and other 
isomers was the inadequate number of observations at high concentrations of these 
isomers to establish a plateau in milk fat concentration. 
 As indicated by the slope (Figure 3.3), the unit decline in milk fat percentage 
per unit increase in milk trans-18:1 isomers, was highest for t6+7+8-18:1 (-2.59) and 
lowest  for t10 (-0.42) suggesting that  t6+7+8-18:1 might be more important than 
t10-18:1 in MFD. Among the CLA isomers, t10c12 CLA was most closely associated 
with milk fat synthesis (slope, -15.51; Figure 3.3. 8.A), followed by the t7c9 CLA 
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(slope, -6.55; Figure 3.3. 9.A), implying a possible role of t7c9 CLA in MFD.  The 
slopes for these CLA isomers were much greater than those observed for t10-18:1 and 
other trans-18:1 isomers. 
 Principal component analysis also showed that t7c9 CLA and t10c12 CLA 
were the CLA isomers most negatively correlated to milk fat percentage.  The 
importance of t10c12 CLA in MFD has already been established (Baumgard et al., 
2000), and Bauman and Griinari (2001) have reported a negative relationship between 
t10c12 CLA and milk fat concentration.  Trans-10, cis12 CLA is also the 
biohydrogenation precursor for t10-18:1 in the rumen (Griinari and Bauman, 1999).  
Earlier studies (Piperova et al., 2000; Peterson et al.,. 2003; Loor et al., 2004) have 
shown that high-concentrate diets supplemented with PUFA can shift ruminal 
biohydrogenation towards formation of t10c12 CLA and t10-18:1 causing MFD. 
Possible effects of t7c9 CLA on milk fat synthesis have not been investigated 
mainly because of a lack of a pure source for experimental use. Feeding (Piperova et 
al., 2002) and abomasal infusion (Corl et al., 2002) experiments have provided 
evidence that t7c9 CLA is almost exclusively produced in the mammary gland via ∆9-
desaturation of ruminally-derived t7-18:1. However, it is very difficult to analytically 
separate t6-, t7-, and t8-18:1, which prevents quantitation of t7-18:1 conversion to 
t7c9 CLA.  
Shingfield et al. (2003) provided evidence that the proportions of t5-, t10-, 
t11- t12-18:1, and t7c9 CLA were simultaneously and substantially increased in milk 
of lactating cows fed diets containing fish oil.  Pottier et al. (2006) recently reported 
that concentrations of both t10-18:1 and t7c9 CLA were reduced in milk fat when 
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dietary vitamin E supplementation successfully alleviated MFD.  These observations 
were consistent with the highly positive correlation found between t7c9 CLA and t10-
18:1 (r=0.61; P < 0.001) in this study (Table 3.3; Figure 3.1).  
The PCA confirmed earlier reports that the c9t11 CLA (Baumgard et al., 
2000) and c11t13 CLA isomers (Perfield et al., 2004) were not associated with 
changes in milk fat (Figure 3.1; Table 3.2).  However, in some cases of dietary-
induced MFD, an increase in t9c11 CLA has been observed.  Abomasal infusion of 
CLA mixture enriched in t9c11 CLA suggested that this isomer may be responsible 
for at least part of the decrease in milk fat production during MFD (Perfield et al., 
2005).  Examination of milk FA composition responses to fish- and sunflower oil- 
supplemented diets for dairy cows showed a strong correlation between milk fat and 
t9c11 CLA (Shingfield et al., 2006).  Using a dietary strategy to reduce milk fat yield 
in lactating cows, Roy et al. (2006) found that decreases in fat yield were 
accompanied by increases in milk t10-18:1 and t9c11-CLA.  The authors suggested 
that these isomers could be directly or indirectly related to anti-lipogenic activities in 
the mammary gland.   
It could be speculated that configuration of the conjugated double bonds may 
define specific effects of individual CLA isomers on milk fat synthesis.  Perfield et al. 
(2006) compared abomasal infusion of t10t12 CLA to that of t10c12 CLA and 
reported that t10t12 CLA did not reduce milk fat yield but significantly altered the 
desaturase index and milk FA composition in lactating cows.  It appears that at least 
some CLA isomers with trans/cis conjugated double bonds have the ability to 
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decrease milk fat (i.e., t10c12, t9c11, and possibly t7c9,) whereas, the major cis/trans 
CLA were not effective (c9t11, c11t13).  
 In summary, the PCA and MA analysis showed that among trans-18:1 
isomers, t10-18:1 was most negatively correlated to milk fat percentage.  However, 
the threshold concentration related to maximum MFD indicated that the relative 
potency was greatest for t6+7+8- and least for t10-18:1. These results suggested that 
t6+7+8-18:1 might be more important than t10-18:1 in MFD.  Principal component 
analysis also showed that t10c12 and t7c9 CLA were the isomers most negatively 
correlated to milk fat percentage, implying a possible role of t7c9 CLA in MFD. 
Additional experiments are needed to establish whether t7-18:1 is involved in MFD 
or that its effects are mediated via the endogenously synthesized t7c9 CLA.  
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Piperova et al., 2000 11 22 Control  diet 
(Forage/concentrate 60/40); 
MFD1 diet (25 % forage and 
70 % concentrate with 5 % 
soybean oil); 
 
Piperova et al., 2002 4 16 High-forage (60% Forage) 
with or without buffer 
addition;  
Low-forage (25% Forage) 
with or without buffer 
addition; 
 
Piperova et al., 2004 5 25 Control;  
100g Ca-tFA2 supplement; 
200g Ca-tFA supplement; 
400g Ca-tFA supplement; 
100g  Ca-CLA supplement; 
 
1Milk Fat Depression 
2 Calcium salts of trans fatty acids 
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Table 3.2.  Correlation coefficients for the milk fatty acids (% of total fatty acids) from individual cow observations reported by 
Piperova et al., (2000, 2002, and 2004)   
  F a t % 1 4 : 0 1 5 : 0 1 6 : 0 1 6 : 1 c 1 7 : 0 1 8 : 0 1 8 : 1 t 1 8 : 1 c 1 8 : 2 1 8 : 2 i 18 :3 C L A t 7 c 9 c 9 t 1 1 t10c12 c11t13 t6+7+8 t 9 t 1 0 t 1 1 t 1 2 t13 t15 t16 
Fat % 1                         
milk, kg -0.271*                         
14:0 0.420** 1                        
15:0 0.019 0.465** 1                       
16:0 0.531** 0.449** -0.198 1                      
16:1c 0.232 -0.065 0.159 0.106 1                     
17:0 0.369** 0.289* 0.218 0.363** 0.023 1                    


















0.651** 0.214 -0.235 0.043 0.662** 
-
0.265** 1                 
18:2 
-
0.614** -0.312* 0.127 
-
0.656** -0.063 -0.463 
-













0.453** 0.636** 1               
18:3 0.044 0.137 0.114 -0.179 -0.050 0.090 -0.081 -0.016 -0.034 0.230 0.153 1              
CLA 
-
0.431** -0.332* 0.037 
-









0.392** -0.215 0.623* 0.023 0.601** 0.388** 0.020 0.462** 1            
c9t11 0.102 0.059 -0.006 0.117 -0.051 0.188 0.204 -0.192 0.398** 0.044 -0.230 0.228 0.464** 0.365** 1           
t10c12 
-






0.426** 0.707* -0.276* 0.687** 0.559** 
-
0.009 0.340** 0.831** 0.051 1          
c11t13 -0.092 -0.111 
-














































0.296** 0.019 0.698** 0.102 0.616** 0.437** 
-







0.398** -0.214 -0.247* 0.221 0.504** 0.363** 0.488** 0.221 
-














0.393** -0.262 -0.207 0.062 0.583** 0.096 0.454** 0.295* 
-
0.010 0.291** 0.538** 0.209 0.465** 0.031 0.607** 0.706** 0.529** 0.660** 0.625** 0.890** 1  
t16 0.047 -0.117 -0.177 0.044 -0.290 0.090 0.502** -0.023 0.475** 0.037 -0.162 
-
0.077 0.094 0.128 0.476* -0.066 0.180 -0.076 0.061 -0.080 0.503** 0.660** 0.539** 0.567** 1 
*P < 0.05   **P <0.01.
 
 80
Table 3.3.  Principal component Eigen values for Principal Component 1 and 
Principal Component 2. 
 
Principal 
Component Eigen value 




PC1 10.12 38.93 38.93 
PC2 4.42 17.00 55.93 




Table 3.4.  Coefficients of the loadings (Eigen vectors) for PC1 and PC2 
Response variable PC1 
% Contribution  
for PC1 PC2 
% Contribution 
for PC2 
Fat % -0.224 -9.73 0.003 0.19 
Milk, kg 0.007 0.30 0.204 12.60 
FA     
14:0 -0.160 -6.90 -0.136 -8.40 
15:0 -0.003 -0.10 -0.281 -17.36 
16:0 -0.248 -10.80 0.109 6.73 
16:1c -0.034 -1.50 -0.203 -12.54 
17:0 -0.168 -7.50 -0.059 -3.64 
18:0 -0.093 -4.00 0.342 21.12 
18:1t 0.295 12.81 -0.083 -5.13 
18:1c -0.040 -1.74 0.399 24.64 
18:2 0.262 11.38 -0.049 -3.02 
18:2i 0.232 10.08 -0.223 -13.77 
18:3 0.015 0.65 -0.050 -3.27 
t7c9  0.244 10.60 0.066 4.08 
C9t11 0.011 0.48 0.251 15.50 
t10c12 0.249 10.82 -0.070 -4.32 
C11t13 -0.037 1.60 0.238 14.70 
tFA     
t6+7+8 0.288 12.51 -0.088 -5.44 
t9 0.281 12.21 -0.030 -1.85 
t10 0.289 12.55 -0.113 -6.98 
t11 0.246 10.69 0.163 10.07 
t12 0.206 8.95 0.285 17.60 
t13 0.257 11.16 0.179 11.06 
t15 0.217 9.43 0.185 11.43 
t16 0.045 1.95 0.363 22.42 
Total loadings 
(absolute) 




























Figure 3.1. Loading plot describing the relationship among milk fatty acids  derived 
from a principal component analysis based on proportions (% of total fatty acids) for 
C14 to C18 FA in milk from 3 experiments (n=63).  Four clusters of FA were 
distinguished. Trans-18:1 isomers (except t16-18:1), total CLA, t10c12 CLA and t7c9 
CLA were loaded opposite (negatively related) to milk fat percentage, while saturated 
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Figure 3.2.  Loading plot describing the relationship among milk CLA isomers 
derived from a principal component analysis, based on the proportions (% of total 
fatty acids) for CLA isomers.  The position of total CLA shifted closer to PC2 
(neutral) axis when t10c12 CLA and t7c9 CLA were subtracted.  
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Figure 3.3.  Relationship between milk fat percentage and fatty acid isomers, as 
explained by multivariate analysis. 
Panels 1.A to 9.A.  The data points are individual observations from the 
experiments reported by Piperova et al., (2000; 2002; and 2004). The break point 
analysis fitted for t6+7+8-, t9-, t10-, and t13+14-18:1 (Panels 1.A, 2.A, 3.A and 
6.A, respectively). A linear relationship was observed between the other FA 
isomers and milk fat percentage.   
Panels 1.B to 8.B. The data points are reported means from the literature studies 
used. Only t10-18:1 (3.B) fitted the breakpoint analysis. A linear relationship was 












































                     If t6+7+8>0.69, Y=1.80





























































































































































































































































































































Chapter 4: EXPERIMENT 2 
 
Milk fat depression induced by trans-18:1 isomers or t10c12-CLA 
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The objectives were to determine the effects of several individual trans-18:1 
isomers and t10c12-CLA on fat synthesis, and expression of lipogenic genes and 
transcription factors in liver and mammary tissues in lactating mice.  Thirty lactating 
C57Bl6J mice were randomly assigned to 6 diets supplemented with one of the 
following isomers t7-, t9-, t11-18:1, t10c12-CLA or PHVO (partially hydrogenated 
vegetable oil) from day 6 to day 10 postpartum. Milk fat percentage was decreased by 
t10c12-CLA (44%; P<0.001), t7-18:1 (27%; P< 0.001) and PHVO (23%; P<0.001), 
compared to Control. Amounts of total CLA were greatest in milk of mice fed t7-18:1 
(2.4%, P <0.01), followed by t10c12-CLA (1.9%, P <0.01) and t11-18:1 (1.1%, P 
<0.01). The increased CLA found in milk of mice fed t7-18:1 was a result of 
substantial endogenous synthesis of t7c9-CLA, representing 87% of total CLA.  In 
the mammary gland, t10c12-CLA decreased gene expression related to de novo FA 
synthesis (FASN, P<0.01; ACACA P<0.01), triacylglycerol formation (AGPAT, 
P<0.01), desaturation (SCD1, P<0.05; SCD2 P<0.05) and transcriptional regulation 
(SREBP-1c, P<0.01; ChREBP, P<0.01; THRSP, P<0.01; PPARA P<0.05; PPARG, 
P<0.05). PHVO and t7-18:1 decreased the expression of AGPAT, SCD1 and THRSP 
(P<0.05). Mammary gene expression was not altered by t-9- or t-11-18:1.  In liver, 
expression of AGPAT was significantly decreased by diets supplemented with t10c12-
CLA (P<0.01), PHVO (P<0.01) and t7-18:1(P<0.01). In contrast to mammary gland, 
CLA increased gene expression of hepatic PPARA (P<0.05) and decreased PPARG 
(P<0.05). There was a substantial increase in total FA(per g of dry tissue) in liver of 
dams fed the t10c12-CLA (81%, P<0.01), PHVO (35%, P<0.05), t7-18:1 (38%, 
 
 88
P<0.05), and t11 18:1- (26%, P<0.05) supplemented diets. The results demonstrated 
extensive conversion of t7-18:1 to t7c9-CLA in mammary and liver tissues of mice 
fed the t7-18:1 diet. The observed milk fat depression suggests potential involvement 
of t7c9-CLA in regulation of milk fat synthesis. In addition to SREBP-1C, the study 
establishes a role of ChREBP, PPARG and INSIG1 in regulation of milk fat synthesis.  
 




















 Effects of transoctadecenoic acids (trans-18:1 FA) on milk fat synthesis in 
lactating mice fed partially hydrogenated vegetable oil (PHVO) were first reported 
by Teter et al. (1990).   Partially hydrogenated vegetable oils contain a mixture of 
positional trans-18:1 isomers ranging from t4-(trans-4) to t16-18:1. Since trans-18:1 
FA are also intermediates in rumen biohydrogenation, it was hypothesized that trans-
18:1 FA are involved in decreased milk fat synthesis (MFD) in lactating dairy cows 
(Gaynor et al., 1995). Studies showed that abomasal infusion of PHVO (Gaynor et al., 
1994; Romo et al., 1996) or dietary supplementation of Ca salts of trans-18:1 FA 
containing all trans-18:1 isomers (Piperova et al., 2004) reduced milk fat content in 
lactating cows.  Concentrations of trans-18:1 FA in milk generally correlates with 
MFD. However, in some studies increases in milk trans-18:1 FA do not correspond to 
reductions in milk fat yield (Kalscheur et al., 1997). Griinari et al. (1998) reported 
that MFD in lactating cows may be associated with changes in trans-18:1 FA isomer 
profile and an increase in t10-18:1 isomer rather than with an increase in total trans-
18:1 content. This suggested a possible involvement of specific isomers in MFD. 
Individual t9- (Rindsig and Schultz., 1974), t10- (Lock et al., 2007), t11- and t12-18:1 
(Baumgard et al., 2000) isomers were examined but no effects on milk fat synthesis 
were observed. However, meta analysis of published data obtained from lactating 
cows fed MFD diets suggested a possible role of t7-18:1 or t7c9-CLA in MFD 
(Kadegowda et al., 2008).  
In contrast to trans-18:1 isomers, the potential role of CLA in MFD is better 
established.  T10c12-CLA was identified as a CLA isomer that inhibits milk fat 
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synthesis (Baumgard et al., 2000). However, concentration of t10c12-CLA in milk 
does not always account for the degree of MFD (Peterson et al., 2003), and MFD 
without changes in t10c12-CLA have been reported by others (Piperova et al., 2004; 
Loor et al., 2005). This implies that other CLA or trans-18:1 isomers may have a role 
in regulating milk fat synthesis, and at least two other CLA isomers, t9c11- 
(Schingfield et al., 2006) and t7c9-CLA (Kadegowda et al., 2008), have shown a 
strong negative correlation to milk fat content. 
The mechanisms involved in MFD are not well understood. Bauman and 
Griinari (2003) reported that diet-induced MFD alters the milk FA profile by 
decreasing de novo FA synthesis.  Similar effects on de novo FA synthesis were 
observed when milk fat yield was reduced by t10c12-CLA (Looret al., 1998).  
Feeding a MFD-diet (Peterson et al., 2003,Piperova et al., 2000) to lactating dairy 
cows, or t10c12-CLA to rats (Ringeseis et al., 2004) and mice (Lin et al., 2004), 
caused a decrease in mRNA abundance and enzymatic activity of mammary lipogenic 
enzymes. Transcriptome profiling of mammary gland of lactating mice demonstrated 
that substantial regulation of lipid synthesis occurred at the level of mRNA 
expression and the transcription factor SREBP-1c was implicated as one of the 
regulators (Rudolph et al., 2007).  Studies with MACT cells (Peterson et al., 2004) 
and lactating cows (Harvatine and Bauman, 2006) have shown that the effect of 
t10c12-CLA on fat synthesis could be regulated via the SREBP-1c transcription factor 
acting as a possible global regulator for milk fat synthesis. However, SREBP-1c 
knockout mice exhibited a 50% decrease in FA synthesis without fully suppressing 
lipogenic gene expression (Liang et al., 2002). This suggested that other transcription 
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regulators may be involved in FA synthesis. Studies with cultured primary 
hepatocytes (Dentin et al., 2004) and SREBP-1c knockout mice (Lizuka et al., 2004) 
have reported a role of the carbohydrate response element binding protein (ChREBP) 
in the coordinated control of glucose metabolism, FA synthesis and triacylglycerol 
(TAG) synthesis in liver. Based on these findings, it was hypothesized that effects of 
dietary FA on milk fat synthesis could be regulated through multiple transcriptional 
regulators in the mammary gland. 
The objectives were to determine the effects of several individual trans-18:1 
isomers and t10c12-CLA on fat synthesis, and expression of lipogenic genes and 
transcription factors in mammary and liver tissues of lactating mice.  
MATERIALS AND METHODS 
Animals, diets and treatments 
 The experimental procedures were approved by the Institutional Animal Care 
and Use Committee of the University of Maryland. Timed pregnant multiparous 
female C56Bl/6J mice used in this study were obtained from the Department of 
Animal and Avian Sciences, University of Maryland. Dams and their pups were 
housed in shoebox cages and provided with ad libitum food and water. Pregnant mice 
were fed a commercial rodent diet (5001 Rodent Lab Diet ®, Purina, Richmond, IN, 
USA) consisting of 23% CP, 4.5% fat and 6.0% fiber until 2 days prepartum.  From 
day 2 prepartum until day 6 postpartum, dams were fed a Control diet. On day 6 
postpartum, they were randomly assigned to one of the six treatment diets (Control, 
PHVO, t10c12-CLA, t7-18:1, t9-18:1 and t11-18:1). The Control diet consisted of 
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sucrose 590 g/kg, vitamin free casein 200 g/kg, alphacel 50 g/kg, fat 100 g/kg (cocoa 
butter 14.3 g/kg, corn oil 30.9 g/kg, olive oil 34.8 g/kg, oleic acid 20 g/kg), AIN 76 
Mineral Mixture 40 g/kg, AIN 76 vitamin mixture 15 g/kg, DL-Methionine 3 g/kg 
and Choline bitartarate 2 g/kg.  The oleic acid was replaced completely with the 
respective fatty acids in treatments t7-18:1, t9-18:1 and t11-18:1, but was replaced at 
30% in the t10c12-CLA treatment consistent with the documented potency of t10c12-
CLA. The fat mixture in the PHVO treatment consisted of vegetable shortening 45.73 
g/kg, corn oil 26.6 g/kg, soybean oil 7.6 g/kg and oleic acid 20 g/kg, and the FA 
composition was similar to that of the Control diet. The fatty acid composition of the 
diets fed to lactating mice is presented in Table 4.1. 
 Except for the Control (n=7) and t-7 18:1 (n=3), treatment groups consisted of 
5 lactating mice. Mice and their pups were randomly assigned to treatments. Litter 
size was adjusted to 6 or 7 pups to maintain uniform milk synthesis among dams. 
Lactating mice were fed the experimental diets from day 6 to day 10 postpartum. 
Daily feed intake was recorded during the experimental period. On day 6 and day 10 
postpartum, milk samples were collected by suction and milk fat percentages 
measured as described by Teter et al. (1990). Milk fat percentages estimated by 
crematocrit as volume percentages were converted to weight percentages using 
calibration factors developed by Teter et al. (1990). The milk samples were stored at 
 -20°C for FA analyses. Body weights of dams and pups were recorded before 
milking. On day 10 postpartum, the animals were sacrificed using isoflurane and 
individual liver and mammary tissues were collected from dams and pooled livers 
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from pups from each diet. The livers were fast-frozen in liquid nitrogen, and stored at 
-80°C until RNA or lipid extraction.  
Fatty acid analyses 
Fats in the diets and  milk samples were saponified with 0.5 N NaOH in 
methanol for 30 min at 50°C and transesterified to FA methyl esters (FAME) as 
previously described (Kadegowda et al., 2008). Trinonadecenoin (Nu-Chek Prep, Inc. 
Elysian, MN, USA) was included as an internal standard.  The FAME were analyzed 
using a Hewlett Packard (HP 5890) gas chromatograph (Hewlett Packard, Sunnyvale, 
CA,  USA) equipped with a 30 m x 0.25 mm fused silica capillary column coated 
with SP-2380 (Supelco Inc., Bellefonte, PA, USA) and FID detector. The injector and 
detector temperature were maintained at 250°C. The initial oven temperature was 
155°C (held for 5 min) and was programmed to increase at a rate of 1.4°C per min, to 
a final temperature of 195°C (held for 10 min).  Peak identification was based on 
relative retention times of commercial standards including GLC-68B and GLC-463 
(Nu-Check Prep Inc.)  
  Individual CLA isomers in milk were analyzed as methyl esters in a Waters 
2690 HPLC separation module (Waters Associates, Milford, MA, USA), equipped 
with a waters 2996 PDA detector, and 3 Chromsphere 5 lipids (250 x 4.6 mm, 5 µM, 
Varian) HPLC columns in series, using conditions described previously (Kadegowda 
et al., 2008). A CLA standard mixture (Nu-Chek Prep Inc.), spiked with t7c9-CLA 
standard, was used to identify individual isomers. 
Liver tissues were lyophilized and FAME were prepared as described for diet 
and milk samples. FAME were analyzed using an Agilent 6890 gas chromatograph 
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(Agilent Technologies, Santa Clara, CA, USA) equipped with a SP 2560 capillary 
column (100 m x 0.25 mm, 0.2 mm, Supelco, Belefonte, CA, USA) and a FID 
detector. Gas chromatograph conditions were as described by Kadegowda et al. 
(2008). The individual FA and 18:1 isomers were identified using GLC-463 standard 
mixture (Nu-Chek Prep Inc.). 
Extraction of total RNA 
Total RNA was isolated from ~1g of tissue using Qiazol lysis reagent (Qiagen 
Inc., Valencia, CA, USA) and RNeasy isolation kits with on-column DNAse 
digestion (Qiagen Inc.). The RNA quality was evaluated using the Agilent 2100 
Bioanalyzer with RNA 6000 Nano Labchip kits (Agilent Technologies) while 
concentrations were determined using the Nanodrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE, USA). 
Quantitative Real-Time RT-PCR 
 Purified RNA, diluted to a concentration of 75 ng/µl, was used for the first-
strand  cDNA synthesis by reverse transcription using the iScript cDNA synthesis kit 
(Bio-Rad Laboratories, Hercules, CA, USA). Seven-hundred and fifty nanograms of 
RNA were used per 30-µl reaction volume. A parallel control reaction was performed 
in the absence of reverse transcriptase for each first-strand synthesis.  Incubation 
conditions were: 25°C for 5 min, 42°C for 30 min, 85°C for 5 min. A 2-µl aliquot of 
cDNA reaction product and 10 pmol of each primer were used per 25-µl real-time 
PCR reaction with 12.5 µl of iQ SYBR Supermix (Bio-Rad Laboratories). Primers 
were designed using Primer3 software (http://frodo.wi.mit.edu/) based on murine 
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mRNA sequences available in GenBank.  Primer sequences and annealing 
temperature used for each gene target are presented in Table 4.2. Real-time PCR was 
performed in the Bio-Rad iCycler (Bio-Rad Laboratories) with the following 
conditions: 95°C for 3 min, followed by 40 cycles of 94°C for 15 sec, annealing 
temperature for 30 sec, and 72°C for 30 sec, with fluorescence detected during the 
extension step.  
 Standards for each gene target were prepared from PCR amplicons using each 
primer pair, purified using the QIAquick gel extraction kit (Qiagen Inc.). Product 
concentrations were determined using the Agilent 2100 BioAnalyzer and DNA 500 
kits (Agilent Technologies). The PCR amplicons were sequenced using a CEQ8000 
automated DNA sequencer and DTCS Quickstart Chemistry (Beckman Coulter, 
Fullerton, CA, USA) to confirm amplification of the expected murine nucleotide 
sequence. The quantity of cDNA in unknown samples was calculated from the 
appropriate external standard curve ranging from 1 x 102 to 1 x 107 molecules/µl run 
simultaneously with samples as described by Connor et al. (Connor et al., 2005). 
Samples and standards were assayed in duplicate. Assay performance for each gene is 
reported in Table 4.2. 
Genes examined 
Lipogenic genes: Fatty acid synthase (FASN), acetyl-Coenzyme A 
carboxylase alpha (ACACA), 1-acylglycerol-3-phosphate O-acyltransferase (AGPAT), 
stearoyl-Coenzyme A desaturase 1 (SCD1), stearoyl-Coenzyme A desaturase 2 
(SCD2), and lipoprotein lipase (LPL); Transcription regulators: thyroid hormone 
responsive SPOT14 homolog (THRSP), sterol regulatory element binding 
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transcription factor 1 (SREBP1c), carbohydrate response element binding protein 
(ChREBP), peroxisome proliferator activated receptor alpha (PPARA), peroxisome 
proliferator activated receptor gamma (PPARG), liver X receptor alpha (LXRA), 
retinoid X receptor (RXR); Co-activators: SREBP cleavage activating protein 
(SCAP), insulin induced gene 1 (INSIG1), and MAX-like protein X (Mlx). 
Statistical Analysis 
Data were analyzed using the Mixed Procedure in the Statistical Analysis 
System (Version 8.2, 2004, SAS Institute, Cary, NC, USA). The fixed effects were 
the treatments, while the random portion of the model included the individual 
animals.  Data from day 6 postpartum were used as a covariate for the analyses of 
milk fat percentage and milk FA composition. Gene expression data were analyzed as 




Feed intake, body and organ weights and pup growth rate. 
 Daily feed intake, body and organ weights and pup growth rate are presented 
in Table 4.3.  Compared to Controls, dietary supplementation of t10c12-CLA 
decreased the average feed intake in dams by 23% (6.98 vs. 5.35 g/d, P<0.03). The 
average dam body weight was not affected by FA supplements on day 10 postpartum. 
Liver weights were increased by 30% with t10c12-CLA and by 20% with t7-18:1 
treatments (P<0.05) but were decreased by 11% in mice fed t9-18:1 diet (P<0.10). 
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The pup growth rates were significantly reduced with t10c12-CLA (P<0.01), t7- 
(P<0.05), and t9-18:1 (P<0.05) FA-containing diets. 
Milk fat percentage and milk volume. 
Milk fat percentage (Table 4.3) was decreased by diets supplemented with 
t10c12-CLA (41%, P<0.001), t7-18:1 (26%, P<0.05) and PHVO (23%, P<0.05). 
The t9- or t11- 18:1 diets did not affect milk fat percentages. Milk volume, calculated 
based on the average litter body weight (29), tended to be lower with t10c12-CLA, t7- 
and t9-18:1 treatments. These data must be interpreted with caution as they may be 
influenced by the lower litter body weight and the decrease in milk fat content 
observed in mice fed the t10c12-CLA and t7-18:1 diets.  
Milk FA composition. 
The decrease in milk fat content observed in mice fed t10c12-CLA, PHVO 
and t7-18:1 diets was predominantly due to reduction in the proportion of medium-
chain (<16:0) FA (MCFA) (Table 4.4). Total MCFA was decreased by 41%, 21%, 
and 16% with the t10c12-CLA, PHVO and t7-18:1 diets, respectively. Compared to 
Control, t10c12-CLA decreased C10:0 (40%, P <0.1), C12:0 (34%, P<0.01) and 
C14:0 (45%, P<0.01), while the decrease of individual MCFA was in the range of 15 
to 20% with PHVO and t7-18:1 supplementation (Table 4.4).  Concentrations of 16:0 
were reduced by the t10c12-CLA (20%, P<0.01) and PHVO (13%, P<0.05) 
treatments. The decrease in MCFA and 16:0 in milk of mice fed t10c12-CLA led to a 
proportional increase in 18:0, 18:1cis9, 18:2 and 20:4 long-chain FA (LCFA).  
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Milk trans-18:1 and CLA isomer profile. 
 The trans-18:1 and CLA isomers provided by the diets were taken up by the 
mammary gland and significant proportions (P<0.01) were incorporated to milk fat 
(Table 4.5). Total trans-18:1 FA was markedly increased with the trans-18:1-
supplemented diets (Table 4.5). The highest amount of trans-18:1 was observed with 
PHVO (3.7%), followed by t9- (3.1%), t11-(1.8%) and t7-18:1(1.6%). Trans-18:1 
isomers from t6- to t14-18:1 were increased with the PHVO diet (P< 0.05). Trans-
18:1 FA were not detected in the milk of mice fed t10c12-CLA and only trace 
amounts of t9-18:1 were found in milk of Control mice. 
Amounts of total CLA were greatest in milk of mice fed t7-18:1 (2.4%), 
followed by t10c12-CLA (1.9%) and t11-18:1 (1.1%) (Table 4.5). The predominant 
CLA was t7c9-CLA in the milk of mice fed t7-18:1 FA.  Small amounts of t7c9-CLA 
(0.08%) were also found in the milk of mice fed PHVO.  The t10c12-CLA was the 
major milk FA isomer of mice fed t10c12-CLA and was not detected in any other 
treatments. The predominant isomer in milk of mice fed the Control, PHVO, t11- and 
t9-18:1-supplemented diets was c9t11-CLA.   
Fatty acid composition of dam liver. 
 The total FAME (per g of dry tissue) in dam liver was substantially increased 
(Table 4.6) by diets supplemented with t10c12-CLA (81%, P<0.01), PHVO (35%, 
P<0.05), t7-18:1 (38%, P<0.05), and t11-18:1 (26%, P<0.05). The proportion of 
16:0 was greater in t10c12-CLA-, t7- (P<0.01) and t9-18:1- (P<0.05) fed mice. 
Compared to Control, the proportion of 18:0 was reduced (P<0.01) in liver of mice 
fed all diets except t9-18:1 where only a tendency (P=0.07) was observed. The 20:4 
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and 22:0 LCFA were also higher (P<0.01) in liver of mice fed the t10c12-CLA-, 
PHVO-, and t7-18:1-supplemented diets (Table 4.6). Total trans-18:1 FA was 
increased (P<0.01), reflecting the uptake of dietary-supplemented isomers (Table 
4.6).  The amount of total CLA was greatest for t7-18:1 (1.5%) followed by t11-18:1 
(1.35%), mainly due to the endogenous CLA synthesis from the respective trans-18:1 
isomers (Table 4.7). T7c9-CLA was found in liver of mice fed t7-18:1 and PHVO. 
Cis9t11-CLA was present in all animals along with smaller amounts of other CLA 
isomers (c11t13, t11t13, and cis / cis CLA). Trans 10cis12-CLA was observed only 
with t10c12-CLA supplementation (Table 4.7). 
Fatty acid composition of pup liver. 
 Compared to dam liver,  proportions of 16:0, 18:0 and 20:4 were 2 to 3 fold 
higher in pup liver, while c9-18:1 was greatly reduced (~50%) (Table 4.8). Total 
trans-18:1 FA was increased (P<0.05) in pup livers nursing dams fed the trans-18:1 
isomers (Table 4.9).  The CLA isomer profile reflected the respective milk CLA 
composition. T7c9-CLA represented 76% and 6.5% of the total CLA in liver of pups 
nursing from mice fed the t7-18:1 and PHVO diets, respectively. The c9t11-CLA was 
75% and 53% of the total CLA in pups nursing from mice fed the t11-18:1 or PHVO 
diets, respectively. 
Gene expression. 
Potential regulatory mechanisms involved in milk fat synthesis were 
examined by measuring the expression of key lipogenic genes, transcription 
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regulators and nuclear receptors in mammary and liver tissues using quantitative RT-
PCR.  
Expression of mammary lipogenic genes. Compared to Controls, the t10c12-CLA 
treatment decreased the expression of genes involved in FA synthesis (FASN (-55%, 
P<0.01), ACACA (-45%, P<0.01)), triacylglycerol (TAG) formation (AGPAT (-34%, 
P<0.01)) and desaturation (SCD1 (-35%, P<0.05), SCD2 (-35%, P<0.05))(Fig 4.1A).  
The PHVO and t7-18:1 treatments decreased mRNA abundance for AGPAT 
(P<0.05), SCD1 (P<0.05) and tended to decrease FASN (P=0.2) (Fig 4.1A). The 
SCD2 was increased by t7-18:1 (53%, P<0.05). Mammary lipogenic genes were not 
affected by the t9- and t11-18:1 FA-supplemented diets, consistent with a lack of 
change in milk fat content. 
Expression of mammary transcription regulators, nuclear receptors and 
transcription co-activators The t10c12-CLA diet decreased the mRNA abundance of 
SREBP-1c (P<0.01), ChREBP (P<0.01), THRSP (P<0.01), PPARA (P<0.05) and 
PPARG (P<0.05) (Fig 4.1A and B). PHVO supplementation decreased the expression 
of SREBF1 (P<0.05), THRSP (P<0.05) and PPARA (P<0.05) (Fig 4.1A). Trans 7-
18:1 decreased THRSP (P<0.05) (Fig 4.1A), increased Mlx (P<0.05) (Fig 4.1A) and 
tended to increase INSIG1 (30% P<0.10) (Fig 4.1A)and LXRA (22%, P<0.16) (Fig 
4.1A). Expression of SCAP was reduced (P<0.15) by the t10c12 diet (20%), t7-18:1- 
(20%) and PHVO- (12%) supplemented diets and was increased (P<0.05) by t9-18:1 






Expression of hepatic lipogenic genes, transcription regulators, and nuclear 
receptors. 
 Of the lipogenic genes examined in the liver, only AGPAT expression was 
significantly decreased by the supplementation of t10c12-CLA (P<0.01), PHVO 
(P<0.01) and t7-18:1 (P<0.05) (Fig 4.2A; 4.2B). All diets supplemented with 
individual (t7-, t9- and t11-) trans-18:1 FA up regulated the expression of SCD2 
(P<0.05) and LPL (P<0.05). In contrast to the mammary gland, the t10c12-CLA-
supplemented diet increased SREBP1 (P<0.01) and PPARA (P<0.05) hepatic gene 
expression and reduced the expression of PPARG (P<0.01), and RXR (P<0.05) (Fig 
4.2C).  The PPARA expression tended to increase with the supplementation of PHVO 
and t9-18:1 (P=0.23). The t7-18:1 FA increased gene expression of SREBP1c 
(P<0.01), LXRA (P<0.01), and INSIG1 (P<0.05) (Fig 4.2C, 4.2D).  Partially 
hydrogenated vegetable oil decreased the expression of SCAP (P<0.05). 
DISCUSSION 
Analysis of the relationship between individual trans-18:1 isomers and milk 
fat percentage has shown differences in their relative potency to reduce milk fat 
content (Kadegowda et al., 2008). Consistent with previous reports (Teter et al., 1990; 
Gaynor et al., 1995; Romo et al., 1996), it was observed that dietary addition of 
PHVO, a source of t4 to t16-18:1 isomers, decreased milk fat synthesis in this study. 
Dietary supplementation of t9- or t11-18:1 did not alter milk fat content and was 
consistent with earlier reports (Teter et al., 2003; Loor et al., 2003).  Using principal 
component analysis of data from lactating cows fed MFD-diets (Kadegowda et al., 
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2008), we hypothesized the potential involvement of trans-7 18:1 isomer in MFD.  
This is the first study to demonstrate that dietary supplementation of t7-18:1 can 
indeed reduce milk fat content in mice. 
 The supplemented trans-18:1 and t10c12-CLA were transferred to milk, 
causing a concomitant increase in the concentrations of these isomers.  The amount of 
apparent milk trans-18:1 FA was greater in mice fed PHVO or t9-18:1 than that 
observed in mice fed the t7- or t11-18:1 diets.  This was due to the substantial 
conversion of these isomers to t7c9- and c9t11-CLA via ∆9 desaturation of the 
respective trans-18:1 precursors.  Experiments with lactating cows where c9t11- and 
t7c9-CLA were measured in rumen fluid (Corl et al., 2002) or duodenal flow 
(Piperova et al., 2002) have shown that these isomers were almost exclusively 
synthesized de novo by the action of ∆9 desaturase in the mammary gland.  To our 
knowledge, this is the first study to show direct conversion of dietary t7-18:1 to milk 
t7c9-CLA. The proportion of t7c9-CLA (2.4% FAME) was higher in milk from mice 
fed t7-18:1 compared to that of c9t11-CLA (1.13% FAME) in mice fed t11-18:1. 
Considering the proportions of the trans-18:1 precursors and the CLA produced, we 
estimated that 58% of t7-18:1 and 36% of t11-18:1 were converted to t7c9-CLA and 
c9t11-CLA, respectively. Conversion efficiencies between 29 and 31% were 
previously reported for t11-18:1 in lactating cows (Griinari et al., 2000; Shingfiled et 
al., 2007). The results suggest that, compared to t11-18:1, t7-18:1 might be a 
preferred ∆9-desaturase substrate in mammary tissue. Due to the significant synthesis 
of t7c9-CLA observed in mice fed t7-18:1, we speculated that the effect of t7-18:1 on 
milk fat synthesis might be mediated through t7c9-CLA. It was previously reported 
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that the t7c9-CLA and t10c12-CLA were the isomers most negatively correlated to 
milk fat percentage (Kadegowda et al., 2008). 
  It is established that MFD is characterized by a reduction of de novo 
synthesized FA (Loor and Herbein, 1998). This reduction in de novo FA synthesis is 
associated with a decrease in mRNA abundance of key lipogenic enzymes in the 
mammary gland (Baumgard et al., 2001). In the present study, changes in FA <16:0 
were observed in milk fat of mice fed t10c12-CLA, PHVO and t7-18:1 diets. The 
expression of ACACA and FAS was reduced with the t10c12-CLA diet, and 
expression of FAS tended to decrease in mice fed the PHVO and t7-18:1 diets. The 
mRNA abundance of genes regulating desaturation (SCD1) and TAG formation 
(AGPAT) were also reduced in mice with MFD.  SCD expression is important for 
TAG synthesis (Ntambi et al., 2004) and desaturation is reported to be essential for 
initiation of lipogenesis or TAG synthesis (Sampath et al., 2007). Two isoforms 
(SCD1, SCD2) of SCD exist that can desaturate 16:0 and 18:0. Although their 
physiological functions are not completely elucidated, it is known that SCD1 is 
predominantly expressed in liver, while the expression of SCD2 increases by several 
folds in the mammary tissue at the onset of lactation (Rudolph et al., 2007).  
In this study, the decrease in mRNA abundance of SCD1 and SCD2 in mice 
fed  t10c12-CLA and PHVO resulted in reduced 18:1c9 in milk, compared to Control. 
Yield of 18:1c9 was also reduced by t7-18:1 but not by the other trans-18:1 
treatments.   Supplementation of t7-18:1 decreased SCD1 but not SCD2, suggesting 
that the desaturation of t7-18:1 to t7c9-CLA may have been regulated by the SCD2 
gene isoform.The expression of LPL, controlls the uptake of LCFA for milk fat 
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synthesis, was not affected by treatment, suggesting that the changes in milk fat 
occurred at the level of de novo FA synthesis and TAG formation rather than FA 
uptake. The lack of an effect of diets containing t-9-18:1 or t11-18:1 on the mammary 
lipogenic gene expression is consistent with their inability to alter milk fat content. 
 Harvatine and Bauman (2006) suggested that the coordinated suppression of 
lipogenic genes in mammary tissue during MFD is controlled via a common 
regulatory mechanism involving the transcription factor SREBP-1c.  SREBP-1c is 
known to regulate at least 30 genes involved in FA and cholesterol metabolism 
(Horton et al., 2003) including ACACA, FAS, SCD and LPL (Shimomura et al., 1998). 
SREBP-1c, synthesized as a precursor protein, is associated with SCAP and is 
anchored to the endoplasmic reticulum membrane through INSIG proteins (Horton et 
al., 2002; Liang et al., 2002). Upon detaching from INSIG proteins, SREBP-1c is 
escorted by SCAP to golgi and is processed to an active fragment, before 
translocation to the nucleus to activate the lipogenic genes (Rawson, 2003). 
Formation of the active nuclear form of SREBP-1c is predominantly regulated 
at the level of transcription by insulin (43), LXRA (44), and SREBP-1c (feed-forward 
regulation) (Horton et al., 2002) and at the level of proteolytic processing of the 
precursor SREBP protein by co-regulators such as INSIG1 (Engelking et al.,2004; 
Takaishi et al., 2004) and SCAP (Matsuda et al., 2001). In this study, SREBP-1c 
mRNA abundance was significantly decreased by t10c12-CLA and PHVO. However, 
these effects were probably not mediated through LXRA as the treatments did not 
affect the LXRA mRNA expression.  Decreased SCAP mRNA expression in response 
to feeding t10c12-CLA and PHVO indicated post-transcriptional secondary 
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regulation of SREBP. Conversely, t7-18:1 treatment tended to increase SREBP-1c 
expression, which correlated with higher LXRA mRNA. There was a tendency of the  
t7-18:1 diet to decrease (20%) SCAP mRNA and to increase (30%) INSIG1 mRNA 
expression, possibly leading to a reduced synthesis of active SREBP-1c form 
(Takaishi et al., 2004; Matsuda et al., 2001). Consequently, the MFD effects of t7-
18:1 might be regulated through the SREBP co-activators SCAP and INSIG1.   
Milk fat depression in dairy cows is generally characterized by a 20 to 50% 
reduction in milk fat content (Baumgard et al., 2001).  Post-ruminal infusion of 
t10c12-CLA (Baumgard et al., 2001) or feeding MFD-diets (Piperova et al., 2000) 
have not reduced milk fat by more than 50%. Similarly, ~50% reduction in FA 
synthesis was observed in liver of SREBP-1c knockout mice (Liang et al., 2002), 
indicating that lipogenic gene expression was incompletely suppressed. This suggests 
a role for other transcription regulators in liver lipogenesis.  Recently, a series of 
studies in vitro (Liang et al., 2002) using primary hepatocytes demonstrated that 
glycolytic and lipogenic gene expression is synergistically regulated by SREBP-1c 
and ChREBP.  A study with SREBP1c-/- knockout mice has confirmed the role of 
ChREBP in coordinated control of glucose metabolism, FA, and TAG synthesis 
(Lizyka et al., 2004).  However, ChREBP has to form a heterodimeric complex with 
another transcription factor, Mlx, for induction of the target genes (Stoeckman et al., 
2004; Ma et al., 2005). In this study, mammary mRNA expression of ChREBP was 
decreased with the t10c12-CLA but not with the other treatments. This effect on 
ChREBP could partially explain the differences in the degree of MFD observed 
between t10c12-CLA and the other FA treatments.   
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 The expression of PPARA and PPARG, known to regulate expression of genes 
involved in liver and adipose tissue lipid metabolism (Smith, 2002) were measured. 
PPARA is also associated with up regulation of genes involved in FA oxidation 
(Smith, 2002). In this study, the expression of PPARA was decreased with PHVO and 
t10c12-CLA, indicating that FA oxidation is not a contributor to MFD. The PPARG 
is mostly expressed in adipose tissue and its role in mammary gland is not well 
understood (Rudolph et al., 2007).  It was observed a decrease in PPARG mRNA 
abundance in the mammary tissue with t10c12-CLA but not with the other treatments. 
Similar effects of t10c12-CLA on PPARG gene expression were reported in mature 
adipocytes (Granlund et al., 2003). These results suggest that the t10c12-CLA effects 
on FA synthesis could be regulated via similar mechanisms in both mammary and 
adipose tissues. 
 THRSP is a nuclear protein associated with regulation of de novo lipid 
synthesis in lipogenic tissues (Kinlaw et al., 1995). Although, the exact function of 
THRSP is unknown, it is speculated that it functions as an allosteric regulator of 
lipogenic genes (Lafave et al., 2006). Zhu et al. (2005) demonstrated that milk TAG 
content in THRSP-null mice was significantly reduced due to a decrease in de novo 
lipid synthesis. Similarly, Harvatine and Bauman (2006) reported that diet-induced 
MFD and t10c12-CLA treatment down regulated the expression of THRSP in 
mammary gland of lactating cows. It was observed that a decrease in THRSP mRNA 
expression reduction was proportional to the degree of MFD in mice fed t10c12-
CLA, PHVO and t7-18:1. 
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 Dietary effects of FA on hepatic lipogenesis during lactation are not well 
understood. We measured the FA profile and lipogenic gene expression in liver to 
determine the effects of trans-18:1 FA and t10c12-CLA on hepatic lipid metabolism 
during lactation. Compared to the proportions found in milk, only 40 to 60% of 
dietary trans-18:1 and 12% of t10c12-CLA isomers were transferred to liver, 
suggesting preferential uptake by the lactating mammary tissue. Liver FA content 
(total FAME per g of liver) was significantly increased with supplementation of 
t10c12-CLA, PHVO, t7- and t11-18:1 and was associated with an increase in liver 
weight. Vishwanadha et al. (2006) reported increased liver weight in growing mice 
fed t10c12-CLA due to accumulation of fat in a dose-dependendent manner. Studies 
by Takahashi et al. (2003) found that accumulation of TAG in the liver of growing 
mice fed t10c12-CLA was accompanied by up regulation of FAS, SCD, THRSP and 
SREBP-1 gene expression. Others have reported that effects of FA on hepatic 
lipogenesis depend on the specific CLA isomer (Clement et al., 2002), duration of 
feeding (Wang et al., 2005) and physiological condition (Lin et al., 2004). Trans 
10c12-CLA is known to cause hepatic steatosis, while feeding c9t11-CLA has no 
effect on liver FA content (Clement et al., 2002). Hepatic steatosis in growing mice 
was observed during long-term (Vishwanatha et al., 2006, Clement et al., 2002) but 
not during short-term feeding (Wang et al., 2005) of t10c12-CLA. Dietary t10c12-
CLA did not affect liver lipid content or hepatic mRNA abundance of ACACA, FAS 
or SCD in lactating mice (Lin et al., 2004). We observed increased accumulation of 
fat without changes in the mRNA expression of major hepatic lipogenic genes, FASN, 
ACACA, SCD1, and THRSP in mice exhibiting MFD.  However, AGPAT mRNA 
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abundance was reduced by the PHVO, t10c12-CLA and t7-18:1 treatments, indicating 
decreased hepatic TAG synthesis. This suggests that the FA delivered by the blood 
TAG-rich lipoproteins were mostly responsible for the hepatic FA accumulation as 
reported by Degrace et al. (2003) in mice fed t10c12-CLA.  There was a shift in the 
proportions of major FA with a substantial increase in 16:0 and decrease in 18:0 in 
mice with expressed MFD. Similar changes in FA composition due to increased 
uptake of plasma NEFA were reported in postpartum cows with fatty liver 
(Rukkwamsuk et al., 1999).  The decrease in liver 18:0 content could be related to an 
increased FA oxidation, due to the up regulation of PPARA expression.  
All diets containing trans-18:1 FA increased expression of liver LPL 
controlling the FA uptake. About 80% of t7-18:1 and 45% of t11-18:1 transferred to 
liver was converted to t7c9-CLA and c9t11-CLA, respectively. To our knowledge, 
this is the first study to demonstrate direct conversion of t7-18:1 to t7c9-CLA in 
hepatic tissue. Compared to mammary gland, the conversion efficiency of the trans-
18:1 precursors to CLA isomers was greater in liver, most likely due to the higher 
expression of hepatic SCD1 or increased SCD2 mRNA abundance in mice fed the 
trans-18:1. 
 In contrast to the lipogenic genes, SREBP-1c expression was significantly up 
regulated in liver of mice fed t10c12-CLA and t7-18:1 diets. However, the INSIG1 
expression was concomitantly increased, which could lead to decreased synthesis of 
active SREBP-1c, and lack of response in the hepatic lipogenic genes. Hence, the FA 
effects on the hepatic lipogenesis could be mediated through INSIG1.  
 
 109
Development of offspring is affected by the maternal diet. Analysis of pup 
liver fat content and FA composition in this study showed that the supplemented FA 
were taken up by the nursing pups. The growth rate of pups nursing mothers with 
MFD was reduced presumably due to decreased energy intake. Decrease in growth 
rate was reported by others (Ringseis et al., 2004; Lin et al, 2004) for pups nursing 
from mothers fed t10c12-CLA.  Loor et al. (2003) reported a 28% decrease in body 
weight of pup litters nursing from dams fed t10c12-CLA.  
In conclusion, MFD was observed in mice fed t10c12-CLA, PHVO and t7-
18:1 diets. The t-7-18:1 isomer was extensively converted to t7c9-CLA in mammary 
and liver tissues of mice receiving the t7-18:1 treatment. Our data suggests that the 
MFD effects of t7-18:1 could have been mediated through t7c9-CLA. All MFD 
treatments altered milk fat at the level of de novo FA synthesis and TAG formation. 
The differences in the milk fat responses due to dietary FA could be related to their 
effects on multiple transcriptional regulators in the mammary gland. In addition to 
SREBP-1C, this study established involvement of ChREBP, THRSP, and PPARG, 
supporting involvement of multiple transcriptional regulators in the regulation of milk 
fat synthesis. Lastly, the effects of FA on lipogenic gene expression were more 
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Table 4.1. Fatty acid composition of the diets fed to lactating mice 
 
 TREATMENT 
Fatty Acid Control PHVO 
t10c12 
CLA t7 18:1 t9-18:1 t11-18:1
                                       ------------------------g/100g FAME----------------------------------- 
14:0 0.4 0.2 0.2 0.2 0.2 0.3 
16:0 11.9 8.8 12.0 11.3 11.6 11.4 
16:1 cis 0.4 0.1 0.4 0.4 0.4 0.4 
18:0 7.3 6.8 6.8 7.1 7.6 7.1 
18:1 cis-9 57.7 47.6 51.9 38.0 38.2 37.5 
18:1 cis-11 0.9 1.8 1.0 1.0 0.9 1.0 
Trans-18:1 isomer:       
   6+7+8  ND1 0.9 0.1 21.1 ND ND 
   9 0.1 7.6 0.1 ND 19.9 ND 
  10 ND 1.5 ND ND ND ND 
  11 ND 1.4 ND ND ND 20.8 
  12 ND 0.8 ND ND ND ND 
  13+14 ND 0.9 ND ND ND ND 
  15 ND 0.5 ND ND ND ND 
  16 ND TR2 ND ND ND ND 
18:2n-6 18.7 18.0 19.5 19.0 19.1 19.3 
18:2i 0.1 0.9 0.1 0.1 0.1 0.1 
18:3n-3 0.6 0.9 0.3 0.6 0.6 0.5 
20:0 0.3 0.3 0.5 0.5 0.0 0.5 
20:1cis-11 0.2 0.1 0.3 0.2 0.2 0.2 
22:0 0.2 0.3 0.2 0.0 0.2 0.1 
cis-9,trans-11CLA 0.1 TR 0.2 TR TR 0.1 
Trans-10, cis-12 CLA TR TR 6.1 TR TR TR 
Other 1.2 0.4 0.4 0.4 0.9 0.4 
1 ND – not detected 



















( r ) 
 Mam1 Liver Mam Liver 
FASN 106 ACCTCTCCCAGGTGTGTGAC TGGATGATGTTGATGATGGA 58.9 90.8 91.3 0.999 0.996 
ACACA 106 GAAAATCCACAATGCCAACC GTCCCAGACGTAAGCCTTCA 58.9 97.7 101.5 0.999 0.995 
AGPAT 125 TTGTCTGTTGCGTTCTGAGG GCCTGTGAGGAGTGTCAGGT 63.3 88.0 85.5 1.000 0.999 
SCD1 124 TCCAGTGAGGTGGTGTGAAA TTATCTCTGGGGTGGGTTTG 63.3 97.1 84.8 0.999 0.999 
SCD2 109 TGTGCCTATGTCCCAGATGA GAAACGGAGTCCTGCATGTT 63.3 90.8 84.8 0.999 0.998 
LPL 119 AGCCCTTGCTAGGAGAAAGC GGGATGCCGGTAACAAATTA 58.9 84.6 85.1 1.000 1.000 
THRSP 116 AGCAAACACGGAATCCAAAG CTTTCCCCAGGGATAAAAGC 58.9 98.0 88.1 0.995 0.998 
SREBP1 103 GTGAGCCTGACAAGCAATCA GGTGCCTACAGAGCAAGAGG 63.3 85.7 85.5 0.994 1.000 
ChREBP 119 TCCTGCACTGTTGCTAATGC TCCTGTTTAGGTCCCCAGTG 63.3 85.9 86.2 0.997 0.999 
PPARA 117 ACTTCGCTATCCAGGCAGAA CAGACCAACCAAGTGTTGTGA 58.9 85.0 92.6 1.000 0.996 
PPARG 94 TGCAGCTCAAGCTGAATCAC ACGTGCTCTGTGACGATCTG 58.9 93.2 94.1 0.999 0.999 
LXRA 108 GATCTGGGATGTCCACGAGT GTCTGCCCTTCTCAGTCTGC 63.3 97.0 85.1 1.000 0.999 
RXR 107 TCCTTGGGAGGGTCTTCTCT GGGCAGGTAGCAACACAGAT 63.3 98.2 81.4 1.000 1.000 
SCAP 106 TCAGCCAAACATTTGCTCAC CTGCGGTCCCAGATACTGAT 58.9 89.7 85.1 0.998 1.000 
INSIG1 105 TGAGTCGCTGTCTGCTGTTT TCACAGATTGCAAGCTCCAC 63.3 89.2 86.0 0.999 1.000 
Mlx 116 AGTCTGTTCAGGGAGCCTCA GAGACCAAGCAGAGGCAAAC 63.3 85.4 90.0 0.999 0.999 
1Mam - Mammary tissue 
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Item Control PHVO 
t10c12 
CLA t7-18:1 t9-18:1 t11-18:1 
 
SEM 
       
Dam   
Milk fat (wt %) 22.55 17.43** 13.28** 16.70* 22.70 20.45 0.96
Milk production1 (g) 3.51 3.23 2.12 2.69 2.73 3.60 0.53
Body wt (g) 26.00 27.24 25.86 26.93 26.75 25.94 0.44
Feed intake (g) 6.98 6.53 5.35* 7.54 6.77 6.81 0.55
Liver wt (% body wt) 6.30 7.03 8.99** 7.49 5.62 6.54 0.58
Mammary tissue (g) 1.23 1.63 1.41 2.00** 1.38 1.35 0.18
        
Pups        
n/litter 6 6 7 7 7 6  
Avg. pup wt (g) 4.14 4.24 4.14 4.42 3.83 4.39 0.28
Pup growth rate (g/d) 0.31 0.25 0.16** 0.21* 0.21* 0.27 0.03
Litter liver tissue (g) 0.27 0.40 0.43 0.42 0.32 0.47 0.09
1 Calculated value 
* * P<0.01 
   * P<0.05
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Table 4.4. Concentrations of fatty acids in milk of mice fed trans-18:1 FA or t10c12-CLA 
 
 TREATMENT 
Fatty Acid Control PHVO 
t10c12   
CLA t7-18:1 t9-18:1 t11-18:1  SEM 
 ------------------------------------- g/100g FAME
1 ----------------------------------------- 
10:0 2.69 1.44 1.64 2.26 2.21 2.06 0.60 
11:0 0.15 0.08 0.04 0.16 0.13 0.17 0.04 
12:0 8.30 6.72 5.48** 6.98 7.74 8.34 0.61 
12:1 0.10 0.09 0.01** 0.09 0.10 0.12 0.03 
14:0 12.69 10.54 6.99** 10.71 12.37 13.58 0.65 
14:1 0.23 0.23 0.08** 0.21 0.23 0.17 0.03 
16:0 22.43 19.58* 17.99** 22.45 23.60 23.67 0.64 
16:1 trans 0.48 0.54 0.76** 0.35 0.44 0.41 0.05 
16:1 2.54 3.23 2.24 3.16 2.93 2.96 0.37 
18:0 1.84 1.90 3.08** 1.94 1.85 1.76 0.18 
18:1 cis-9 35.38 36.04 3.94** 32.28 31.67 29.08* 1.36 
18: 1cis-11 2.03 2.84** 2.03 2.57 2.24 2.29 0.17 
Total trans-18:1 0.02 3.67** ND2 1.56 3.07** 1.78 0.46 
18:2 n-6 7.16 7.76 9.88** 8.73 7.88 7.83 0.37 
Total CLA 0.23 0.65 1.82** 2.41** 0.22 1.13** 0.12 
18:3 n-3 0.05 0.04 0.06 0.01 0.02 0.04 0.03 
20:0 0.02 ND 0.13 ND ND ND 0.03 
20:1 1.48 1.51 1.41 1.73 1.30 1.54 0.18 
20:2 0.58 0.72 0.63 1.04 0.71 0.92 0.11 
20:3 0.59 0.51 0.38 0.29 0.43 0.57 0.08 
20:4 0.54 0.78 1.32 0.53 0.40 0.68 0.10 
22:1 0.19 0.19 0.15 0.27 0.13 0.18 0.04 
22:4 0.27 0.29 0.26 0.10 0.10 0.70 0.16 
Other 0.13 0.11 0.27 0.04 0.13 0.08 0.06 
Summary:        
<16:0 24.18 19.16 14.26** 20.36 22.74 24.39 1.58 
16:0 22.42 19.57* 17.99** 22.44 23.60 23.62 0.62 
>16:0 50.48 57.74* 66.68** 53.41 50.18 48.00 1.67 
MUFA3 40.26 42.53 48.86** 38.21 37.08 34.52 1.54 
1 FAME - Fatty acid methyl esters 
2  ND - Not detected 
3 MUFA - Mono unsaturated fatty acids 




Table 4.5. Concentrations of trans-18:1  and CLA isomers in milk fat of lactating mice fed trans- 
  18:1 FA or t10c12-CLA 
 
 TREATMENT 
Fatty Acid Control PHVO 
t10c12 
CLA t7-18:1 t9-18:1 t11-18:1  SEM 
                                --------------------------------------g/100g FAME1-------------------------------------- 
Total 18:1 trans 0.02 3.68**   ND2 1.56* 3.07** 1.78* 0.46 
Trans 18:1 isomer:       
    6+7+8 ND 0.47* ND 1.56** ND ND 0.12 
    9 0.02 0.85** ND ND 3.07** ND 0.13 
  10 ND 1.13** ND ND ND ND 0.12 
  11 ND 0.35* ND ND ND 1.78** 0.15 
  12 ND 0.48** ND ND ND ND 0.05 
  13+14 ND 0.40** ND ND ND ND 0.06 
        
Total CLA 0.24 0.78** 1.91** 2.38** 0.22 1.13** 0.12 
CLA isomer:        
  cis-11, trans-13 0.02 0.10 0.01 0.02 0.01 0.11 0.02 
  trans-10, cis-12 ND ND 1.42 ND ND ND 0.09 
  cis-9, trans-11 0.19 0.48** 0.21 0.16 0.19 1.01** 0.06 
  trans-8, cis-10 TR3 0.01 0.08* ND 0.01 0.01 0.01 
  trans-7, cis-9 ND 0.08 ND 2.17** ND ND 0.02 
  trans, trans CLA 0.01 0.04 0.16* 0.01 0.06 0.04 0.02 
  cis, cis CLA TR 0.02 0.03* 0.03 TR 0.01 0.01 
1 FAME – Fatty acid methyl ester 
2 ND - Not detected 
3 TR- traces (<0.01) 
* * P<0.01 
   * P<0.05
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Table 4.6.  Concentrations of fatty acids in liver of mice fed trans-18:1 FA or  t10c12-CLA 
 
 TREATMENT  
Fatty Acid Control PHVO 
t10c12  
CLA t7-18:1 t9-18:1 t11-18:1 SEM 
Total FAME/liver, 
dry, (g) 0.26 0.35** 0.47** 0.36* 0.30 0.33* 0.03 
   ----------------------------------  g/100g FAME1 -----------------------------------
14:0 0.54 0.55 0.74** 0.64* 0.62* 0.55 0.03 
16:0 12.88 13.44 21.51** 17.01** 15.27* 13.87 0.68 
16:1 1.47 1.92 2.80** 2.10 2.05 1.85 0.23 
16:1t 0.02 0.01 0.02 0.03 0.02 0.02 0.00 
17:0 0.08 0.06 0.06 0.01 0.09 0.09 0.01 
17:1 0.13 0.12 0.11 0.14 0.12 0.10 0.01 
18:0 6.54 5.04** 3.67** 4.57** 5.63 5.10** 0.37 
18:1 cis-9 55.15 55.37 54.01 54.00 51.18 54.32 1.74 
18:1 cis-11 3.90 4.07 3.72 4.27 3.79 3.79 0.27 
Total trans-18:1 0.28 1.56** 0.28 0.45 2.09** 0.95** 0.14 
18:2 7.14 6.53 6.00 7.87 8.68 8.29 0.85 
Total CLA 0.56 0.57 0.54 1.50** 0.60 1.35** 0.06 
GLA2 0.20 0.16 0.15 0.09 0.24 0.26 0.04 
18:3 1.51 1.36 1.13* 1.58 1.37 1.39 0.07 
20:0 0.06 0.04 0.04 0.04 0.06 0.03 0.01 
20:2 0.19 0.07 0.08* 0.11 0.21 0.16 0.04 
20:4 5.11 3.61* 1.91** 2.63** 4.30 4.01 0.42 
22:0 0.77 0.48* 0.26** 0.33** 0.83 0.66 0.09 
24:0 0.11 0.11 0.06 0.08 0.17 0.14 0.04 
Other 3.40 4.73* 3.00 2.75 2.81 3.25 0.27 
1 FAME - Fatty acid methyl ester 
2 GLA - Gamma linoleic acid 
* * P<0.01 
   * P<0.05
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Table 4.7. Concentrations of trans-18:1  and CLA isomers in liver fatty acids of lactating mice fed 
trans-18:1 or t10c12-CLA. 
 
 TREATMENT  
Fatty Acid Control PHVO 
t10c12-
CLA t7 18:1 t9 18:1 t11-18:1 SEM 
                               ---------------------------------  g/100g FAME1 ----------------------------------
Total trans-18:1 0.28 1.56** 0.28 0.45 2.09** 0.95** 0.14 
Trans 18:1 isomer:        
    6+7+8  ND2 0.05  0.27    
    9 0.22 0.28 0.13 0.08 1.94** 0.11 0.09 
  10   0.62     0.05 
  11  0.03 0.14** 0.12 0.02 0.14 0.80** 0.14 
  12   0.21      
  13+14   0.13      
  16  0.02 0.13* 0.02 0.08 0.02 0.04 0.03 
        
Total CLA 0.56 0.57 0.54 1.50** 0.60 1.35** 0.06 
CLA isomer:        
  trans-7, cis-9  0.02  1.00   0.15 
  cis-9, trans-11  0.04 0.25** 0.07 0.08 0.03 0.64** 0.04 
  trans-10, cis-12   0.20**    0.01 
  cis-11, trans-13 0.07 0.04 0.06 0.15 0.03* 0.06 0.02 
  trans-11, trans-13 0.08 0.01 0.12 0.05 0.26 0.15 0.06 
  cis, cis CLA 0.36 0.24 0.12** 0.24 0.27 0.36 0.07 
1 FAME - Fatty acid methyl ester 
2 ND – Not detected 
* * P<0.01 




Table 4.8.  Concentrations of fatty acids in liver tissues of pups nursing dams fed trans-18:1 FA or 
t10c12-CLA 
 
 TREATMENT  
Fatty Acid Control PHVO 
t10c12 
CLA t7-18:1 t9-18:1 t11-18:1 SEM 
                                               -------------------------  g/100g FAME1 --------------------------  
Total FAME/liver (g), dry 0.17 0.14 0.11 0.13 0.18 0.14 0.02
        
14:0 2.99 2.17 0.93** 2.09 2.68 2.28 0.33
16:0 23.30 21.72 22.02 24.04 23.31 24.59 0.90
16:1 0.13 0.98 0.75* 1.08 1.19 1.02 0.12
16:1t 0.08 0.03 0.07 0.06 0.07 0.06 0.02
17:0 0.09 0.09 0.17** 0.12 0.10 0.12 0.01
17:1 0.08 0.10 0.16* 0.09 0.11 0.09 0.02
18:0 11.25 10.87 15.76* 12.93 10.90 12.86 1.38
18:1 cis-9 27.94 24.71 21.36 22.15 24.16 19.91 3.21
18:1 cis-11 2.15 2.15 1.85* 2.17 2.25 2.08 0.10
Total trans-18:1 0.10 3.47** 0.23 0.67* 2.37** 1.42** 0.16
18:2 11.89 12.91 12.77 14.51** 13.04* 13.06* 0.32
Total CLA 0.73 0.30 0.71 0.52 0.59 0.53 0.09
GLA2 0.31 0.32 0.21 0.26 0.36 0.34 0.05
18:3 0.53 0.47 0.46 0.54 0.51 0.48 0.05
20:0 0.25 0.05** 0.56* 0.03** 0.02** 0.02** 0.04
20:2 0.48 0.57 0.40 0.61 0.44 0.54 0.08
20:4 13.93 14.66 19.27 14.92 14.42 16.57 1.81
22:0 0.32 0.39 0.41 0.27 0.32 0.22 0.07
24:0 0.35 0.53 0.29 0.09 0.26 0.55 0.23
Others 2.72 4.03 3.06 2.88 3.06 3.27 0.35
1 FAME - Fatty acid methyl ester 
2 GLA - Gamma linoleic acid 
* * P<0.01 
   * P<0.05
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 Table 4.9. Concentrations of trans-18:1  and CLA isomers in liver of pups nursing dams fed trans-
18:1 FA or t10c12-CLA. 
 
 
 TREATMENTS  
 Control PHVO 
t10c12-
CLA t7-18:1 t9-18:1 t11-18:1 SEM 
                               ---------------------------------  g/100g FAME1 -------------------------------
Total trans-18:1 0.10 3.47** 0.23   0.67*  2.37**   1.42** 0.16 
Trans isomer:        
    5 ND2 0.03 ND ND ND ND 0.01 
    6+7+8 ND 0.15** ND  0.49** ND ND 0.06 
    9 0.07 0.63** 0.12   0.09  2.30**   0.08 0.11 
  10 ND 0.73 0.03 ND ND ND 0.06 
  11 0.03 0.59** 0.05   0.05 0.04 1.33** 0.05 
  12 ND 0.69 ND ND ND ND 0.07 
  13+14 ND 0.58 ND ND ND ND 0.08 
  16 ND 0.08 0.03   0.04 0.04 0.02 0.01 
       
Total CLA 0.73 0.30 0.71   0.52 0.59   0.53 0.09 
CLA isomer:        
  trans-7, cis 9  ND 0.02** ND  0.40** ND ND 0.14 
  cis-9, trans-11  0.04 0.16** 0.05   0.06 0.03  0.40** 0.03 
  trans-10, cis-12 ND ND  0.24** ND ND ND 0.04 
  cis-11, trans-13 ND ND  0.24** ND 0.03   0.04 0.04 
  trans-11, trans-13 0.11 0.09 0.06   0.05 0.12   0.09 0.02 
  cis ,cis CLA 0.54 0.03* 0.11   0.02 0.36   0.03 0.12 
        
1 FAME - Fatty acid methyl ester 
2 ND – Not detected 
* * P<0.01 
   * P<0.05
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Figure 4.1A. Effects of trans18:1 FA and t10c12 CLA on the expression of mammary FASN, ACACA, AGPAT, SCD1, SCD2, LPL and THRSP. 
Values are means±S.E, n=7 for control, 3 for t7-18:1 and 5 for PHVO, t9- and t11-18:1 treatments. Values are molecules/50ng of RNA. 
Asterisks indicate differences from Control. * P<0.05 and **P<0.01. 
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* * P<0.01 
   * P<0.05
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Figure 4.1B. Effects of trans18:1 FA and t10c12 CLA on the expression of mammary 
mammary transcriptional regulators SREBP1, ChREBP, PPARA, PPARG, LXRA and 
RXR . Values are means±S.E, n=7 for control, 3 for t7-18:1 and 5 for PHVO, t9- and 
t11-18:1 treatments. Values are molecules/50ng of RNA. Asterisks indicate 










* * P<0.01 




Figure 4.1C. Effects of trans18:1 FA and t10c12 CLA on the expression of mammary 
and transcriptional co-activators SCAP, INSIG1 and Mlx. Values are means±S.E, n=7 
for control, 3 for t7-18:1 and 5 for PHVO, t9- and t11-18:1 treatments. Values are 






































Figure 4.2A. Effects of trans18:1 FA and t10c12 CLA on the expression of hepatic 
FASN, ACACA, SCD1,and THRSP. Values are means±S.E, Control n=7, t7-18:1 n=3 
and PHVO, t9- and t11-18:1 n=5. Values are molecules/50ng of RNA. Asterisks 
indicate differences from Control. *P<0.05, and **P<0.01. 
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Figure 4.2B. Effects of trans18:1 FA and t10c12 CLA on the expression of AGPAT, 
SCD2 and LPL in liver. Values are means±S.E, Control n=7, t7-18:1 n=3 and PHVO, 
t9- and t11-18:1 n=5. Values are molecules/50ng of RNA. Asterisks indicate 
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* * P<0.01 
   * P<0.05
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Figure 4.2C. Effects of trans18:1 FA and t10c12 CLA on the expression of hepatic 
transcriptional regulators- SREBP1, ChREBP, PPARA, PPARG, LXRA and RXR . 
Values are means±S.E, Control n=7, t7-18:1 n=3 and PHVO, t9- and t11-18:1 n=5. 
Values are molecules/50ng of RNA. Asterisks indicate differences from Control. 




























* * P<0.01 




Figure 4.2D. Effects of trans18:1 FA and t10c12 CLA on hepatic expression of 
transcriptional co-activators SCAP, INSIG1, Mlx. Values are means±S.E, Control 
n=7, t7-18:1 n=3 and PHVO, t9- and t11-18:1 n=5. Values are molecules/50ng of 
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The objective of this study was to compare the effects of abomasal infusion of 
butterfat containing all fatty acids (FA) present in milk, including the short and 
medium chain FA, with infusion of only the long chain FA (LCFA) present in milk, 
on the FA composition and milk fat yield in lactating dairy cows. Eight rumen 
fistulated Holstein cows, in early lactation (49±20 DIM) were used in a replicated 4x4 
Latin square design.  Treatments were abomasal infusion of: 1) no infusion (Control);  
2) 400 g/d butterfat (Butterfat);  3) 245 g/d LCFA (blend of 59% cocoa butter, 36% 
olive oil, and 5% palm oil) providing 50% of the 16:0 and equivalent amounts of C18 
FA as found in 400 g of butterfat; and 4) 100 g/d conjugated linoleic acid (CLA, 
negative control), providing 10 g of t10c12 CLA. Fat supplements were infused in 
equal portions 3 times daily at 0800, 1400, and 1800 h during the last 2 wk of each 3 
wk experimental period. Daily dry matter intake (DMI) and milk production were 
unaffected by the infusion treatments. Butterfat infusion increased milk fat percentage 
by 14% (P < 0.03) to 4.26% and milk fat yield by 21% (P < 0.02) to 1421 g/day 
compared with Controls (3.74 % and 1178 g/day).  Milk fat percentage and fat yield 
were decreased by 43% (P < 0.001) by CLA.  Milk protein percentage was higher 
(3.70%; P < 0.01) in CLA infused cows than in Control (3.30%), Butterfat (3.28%) or 
LCFA (3.27%) treatments.  While LCFA had no effect on fat synthesis, abomasal 
infusion of butterfat increased milk fat percentage and yield suggesting that the 
availability of short and medium chain FA may be a limiting factor for milk fat 




 The current milk component pricing system (MCP) was introduced by the 
Federal Milk Marketing Administration in 2000. Accordingly, there has been a shift 
in the producer payment from the historic system based on the volume of milk 
(adjusted for fat content) to one based primarily on the amounts of milk fat and 
protein produced. The MCP system provides a powerful economic incentive for dairy 
producers to produce high value milk components, namely fat and protein. Milk 
component yields are driven by both milk volume and component concentration. The 
dairy cow’s diet has no effect on milk lactose and mineral content (Sutton, 1989). 
Compared to milk fat responses, only modest effects of diet have been reported on 
milk protein concentration (Sutton, 1989). Milk fat is the milk component most easily 
manipulated by diet (Sutton, 1989). Reports in the literature have shown that milk fat 
percentage and yield can be reduced up to 46% (Piperova et al., 2000; Peterson et al., 
2003) by milk fat depressing diets (MFD) containing high levels of grain and 
polyunsaturated fatty acids (PUFA).  
In contrast, very few studies have demonstrated consistent ways to increase 
milk fat concentration.  Abomasal infusion of mostly saturated long chain fatty acids 
(LCFA) tended to increase milk fat yield compared with infusion of mostly 
unsaturated fatty acids (FA) or mixtures of both (Drackley et al., 1992). Abomasal 
infusion of canola, soybean or sunflower oil did not significantly affect milk fat 
percentage in lactating cows, but changed milk FA profile reflecting the FA 
composition of the infused oils (Christensen et al., 1994). Inclusion of fats and oils in 
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the diet of lactating cows usually decreases the proportion of de novo FA produced by 
the mammary gland (Clapperton and Banks, 1985; LaCount et al., 1994)   
Short and medium chain FA (6:0 to 14:0, plus 50% of 16:0), constitute 50% of 
total milk FA and originate from de novo FA synthesis in the mammary gland 
(Palmquist and Jenkins, 1980). These FA are essential for the formation of milk 
triacylglycerols (Moore and Christie, 1979) and for maintaining the fluidity of milk 
fat (Barbano and Sherbon, 1980). With exception of oleic acid, which is produced 
from stearic acid by the delta-9 desaturase system in the mammary gland, the LCFA 
in milk are derived from dietary sources (Palmquist and Jenkins, 1980).  Experiments 
with MFD in lactating cows have demonstrated that yields of short and medium chain 
FA synthesized de novo were reduced to a greater extent than LCFA yields (Loor and 
Herbein, 1998; Chouinard et al., 1999; Baumgard et al., 2002).  These observations 
suggest that provision of short and medium chain FA via dietary means might 
enhance milk fat content, reducing the need for de novo synthesis.  
One could reason that a fat containing the FA composition identical to milk 
fat would provide the “Ideal” fat supplement for milk fat production.  Alternatively, if 
short and medium chain FA are not limiting, then a fat supplement containing only 
LCFA with a composition identical to that found in milk fat would be “Ideal” for 
meeting the needs of FA that are typically absorbed from the diet.  These conceptual 
approaches were used as means to potentially increase milk fat synthesis.  The 
objective of this study was to compare the effects of abomasal infusion of butterfat 
containing all FA present in milk, including the short and medium chain FA, with 
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infusion of only the long chain FA present in milk, on the FA composition and milk 
fat yield in lactating dairy cows. 
  
MATERIALS AND METHODS 
Animals, Experimental Design, Treatment and Sampling 
All procedures for this experiment were conducted under a protocol approved by 
the University of Maryland Institutional Animal Care and Use Committee.  Eight 
rumen fistulated multiparous Holstein cows in early lactation (49±20 DIM) were used 
in a replicated 4x4 Latin square design balanced for carryover effects.  Treatments 
were abomasal infusion of:  1) no infusion (Control);  2) 400 g/d butterfat as a source 
of short and long chain FA (Butterfat);  3)  245 g/d of a LCFA mixture providing 
50% of the 16:0 and equivalent amounts of C18 FA as found in 400 g of butterfat 
(LCFA); and 4) 100 g/d of commercial conjugated linoleic acid (CLA) mixture 
providing 10 g of trans (t)10, cis(c)12 CLA/day which served as a negative control.   
In the LCFA treatment, only 50% of the palmitic acid found in the butterfat was 
included, as 50% of palmitic acid is thought to be synthesized de novo (Palmquist and 
Jenkins, 1980).  The LCFA mixture was a blend of 59% cocoa butter, 36% olive oil 
(Unilever, Englewood Cliffs, NJ), and 5% palm oil (GloryBee Foods Inc., Eugene, 
OR, USA).  In the Butterfat treatment, butter oil was prepared from commercially 
available unsalted butter (Wellsley Farms, USA) melted at 37°C, and separated from 
the protein coagulate by filtering.  The CLA mixture was provided by Vitrus 
Nutrition (Corcoran, CA). Amounts of post-ruminally infused individual FA in the 
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LCFA mixture and Butterfat are shown in Figure 5.1.  The FA composition of the fat 
supplements is presented in Table 5.1. 
Experimental periods were 3 wk.  The first wk of each period was without fat 
infusion to reduce carryover effects. This was followed by 2 wk of abomasal infusion.  
The fat was infused via tygon® tubing (0.48 cm i.d, 0.64 cm o.d; VWR Scientific, 
Bridgeport, NJ) that  passed through the ruminal cannula, the rumen, the omasum and 
into the abomasum, where the line was maintained using a 10 cm circular plastisol 
flange.  The fat mixtures were solubilized at 50°C in air oven and mixed well before 
infusion. The amount of each FA mixture was divided into equal portions and 
manually infused three times a day (133.33 g of butterfat, 81.6 g of LCFA and 33.33 
g of CLA at 0800, 1400, and 1900 h). Actual amounts of infused fat were recorded 
each day.  Patency and location of the infusion line inside the cow were checked on 
alternate days. 
Cows were housed in individual tie stalls and were fed a basal diet containing 
55% forage and 45% concentrate (DM basis) to meet NRC (2001) nutrient 
specifications for a 650 kg cow producing 40 kg milk containing 3.7% milk fat and 
3.1% milk protein. Ingredient and chemical composition of the basal diet is given in 
Table 5.2. Diets were fed as TMR once daily at 0800 h.  Forage and ingredient DM 
were measured weekly, and the TMR was adjusted accordingly to maintain a constant 
forage-to-concentrate ratio on a DM basis.  Amounts of feed offered and refused were 
recorded once daily.  Cows were milked twice-a-day at 0600 and 1600 h and milk 
production was recorded electronically at each milking.  Samples for milk 
composition and FA analysis were collected from the last 6 consecutive milkings of 
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wk 3 of each experimental period. Milk fat, protein, and SCC were determined by 
infrared analysis (Foss Milk-O-Scan, Foss Food Technology Corp., Eden Prairie, 
MN) on fresh samples from individual milkings.  A subset of samples from each 
milking was composited and frozen at -20oC for subsequent analysis of individual 
FA.  
Fatty acid composition 
 Milk fat was extracted using a modified Folch procedure (Christie, 1982) from 
composited wk 3 samples. The FA methyl esters (FAME) were prepared by mild 
transesterification with 0.4 mol/L H2SO4 in methanol (Christie, 1982) at room 
temperature, using trinonadecenoin (Nu-Chek Prep, Inc. Elysian, MN, USA) as 
internal standard (Piperova et al., 2002). The FAME were analyzed using Agilent 
6890 gas chromatograph (Agilent Technologies, Santa Clara, CA, USA) equipped 
with a Supelco 2560 capillary column (100 m x 0.25 mm, 0.2 mm, Supelco) and a 
FID detector.  The column was maintained at 173°C isothermal.  Hydrogen was used 
as carrier gas with a linear velocity of 26 cm/s, and split ratio 1:100.  The injection 
port and detector were maintained at 250°C.  Detector air flow was 400 ml/min, and 
hydrogen flow was 30 ml/min. Helium make-up gas was used at 30 ml/min.  
Individual FA and 18:1 isomers were identified using GLC-463 standard mixture 
(Nu-Chek Prep Inc., Elysian, MN). 
Although GC conditions can be adjusted to quantify fatty acids methyl esters 
from 8:0 to 12:0 with some accuracy, the very short fatty acid methyl esters are 
volatile, water soluble and require correction factors (Krammer et al., 1997). To avoid 
 
 142
these difficulties, short and medium chain fatty acids were analyzed as butyl esters 
(FABE), which were mathematically converted to FAME and normalized to the 
FAME chromatogram.  The original FABE procedure of Gander et al., (1963) was 
modified as previously described (Piperova et al., 2000).  Milk samples (200 µL), in 
screw capped glass tubes were heated at 100°C for 1h in the presence of 1 mL of 
butyl alcohol and 200 µL of acetyl chloride. Aliquots of the upper layer, containing 
FABE were analyzed on a short 25 m x 0.2 mm fused silica capillary column coated 
with HP1 (Hewlett Packard; Avondale, PA) using a Hewlett-Packard 5880 GLC 
(Avondale, PA) equipped with a split injector and flame ionization detector. Helium 
was used as the carrier gas at a flow rate of 2mL/min with a split ratio of 45:1. After 5 
min at 90°C, the column temperature was raised (4°C /min) to 106°C and at 10 
minutes, programmed at 5°C/min to a final temperature of 250°C. Standard mixtures, 
including GLC-60 (Nu-Chek Prep Inc., Elysian, MN), were converted to FABE to aid 
in the identification and quantification of components.  
 Individual CLA were analyzed as methyl esters using a Waters 2690 HPLC 
(Waters Associates, Milford, MA) separations module, equipped with a waters 2996 
PDA detector, and 3 Chromspher 5 lipids (250x 4.6 mm, 5 µM, Varian) HPLC 
columns in series.  The mobile phase was 0.1% acetonitrile in hexane, at 1 ml/min, 
kept in a sealed bottle at -15oC. The PDA detector was operated between 190 nm and 
300 nm, and HPLC chromatograms read at 233 nm were used for quantitative 
analysis.  Columns were maintained at 20°C.  Typical injection volume was 1 µL, 
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containing 10-25µg of FAME.  A CLA standard mixture (Nu-Chek Prep Inc., 
Elysian, MN) was used to identify individual isomers. Details on the identification 
and quantification of the CLA isomers by HPLC analysis have been reported 
elsewhere (Eulitz et al., 1999;  Sehat et al., 1998). 
Statistical analysis 
Milk production, milk components, and FA composition data were analyzed 
as a replicated 4 x 4 Latin square using the Mixed Procedure in the Statistical 
Analysis System (Version 8.2, 2004, SAS Institute, Cary, NC).  The fixed effects 
were the treatments while the random portion of the model included cow, square, and 
period. Probability of P ≤ 0.05 was considered statistically significant.  One cow was 
diagnosed with displaced abomasum at the end of Period 1 that was surgically 
repaired.  To allow for recovery from surgery, data from this cow were not included 
for experimental Periods 1 and 2 (Control and LCFA treatments, respectively).  
Because of missing data for this cow, the results are presented as least squares means. 
The largest standard error was reported in the treatments with unequal replication. 




 The FA profile of the infused mixtures is presented in Table 5.1.  Butterfat 
infusion provided short and medium chain FA (C < 16), in addition to palmitic acid 
and C > 18 LCFA.  Also, the Butterfat treatment contained small amounts of CLA 
(0.63 %) with c9t11 CLA being the predominant isomer.  The LCFA mixture was 
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formulated to provide equivalent amounts of LCFA of dietary origin, as in the infused 
butterfat, assuming that 50% of 16:0 in milk fat is derived from the diet. The CLA 
supplement contained 55% of CLA with c9t11 (14.59%), c11t13 (9.44%) and t10c12 
(9.66%) being the major isomers.  
  Average daily DMI, milk production, and milk composition are presented 
in Table 5.3.  The daily DMI and milk production was not affected by the infusions. 
However, Butterfat infusion significantly (P < 0.05) increased FCM (3.5%) compared 
to the Control. Milk production efficiency (FCM/NELI) was lower with CLA 
infusions but did not differ due to butterfat or LCFA infusions from the Control.  
  Butterfat infusion increased milk fat percentage by 14% (P < 0.03) to 4.26% 
and milk fat yield by 21% (P < 0.02) to 1421 g/day compared to controls (3.74 % and 
1178 g/day).  Infusion of LCFA had no effect on either milk fat percentage or milk fat 
yield although milk fat yield was numerically (8.5%) higher compared to Controls.  
Infusion of CLA decreased milk fat percentage and fat yield by 43% (P < 0.001), 
while, milk protein percentage was 0.40 to 0.43 percentage units greater (3.70%; P < 
0.01) compared to the other treatments. 
 Concentrations (g/100g FAME) and yield (g/d) of individual FA in milk are 
shown in Tables 5.4 and 5.5, respectively.  Fatty acid concentrations of individual 
short and medium chain FA that are synthesized de novo in the mammary gland did 
not differ between Control and Butterfat or LCFA infused cows. Compared to the 
Controls, concentrations of C < 16:0 (total short and medium chain) FA, palmitic acid 
or C > 16:0 FA were not altered due to butterfat infusion while LCFA infusion 
decreased C<16:0 and palmitic acid but increased C > 16:0 FA. Concentrations of the 
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total monounsaturated FA (MUFA) were significantly greater (P < 0.05) in cows 
infused with Butterfat and LCFA compared to the Controls (Table 5.4). The yield of 
short and medium chain FA was increased by 21% with Butterfat (P < 0.05). Cows 
infused with butterfat produced milk with numerically the highest yield of 16:0 and 
significantly greater yields of 14:0, 15:0 and 17:0 (Table 5.5, P < 0.02, 0.01, and 
0.02, respectively). Milk of cows infused with Butterfat was enriched with 14:1, 16:1, 
17:1 and 18:1 cis, causing a 37% (P < 0.001) increase in the yield of total MUFA.  
Similar changes were observed in the yield of PUFA (18:2n-3, P < 0.004; 18:2i, P < 
0.001; and 18:3n-3, P < 0.001) with the Butterfat treatment. Yields of 18:1 cis-9 
(26% increase; P < 0.005) and 18:2n-6 (P < 0.002) FA were most affected by the 
LCFA infusion. Total saturated FA (SFA) were marginally increased with Butterfat 
and LCFA infusion. 
  Except for 4:0 concentrations, CLA infusion reduced concentrations (20%, 
P < 0.001) and yield (56%, P < 0.0001) of all short and medium FA and 16:0. CLA 
had similar effect on the yield of FA C > 16:0 (38% decrease; P < 0.001) and 
proportionally decreased all SFA (Table 5.5).  Compared with the Controls, the 
concentration (489%, P < 0.001; Table 6) and yield (336%, P < 0.001; Table 7) of 
total CLA increased in cows infused with CLA.  This reflected the increase in the 
percentage and yield of individual CLA isomers (Table 5.6 and 5.7).  The c9t11 CLA 
isomer was the predominant CLA isomer in milk fat of cows receiving all treatments.  
Milk fat percentage of trans-18:1 was increased in cows infused either with Butterfat 
or CLA (Table 5.6), compared to the Control or LCFA infused cows. However, the 
yield of trans-18:1 was lowest in cows receiving CLA due to the reduction of milk fat 
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(Table 5.7). Trans-11-18:1 was the predominant isomer in milk of cows receiving all 
treatments.   Trans-18:1 and CLA isomer profile in cows infused with LCFA was 
similar to that in the Control. 
DISCUSSION 
 This is the first study to examine the effects of post ruminal infusion of de 
novo (short and medium-chain FA) versus dietary derived (LCFA) FA on milk fat 
synthesis in lactating cows. As our LCFA treatment contained nearly identical 
amounts of LCFA (C 18 plus 50% of 16:0) as in butterfat, inferences about the role of 
short and medium chain FA on milk fat synthesis can be made by comparing the 
Butterfat and LCFA treatments.  In contrast, CLA infusion was used as a negative 
control to demonstrate responsiveness of cows to changes in FA infusion.   The CLA 
mixture provided 10 g/day of t10c12 CLA and decreased milk fat yield by 43%. 
Consistent with other CLA infusion experiments (Chouinard et al., 1999, Baumgard. 
et al., 2000), de novo FA synthesis and FA desaturation were predominantly 
inhibited. 
 Generally, DMI is affected by abomasal infusion of highly unsaturated FA 
(Bremmer et al., 1998; Benson et al., 2001) and to a lesser degree of saturated LCFA 
(Bremmer et al., 1998). The infusion mixtures in this study contained both saturated 
and unsaturated FA (Table 1), and the maximum amount of FA infused was limited to 
400 g/d to avoid possible adverse effects on DMI (Drackley et al., 1992).   
  Infusion of FA did not affect DMI and resulted in a marginal increase in 
milk production in cows infused with Butterfat and LCFA treatments.  Milk fat 
percentage and yield were significantly increased with the Butterfat but not with 
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LCFA infusion treatments.  The increase in total milk fat was more apparent when 
yields of individual FA were compared. The differences in the effects of Butterfat and 
LCFA were associated with the short and medium FA provided by the butterfat.  
Earlier experiments (Storry et al., 1969) did not show changes in milk fat yield when 
synthetic tripropionin, tributyrin, tricaproin, tricaprylin, tricaprin containing short 
chain FA (3:0, 4:0, 6:0, 8:0 and 10:0) were intravenously infused for 2 days in 
lactating dairy cows. However, milk fat yield was increased by 16% during 
intravenous infusion of trilaurin (12:0) and trimyristin (14:0) (Storry et al., 1969).  
Similarly, a 12% increase in milk fat yield was reported in lactating cows fed diets 
supplemented with coconut oil, containing predominantly 12:0 and 14:0 FA (Astrup 
et al., 1974; Storry et al., 1971).  Pure saturated FA (12:0, 14:0, 16:0 or 18:0) fed to 
lactating cows (Steele and Moore, 1968b) produced variable changes in milk fat 
content but increased these FA in milk, suggesting that the proportions of FA from 
treatment supplements were increased in blood triacylglycerols.   Comparable results 
were reported (Enjalbert et al., 2000) in lactating cows receiving duodenal infusion of 
palmitic, stearic or oleic acids. 
 In this study, infusion of butterfat significantly increased the yield of FA 
with C ≤ 16:0, raising the overall milk fat yield compared to the other treatments.  
The increase was predominantly due to greater yield of 12:0 to 14:0 medium chain 
FA.   Short and medium chains FA are better absorbed than LCFA and are 
transported via the portal venous blood system (Grummer and Socha, 1989).  
Nevertheless, their transfer to milk fat may be reduced due to extensive metabolism 
by the extra-mammary tissues (Grummer and Socha, 1989).   
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The apparent transfer efficiency of the abomasally infused FA was calculated 
(amount of FA excreted in milk fat as a % of the amount infused) by subtracting the 
FA yield in the Control treatment.  It should be recognized that these apparent values 
reflect changes not only in uptake but also in the net synthesis of FA. The overall 
transfer efficiency for C ≤ 16:0 in milk of cows infused with Butterfat was 63% with 
transfer efficiencies of 44% (4:0), 0% (6:0), 0% (8:0), 33% (10:0), 67% (12:0), 83% 
(14:0), and 58% (16:0), respectively.  While 6:0 and 8:0 were most likely metabolized 
by other tissues, the transfer efficiencies of 10:0, 12:0 and 14:0 FA increased with the 
increase in chain length.  Storry et al., (1974) reported a net transfer of 42% and 48% 
for 12:0 and 14:0, respectively to milk when protected coconut oil was fed to 
lactating cows.  Compared to the Control or LCFA infused cows, yields of 10:0 and 
12:0, tended to be higher, and yield of 14:0 was significantly greater in milk of cows 
infused with butterfat. The potential of 12:0 and 14:0 to increase is greater than that 
of shorter chain length FA probably because the ratio of lymphatic to hepatic portal 
vein uptake (greater lymphatic absorption) is positively correlated to FA chain length 
(Leveille et al., 1967).  These FA might be expected to be metabolized to a lesser 
degree by the liver and be more available for the mammary gland (Grummer and 
Socha, 1989). 
About 60% of 16:0 present in the Butterfat was transferred in milk, and yield 
of 16:0 tended to be higher compared to the control or LCFA infused cows. Feeding 
studies (Steele and Moore, 1968) have shown that dietary addition of pure palmitic 
acid caused the greatest increase in milk fat yield in dairy cows, compared to addition 
of myristic or stearic acid.  Addition of palmitic acid increased percentages and yields 
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of 16:0 and 16:1 FA in milk fat and decreased 10:0, 12:0 and 14:0 as well as 18:0 and 
18:1.  Similarly, yield of 16:0 was increased and total FA in milk were significantly 
higher during duodenal infusion of palmitic acid (Enjalbert et al., 2000).  
Palmitic acid is an important FA for the synthesis of triacylglycerol in the 
mammary gland (Hansen and Knudsen, 1987). Initiation of acylation of the sn-1 
position is a prerequisite for triacylglycerol synthesis and palmitic acid is the most 
preferred substrate for the initial acylation of L-α glycerolphosphate by 
acyltransferase to form sn-1-lysophasphatidic acid (Kinsella and Gross, 1973).  It has 
been shown (Kinsella and Gross 1973) that myristyl, stearyl and oleyl CoA were 
rapidly acylated when sn-1-lysophasphatidic acid was used as substrate but were 
poorly acylated without the latter indicating that these FA are taken up mostly in the 
second step of triacylglycerol synthesis.   
 Infusion of LCFA did not significantly alter milk fat yield. In contrast with 
other reports (Grummer, 1991; LaCount et al., 1994), yield of FA C < 16:0, including 
de novo FA was not significantly reduced by LCFA infusion but rather it was 
maintained as in the Controls. Butterfat and LCFA infusion mixtures contained equal 
amounts of LCFA (except for 16:0) resulting in a similar increase in milk FA C > 
16:0.  However, compared to the Butterfat treatment, the proportion of C18 FA was 
considerably greater than the proportion of palmitic acid in the LCFA infusion 
mixture. Steele and Moore (1968a) reported that addition of cottonseed oil 
(containing 21% palmitic acid and 76% total C18 FA) or tallow (containing 30% 
palmitic acid and 60 % total C18 FA) to the diet of lactating cows increased stearic 
and oleic acids in milk fat but did not alter yield of 16:0.  In contrast, yields of 16:0 
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and 18:1 were increased when a mixture of 64% palmitic acid and 34% total C18 FA 
was added to the diet of lactating cows (Steele and Moore, 1968b).  In our study, 
yield of 16:0 in cows infused with LCFA, was maintained at a level similar to that 
observed in the Controls, while the yield of 16:0 was increased with Butterfat 
treatment. The difference between these treatments may have been influenced by the 
C18 to 16:0 ratios in the infusion mixtures. It has been suggested (Steele and Moore, 
1968a; Grummer,1991), that if de novo synthesis of 16:0 is inhibited by increased 
uptake of LCFA from the blood, the net yield of 16:0 in milk fat will depend on 
whether dietary transfer of  16:0 to milk fat is sufficient to compensate for the 
decrease in de novo synthesis.  
 In conclusion, the abomasal infusion of butterfat compared with LCFA 
demonstrated that milk fat synthesis could be regulated by the supply of short and 
medium chain FA in lactating cows. In addition, the increased availability of palmitic 
acid, the preferred substrate for the initial acylation of L-α- glycerophosphate may 
have also stimulated triacylglycerol synthesis in the mammary gland. Compared to 
the Controls, cows infused with butterfat produced milk fat with greater amounts of 
12:0 and 14:0, MUFA, and PUFA.  An increase in the proportions of unsaturated FA 
in milk fat is desirable because of the potential health benefits when included in 
human diet. However, further studies are needed to test and refine the role of short 
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Table 5.1. Fatty acid composition of the Butterfat,  LCFA1 and CLA2  supplements 
 
Fatty acid Butterfat LCFA CLA 
 g/100g FAME3 
4:0 3.34   
6:0 2.22   
8:0 1.06   
10:0 1.93   
12:0 3.00   
14:0 12.09 0.18 0.15
14:1 0.66   
15:0 0.89   
15:1 0.01   
16:0 26.73 24.41 5.79
16:1 1.17 0.55 0.12
T16:1 0.02   
17:0 0.61   
17:1 0.18   
18:0 11.45 21.17 2.54
18:1 cis-9 26.79 45.67 29.02
18:1 cis-11 0.54  0.72
18:1 cis-12 0.55  0.02
18:1 cis-13 0.09  0.06
18:1cis-14+19:0 0.18  0.62
18:1 trans total 2.09  0.23
18:2 n-6 2.80 6.37 0.88
18:3 0.39 0.44 0.29
22:0 0.04  0.14
Others 0.56 1.21 3.21
4c85t10 18:2 0.00  0.68
t8c10 18:2 0.00  0.75
c9t11 18:2 0.55  14.59
c9t13 18:2 0.00  0.74
c13t12 18:2 0.00  1.09
c11t13 18:2 0.01  9.44
10c12 18:2 0.01  9.66
t11c13 18:2 0.03  1.00
t11t13 18:2 0.00  1.17
tt18:2 0.02  10.71
cc18:2   6.21
1 Long chain Fatty Acids 
2Conjugated linoleic acids. 





Table 5.2. Ingredient and chemical composition of the basal diet 
 
Ingredients           % DM 
Corn silage 30.13 
Alfalfa haylage 23.00 
Corn grain, ground 21.71 
Citrus pulp 8.05 
Soybean meal 14.35 
Limestone 0.26 
Salt 0.48 
Magnesium oxide 0.32 
Sodium bicarbonate 1.04 
Potassium magnesium sulfate 0.17 
Dicalcium phosphate 0.39 
Trace minerals and vitamins1 0.10 
  
Chemical composition  
DM % 66.71 
  ------------------------- % of DM ----------------------------- 




NEL 2, Mcal/kg 1.75 
Ca  0.69 






1 Trace mineral and vitamin mix combined (per kg mix) 
15mg Mn,  50mg Zn, 10 mg Cu, 0.60mg I,  0.20 mg Co,  
0.30 mg Se, 0.12 g retinyl acetate,  0.40g cholecalciferol 




 Table 5.3.  Least squares means for dry matter intake (DMI), milk production, and 
milk composition from cows fed the Control diet or the Control diet plus abomasal 




1Conjugated linoleic acids. 
2Long chain fatty acids. 
abc  Least square means within a row with different superscripts differ (P < 0.05) 
 
 
 Treatment  
Item Control CLA Butterfat LCFA SEM
DMI, kg/d 23.7 24.1 24.2 25.7 1.1 
Milk      
  kg/d     31.8ab        29.9b      33.7a     33.1ab 2.5 
  FCM, 3.5%     32.87b      23.65c      37.72a     35.04ab 2.71 
  Efficiency, FCM/NEL      0.78a       0.55b       0.83a      0.77a 0.44 
  Efficiency, FCM/DM      1.37b      0.98c       1.51a      1.38b 0.07 
  Milk NE/ NE Intake      0.53a       0.41b       0.56a      0.52a 0.02 
  Fat, %      3.74b       2.16c       4.26a      3.79ab 0.19 
  Fat yield, g/d 1178b      661c  1421a 1279ab 107.7 
  Protein,%      3.30b       3.70a        3.28b      3.27b 0.12 
  Protein, g/d 1033 1086 1061 1085 62.6 
  Lactose, %      4.63a       4.45b        4.59ab      4.70a 0.08 
  SCC, (103/ml) 102 174 205 97 82.8 
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Table 5.4.  Least squares means for fatty acid composition of milk from 
 cows fed the Control diet or the Control diet plus abomasal infusion of 
 CLA1, Butterfat, or LCFA2 supplements 
 Treatment 
 Fatty acid Control CLA Butterfat LCFA SEM 
 ---------------g/100g of FAME
3 ----------------- 
4:0   3.45     3.04 3.52 3.47 0.36
6:0   1.81a     0.83b 1.54a 1.71a 0.10
8:0   1.24a     0.55b 1.06a 1.17a 0.08
10:0   3.22a     1.55b 2.83a 2.96a 0.19
12:0   4.01a     2.41b 3.91a 3.73a 0.25
14:0 12.31a   10.96b 12.65a 11.78ab 0.37
14:1   1.14ab     1.19ab 1.38a 1.05b 0.08
15:0 (iso)   0.23a     0.19b 0.22a 0.23a 0.02
15:0 (anteiso)   0.51     0.47 0.51 0.50 0.03
15:0   1.22     1.25 1.27 1.13 0.04
15:1   0.07     0.03 0.02 0.01 0.02
16:0 35.08a   35.41a 33.10ab 31.53b 1.33
16:0 (iso)   0.36     0.31 0.35 0.33 0.03
16:1   1.63     1.98 1.76 1.22 0.16
t16:1   0.04     0.03 0.03 0.03 0.01
17:0   0.79a     0.71b 0.78a 0.74ab 0.03
17:0 (iso)   0.06     0.06 0.06 0.06 0.00
17:1 (iso)   0.15b     0.18a 0.19a 0.20a 0.01
17:1 (anteiso)   0.43     0.39 0.41 0.38 0.03
17:1   0.21a     0.23a 0.21a 0.18b 0.01
18:0   8.08ab     8.91a 7.31b 8.47ab 0.42
18:1 cis-9 16.50b   18.01b 18.13b 20.84a 0.84
18:2i4   0.47b     0.58a 0.60a 0.44b 0.03
18:2n-6   2.40b     2.89a 2.52b 2.93a 0.14
18:3i5   0.14b     0.09c 0.11c 0.17a 0.01
18:3n-3   0.40b     0.46a 0.40b 0.43ab 0.03
20:0   0.10ab     0.11a 0.09b 0.12a 0.01
GLA6   0.03     0.03 0.03 0.03 0.00
Other   0.55ab     0.73a 0.59ab 0.49b 0.07
Summations     
<16:0 29.21a   22.47b 28.91a 27.74a 0.89
>16:0 31.40b   34.63ab 32.60b 36.21a 1.35
>20:0   0.16b     0.20a 0.20a 0.20a 0.01
MUFA7 20.17b   22.04ab 22.13a 23.91a 1.19
SFA8 72.47a   66.76c 69.20ab 67.93bc 1.38
PUFA9   3.04c     3.59a 3.26bc  3.57ab 0.16
1Conjugated linoleic acids. 2Long chain fatty acids. 3Fatty acid methyl esters. 
4 Non-conjugated 18:2 isomers. 5 Non-conjugated 18:3 isomers. 6 Gamma linoleic 
acid. 7 Mono unsaturated fatty acids.  8 Saturated fatty acids. 9Polyunsaturated fatty 
acids.abc  Least square means within a row with different superscripts differ (P < 0.05)
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Table 5.5. Least squares means for yield of fatty acids in milk from  
cows fed the Control diet or the Control diet plus abomasal infusion  
of CLA1, Butterfat, or LCFA2 supplements 
  Treatment 
 Fatty acid Control CLA Butterfat LCFA SEM 
 -----------------g FAME
3/day ----------------- 
4:0 39.19a 18.48b 49.30a 45.43a 5.75 
6:0 21.02a 5.98b 21.02a 26.76a 2.50 
8:0 14.13a 3.93b 14.56a 15.53a 1.59 
10:0 36.52a 10.96b 39.12a 31.40a 3.78 
12:0 46.07a 16.07b 54.58a 48.99a 4.75 
14:0 144.31b 73.24c 179.34a 149.56ab 14.51 
14:1 13.30b 7.59c 19.70a 13.75b 1.65 
15:0 (iso) 2.76a 1.31b 3.14a 2.81a 0.26 
15:0 (anteiso) 6.08a 3.30b 6.96a 6.29a 0.61 
15:0 14.24b 8.27c 18.33a 14.45b 1.60 
15:1 0.69 0.05 0.15 0.12 0.29 
16:0 417.36a 234.29b 476.21a 415.79a 46.61 
16:0 (iso) 3.47a 2.14b 4.67a 4.24a 0.55 
16:1 18.87b 11.32c 25.10a 14.80bc 2.11 
t16:1 0.31ab 0.14b 0.42a 0.24ab 0.10 
17:0 9.24b 4.78c 11.21a 9.42b 0.90 
17:0 (iso) 0.75a 0.41b 0.80a 0.72a 0.08 
17:1 (iso) 1.44b 1.18b 2.58a 2.56a 0.28 
17:1 (anteiso) 5.16ab 2.76c 5.72a 4.53b 0.54 
17:1 2.41b 1.45c 3.08a 2.29b 0.42 
18:0 90.10a 60.54b 102.17a 105.14a 8.85 
18.1 cis-9 193.42b 117.59c 256.41a 258.40a 15.77 
18:2i4 5.68b 3.84c 8.34a 5.68b 0.58 
18:2n-6 28.26b 18.59c 35.62a 36.49a 2.23 
18:3i5 1.12bc 0.62c 1.40a 1.23ab 0.17 
18:3n-3 4.73a 3.07b 5.55a 5.31a 0.45 
20:0 0.94bc 0.77c 1.26ab 1.52a 0.15 
GLA6 0.37a 0.15b 0.34a 0.38a 0.06 
Other 6.46b 4.73c 8.29a 5.97bc 0.68 
Summations      
<16:0 338.31b 149.18c 406.20a 355.09ab 30.42 
>16:0 361.86b 226.44c 458.74a 447.19a 33.11 
>20:0 1.78bc 1.32c 2.45ab 2.49a 0.13 
MUFA7 235.60b 142.08c 313.16a 296.36a 20.13 
SFA8 849.97a 446.77b 986.96a 881.84a 78.03 
PUFA9 36.37b 23.97c 46.96a 45.30a 3.27 
1Conjugated linoleic acids.2Long chain fatty acids.3Fatty acid methyl esters. 
4 Non-conjugated 18:2 isomers.5 Non-conjugated 18:3 isomers.6 Gamma linoleic 
acid.7 Mono unsaturated fatty acids.8 Saturated fatty acids.9Polyunsaturated fatty 
acids.abc  Least square means within a row with different superscripts differ (P < 0.05)
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Table 5.6. Least squares means for CLA1, trans-18:1, and cis-18:1 
 isomers in milk fat of cows fed the Control diet or the Control diet 
 plus abomasal infusion of CLA, Butterfat, or LCFA2 supplements 
 Treatment 
 Fatty acid Control CLA Butterfat LCFA SEM 
 ---------------g/100g of FAME
3 -------------- 
CLA  
  c8t10 trace 0.04a trace trace 0.01
  c9t11 0.40b 0.83a 0.51b 0.38b 0.07
  t8c10 trace 0.28a trace trace 0.03
  c10t12 trace 0.02a trace trace 0.00
  t9c11 trace 0.06a trace trace 0.01
  c11t13 trace 0.44a 0.01b 0.02b 0.12
  t10c12 trace 0.24a trace 0.01b 0.06
  t11c13 +21:0 0.04b 0.05a 0.03b 0.03b 0.01
  cis/cis CLA trace 0.28a trace trace 0.03
 trans/trans CLA 0.09b 0.35a trace trace 0.04
Total CLA 0.53b 2.59a 0.55b 0.44b 0.21
trans 18:1     
  4 0.01 0.01 0.01 0.01 0.00
  5 0.01 0.01 0.01 0.01 0.00
  6+7+8 0.17c 0.22a 0.20ab 0.17bc 0.04
  9 0.20b 0.25a 0.24a 0.21b 0.01
  10 0.27c 0.40a 0.36ab 0.28bc 0.10
  11 0.80 0.84 0.84 0.81 0.07
  12 0.21b 0.26a 0.26a 0.22b 0.02
  13+14 0.47c 0.56a 0.52b 0.41d 0.02
  16 0.20b 0.26a 0.23b 0.20b 0.01
Total trans 18:1 2.34b 2.81a 2.67a 2.32b 0.10
cis 18:1     
  11 0.47b 0.64a 0.50ab 0.52ab 0.04
  12 0.27b 0.29ab 0.32a 0.27b 0.01
  13 0.05c 0.08a 0.07b 0.04d 0.00
  cis 14 + 19:0 0.13b 0.15a 0.14ab 0.13b 0.01
1Conjugated linoleic acids. 
2Long chain fatty acids. 
3Fatty acid methyl esters. 
4 c=cis 
5 t=trans 
abc  Least square means within a row with different superscripts differ (P < 0.05)
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Table 5.7.  Least squares means for yields of CLA1, trans-18:1,  
and cis-18:1 isomers in milk of cows fed the Control diet or 
the Control diet plus abomasal infusion of CLA, Butterfat, or LCFA2 
supplements 
  Treatment 
 Fatty acid Control CLA Butterfat LCFA SEM 
 -----------------g FAME
3/day ------------------ 
CLA      
  4c85t10  0.25    
  c9t11 4.72b 5.24b 7.28a 4.83b 0.63 
  t8c10 0.05b 1.27a 0.02b  0.24 
  c10t12  0.06    
  t9c11 0.01b 0.32a   0.09 
  c11t13 0.04b 2.34a 0.04b 0.04b 0.29 
  t10c12 0.02b 1.50a 0.01b 0.02b 0.13 
  t11c13 +21:0 0.35 0.31 0.30 0.35 0.05 
cis/cis CLA 0.02b 1.81a 0.01b 0.00b 0.17 
trans/trans CLA 0.15b 1.65a 0.09b 0.08b 0.22 
Total CLA 5.63b 16.77a 7.87b 5.40b 1.51 
trans 18:1      
  4 0.14 0.08 0.12 0.14 0.03 
  5 0.13 0.09 0.13 0.13 0.03 
  6+7+8 2.03bc 1.50c 2.82a 2.17b 0.23 
  9 2.42b 1.63c 3.44a 2.61b 0.25 
  10 3.22bc 2.63c 5.08a 3.55b 0.40 
  11 9.50b 5.72c 11.76a 10.31ab 1.17 
  12 2.34b 1.73b 3.38a 2.39b 0.36 
  13+14 5.58b 3.77c 7.31a 5.16b 0.67 
  16 2.42b 1.72c 3.14a 2.53b 0.24 
Total trans 18:1 27.78b 18.87c 37.18a 28.99b 2.82 
cis 18:1      
  11 5.42bc 4.07c 7.31a 6.57ab 0.68 
  12 3.19b 1.97c 4.47a 3.54b 0.39 
  13 0.64b 0.48c 0.93a 0.57b 0.06 
cis 14 + 19:0 1.60b 1.02c 2.03a 1.61b 0.16 
1Conjugated linoleic acids. 
2Long chain fatty acids. 
3Fatty acid methyl esters. 
4 c=cis 
5 t=trans 
abc  Least square means within a row with different superscripts differ (P < 0.05)  
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Effect of abomasal infusion of butterfat, long chain fatty acids or 
CLA on milk fatty acid composition and mammary tissue lipogenic 








1 Presented in part at the annual ADSA-ASAS conference, 2008. 
A. K. G. Kadegowda, J. J. Loor, L. S. Piperova and R. A. Erdman. 2008. J. 




Mammary tissue lipogenic gene expression and milk fatty acid composition 
were studied during abomasal infusion of butterfat, long chain fatty acids or CLA 
mixture in lactating cows. Eight rumen fistulated Holstein cows (49±20 DIM) were 
used in a replicated 4x4 Latin square design.  Treatments were: 1) Control (no 
infusion); or  abomasal infusion of; 2) 400 g/d Butterfat; 3) 245 g/d LCFA (blend of 
59% cocoa butter, 36% olive oil, and 5% palm oil) providing 50% of the 16:0 and the 
amounts of C18 FA, equivalent to that found in 400 g of butterfat (LCFA); and 4) 100 
g/d conjugated linoleic acid (CLA, negative control), providing 10 g of t10c12 CLA. 
Lipid supplements were infused in equal portions 3X daily during the last 2 wk of 
each 3 wk experimental period. Compared with Controls, Butterfat infusion increased 
milk fat yield by 21% (P < 0.02), CLA decreased milk fat yield by 43% (P < 0.001), 
and LCFA had no effect on fat yield. Infusion of Butterfat increased (21%, P<0.05) 
the yield of FA with ≤16:0-carbons. Milk yield of mono- and poly-unsaturated FA 
was greater in cows infused with Butterfat (by 33% and 29%) or LCFA (by 25% and 
24%), compared to Control. Infusion of CLA reduced yield of all FA synthesized de 
novo (56%, P<0.001) and reduced FA desaturation index (40%, P<0.001). Expression 
of genes involved in FA uptake (LPL, CD36), intracellular FA activation and 
transport (FABP3, ACSS2, ACSL1), de novo FA synthesis (ACACA, FASN), 
desaturation (SCD), and trigacylglycerol synthesis (AGPAT6, GPAM) tended to 
increase by 30% to 40% due to Butterfat, while LCFA showed opposite effects. The 
expression of lipogenic genes were not modified by CLA. Results suggest that supply 
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of short and medium chain FA with Butterfat infusion might potentially up regulate 
mammary lipogenic gene expression and increase milk fat yield in lactating cows. 




The current federal milk pricing system (MCP) provides powerful economic 
incentives for dairy producers to produce milk solids that have high commercial value 
(fat and protein) while there is little or no incentive to produce components directly 
associated with milk volume (lactose and minerals) that have little or no value 
(Erdman, 2008). The ability to manipulate yield of milk components according to the 
prevailing market trends would be economically advantageous for dairy producers. 
Among major milk components, milk fat concentration can be easily manipulated by 
dietary interventions (Sutton, 1989).  
One of the strategies used to alter milk fat content and fatty acid (FA) 
composition in lactating dairy cows is the use of dietary lipid supplements. 
Supplementation of polyunsaturated FA (PUFA) to a  high concentrate diet can 
reduce milk fat content up to 46% (Piperova et al., 2000). The phenomenon of 
decreased milk fat synthesis due to supplementation of highly digestible 
carbohydrates and/or vegetable/marine oils is known as “Milk Fat Depression” 
(MFD). Significant research has been done on MFD in lactating dairy cows. Feeding 
and abomasal infusion experiments have established the role of trans-18:1 FA and 
CLA in development of MFD. Specifically, t10c12 CLA has been identified as the 
isomer responsible for MFD (Baumgard et al., 2000). Recently other CLA isomers –
t9c11 (Shingfield et al., 2006) and t7c9 CLA (Kadegowda et al., 2008) have been 
negatively correlated to changes in milk fat content and their role has been 
investigated. The classical dietary-induced MFD is characterized by predominant 
decrease in the short (SCFA) and medium chain fatty acids (MCFA) and to a lesser 
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extent, the long chain FA (LCFA). The decrease in de novo synthesized FA is 
associated with inhibition of lipogenic enzymes activity and mRNA abundance 
(Piperova et al., 2000).  Peterson et al. (2003) reported that dietary-induced MFD 
affects expression of mammary genes involved in de novo FA synthesis, FA uptake 
and transport, FA desaturation  and triacylglycerol (TAG) synthesis. The magnitude 
of decrease corresponded with the intensity of MFD (Piperova et al., 2000, Peterson 
et al. 2003). 
 Conversely, very few studies have shown that lipid supplementation can 
consistently increase milk fat synthesis (Banks et al., 1990; Drackley et al., 1992; 
Harrison et al., 1995; Enjalbert et al., 2000). Recently, using abomasal infusion of 
butterfat compared to long chain FA, it was demonstrated that milk fat yield can be 
increased by supply of SCFA and MCFA (Kadegowda et al., 2008). The mechanisms 
regulating these alterations of milk fat synthesis are not completely understood.  
A large-scale transcript analysis of lipogenic genes in lactating mice have 
shown that regulation of mammary lipid synthesis occurs at the level of mRNA 
expression (Rudolph et al., 2007).  Gene transcription exerts long-term regulation of 
metabolism (Desvergne et al., 2006), and as such, represents an important control 
point. In lactating cows, the effects of dietary saturated and unsaturated FA on 
mammary lipid metabolism occur partly through changes in lipogenic enzyme 
abundance or activity (Shingfield and Griinari, 2007). Although, the molecular 
mechanisms by which fatty acids regulate bovine mammary lipogenic gene 
expression are not completely established, there is evidence that transcriptional 
regulators are involved (Peterson et al., 2004; Harvatine and Bauman, 2006).   
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The transcription factor SREBP-1c is one of the regulators with a role in 
mammary lipid metabolism (Rudolph et al., 2007).  Studies with MACT cells 
(Peterson et al., 2004) and lactating cows (Harvatine and Bauman, 2006) have shown 
that the effect of t10c12-CLA on fat synthesis could be regulated via the SREBP-1c 
transcription factor acting as a possible global regulator for milk fat synthesis. In 
addition, MFD was associated with decrease in THRSP expression (Harvatine and 
Bauman, 2006). We hypothesize that the regulation of mammary lipid synthesis could 
occur at multiple regulatory points. An increase in milk fat synthesis could be a result 
of up-regulated lipogenic gene expression as opposed to down-regulated lipogenic 
gene expression observed during MFD. The objective of the study was to determine 
the effects of abomasal infusion of butterfat, a source of short and medium chain fatty 
acids versus the LCFA on bovine mammary lipogenic gene expression.  
 
MATERIALS AND METHODS 
Animals, Experimental Design and Treatment 
 Details of the animals and experimental design were reported previously 
(Kadegowda et al., 2008). Briefly, eight rumen-fistulated multiparous Holstein cows 
in early lactation (49±20 DIM) were used in a replicated 4x4 Latin square design. The 
treatments were: 1) Control (No infusion); 2) Butterfat (Post-ruminal infusion of 400 
g/d butterfat as a source of short and medium chain FA); 3; LCFA (Post-ruminal 
infusion of 245 g/d long chain FA mixture delivering equivalent amount of long chain 
FA as found in 400 g of milk fat); and  4) CLA (Post-ruminal infusion of 100 g of 
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CLA mix providing 10 g of t10c12 CLA/d). Details on the composition of fat 
mixtures, infusion technique, and ingredient and nutrient composition of the diet have 
been previously described (Kadegowda et al., 2008). All procedures for this 
experiment were conducted under protocol R-06-41 approved by the University of 
Maryland Institutional Animal Care and Use Committee.   
Mammary Tissue Biopsy 
 Mammary tissue samples were collected at the end of each period using a 
modified  procedure described by Farr et al (1996).  Briefly, a 1-2 cm scalpel (sterile) 
incision was made through the skin, and the mammary gland capsule punctured.  A 
core of mammary tissue was taken from the gland using the biopsy tool, rotated by a 
slow speed electric motor.  The core was cut, the retractable blade extended and the 
core was severed with a few revolutions of cutting blade of the biopsy tool.  The 
mammary biopsy samples were immediately frozen in liquid N2, and preserved at  
-80° C for RNA extraction.  
 Immediately after removal of the biopsy tool, pressure was applied until the 
visual signs of bleeding were absent. To reduce bleeding and swelling, a plug of 
Surgicel (Ethicon Ltd, Somerville, NJ), a cellulose absorbable hemostat, was inserted 
into the wound and closed with stitches.  Antibiotic powder and single intramuscular 
injection of 100 mg of the systemic antibiotic Oxytetracycline was applied. Incision 
sites were inspected daily, kept clean and treated with topical antiseptic and/or 
aerosol bandage spray as needed. The cows were hand-milked for 3 days to 
thoroughly remove the blood clots lodged in the gland. The animals were monitored 
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for signs of site effects, fever, changes in defecation, feed intake and refusals, daily 
milk production and daily temperature. 
RNA Extraction 
 Total RNA was extracted from ~0.5 g tissue using ice-cold TRIZOL reagent 
(Invitrogen, Carlsbad, CA). The RNA concentrations were quantified with a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) 
and the quality was evaluated using 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA).  Only samples (n=24) with an RNA integrity number of 6 to 9 were 
used for further analysis (Control (n=7), Butterfat (n=5), CLA (n=7), LCFA (n=5). 
Genomic DNA was removed with DNase using RNeasy Mini Kit columns (Qiagen, 
Valencia, CA). A portion of the assessed RNA was diluted to 100 mg/L using DNase-
RNase free water prior to reverse transcription.  
Quantitative Real Time Polymerase Chain Reaction (qRT-PCR) 
Sufficient cDNA was prepared to run all selected genes- ACACA, FASN, SCD, 
AGPAT6, GPAT, DGAT1, LPL, ACSL1, ACSS2, CD36, SREBP1, SREBP2, LPIN1, 
SCAP, INSIG1, PPARγ, THRSP. Each cDNA was synthesized by RT-PCR and cDNA 
used for qPCR previously described (Bionaz and Loor, 2007).  Briefly, each cDNA 
was synthesized by RT using 100 ng RNA, 1 µL dT18 (Operon Biotechnologies, 
AL), 1 µL 10 mM dNTP mix (Invitrogen Corp.), 1 µL Random Primers (Invitrogen 
Corp., CA), and 7 µL DNase/RNase free water.  The mixture was incubated at 65°C 
for 5 min and kept on ice for 3 min.  A total of 9 µL of master mix composed of 4.5 
µL 5X first-strand buffer, 1 µL 0.1 M DDT, 0.25 µL (100 U) of SuperScriptTM III 
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RT (Invitrogen Corp.), and 0.25 µL of RNase Inhibitor (Promega, WI) and 3 mL 
DNase/RNase free water were added.  The reaction was performed in an Eppendorf 
Mastercycler® Gradient using the following temperature program: 25°C for 5 min, 
50°C for 60 min and 70°C for 15 min.  The cDNA was then diluted 1:3 with 
DNase/RNase free water.   
For qPCR analysis, 4 µL of diluted cDNA were combined with 6 µL of a 
mixture composed of 5 µL 1x SYBR Green master mix (Applied Biosystems, Foster 
City, CA), 0.4 µL each of 10µM forward and reverse primers, and 0.2 µL 
DNase/RNase free water in a MicroAmp™ Optical 384-Well Reaction Plate (Applied 
Biosystems).  Each sample was run in triplicate and a 4-point relative standard curve 
(4-fold dilution) plus the non-template control were used (User Bulletin #2, Applied 
Biosystems).  The reactions were performed in an ABI Prism 7900 HT SDS 
instrument (Applied Biosystems) using the following conditions: 2 min at 50 °C, 10 
min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at 60°C.  The presence of a single 
PCR product was verified by the dissociation protocol using incremental temperatures 
to 95°C for 15 sec plus 65°C for 15 sec.  Complete details regarding qPCR protocol 
can be found at http://docs.appliedbiosystems.com/pebiodocs/04364014.pdf.  Data 
were analyzed with the 7900 HT Sequence Detection Systems Software (version 
2.2.3, Applied Biosystems). 
Primer Design and Testing 
Primer Express 3.0 software (Applied Biosystems), optimized for use with 
Applied Biosystems qPCR Systems, was used for primers design using default 
features, except for the amplicon length, which was fixed at minimum of 100 bp . 
 
 173
Primers were designed across exon junctions when possible to avoid amplification of 
genomic DNA. The exon junctions were uncovered blasting the sequence against 
bovine genome(Genome Browser Gateway, 2008). Primers were aligned against 
publicly available sequences in NCBI (National Center for Biotechnology 
Information, 2008) and UCSC(Genome Browser Gateway, 2008). The primer 
sequences are presented in Appendix 1.  Prior to qPCR, primers were tested using the 
same protocol as for qPCR without the dissociation step in a 20µL reaction. Part of 
the PCR product was analyzed in a 2% agarose gel stained with ethidium bromide to 
assess presence of the product to an expected size and the presence of primer-dimer, 
with the remainder being purified using Qiaquick PCR purification kit (Qiagen) and 
sequenced at the Core DNA Sequencing Facility of the Roy J. Carver Biotechnology 
Center at the University of Illinois, Urbana. Only primers with high specificity 
evaluated by a single band on agarose gel, absence of primer-dimer, amplification of 
the target cDNA verified by sequencing, and a unique peak in the dissociation curve 
after qPCR reaction were used. 
Statistical Analysis 
A normalization factor calculated as a geometric mean of 4 internal control 
genes (EIF3K, GPR175, MRPL39 and UXT) using geNorm was used to normalize the 
qPCR data. The Mixed procedure in the Statistical Analysis System (Version 8.2, 
2004, SAS Institute, Cary, NC) was used to evaluate the treatment effects on the 
normalized mRNA abundance. Model fixed effects were the treatments while the 
random effects included cow, square and period. Probability of (P ≤ 0.05) was 
considered as statistically significant. 
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The qPCR data are presented as percentage change relative to the Control 
group. The standard error for each treatment was estimated as described by Bionaz 
and Loor (2008a). Briefly, normalized data were transformed to obtain a perfect mean 
of 1.0 for Control, leaving the proportional difference between the biological 
replicate. The same proportional change was calculated in all the treatments to obtain 
a fold change relative to Control. 
 
RESULTS 
 The relative mRNA abundance of 20 genes related to FA uptake, transport, 
FA and triacylglycerol (TAG) synthesis and transcriptional regulation are presented 
in Table 6.1, Table 6.2 and Figure 6.1.  The greatest relative mRNA abundance were 
observed for SCD (29.99%), FASN (23.57%), FABP3 (18.22%) and CD36 (10.39%) 
which accounted for 82% of the overall mRNA abundance.  The genes ACACA 
(0.94%), ACSS2 (0.9%), DGAT1 (0.08%), PPARG (0.08%), SCAP (0.09%), THRSP 
(0.02%) and ChREBP (0.001%) had lower expression. This low abundance is 
reflected in the median threshold cycle (Ct), which is the cycle number at which the 
sequence detector was able to amplify the product (Figure 6.2).  
 The mRNA abundance of LPL, a key enzyme involved in the hydrolysis of 
plasma triacylglycerol and CD36, a plasma membrane-bound protein involved in 
cellular FA entry were affected by the FA infusions. Compared to Control, butterfat 
infusion significantly increased LPL expression (47%, P < 0.05) and tended to 
increase CD36 (47%, P = 0.25, Figure 6.5). Conversely, LCFA treatments tended 
(P<0.3) to decrease the expression of LPL (-187%, Figure 6.3) and CD36 (-61%, 
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Figure 6.5) while CLA did not affect LPL expression but tended to increase the 
expression of CD36 (35%, P < 0.2, Figure 6.5).  
 Compared to Control, the expression of ACSL1 and ACSS2, genes related to 
intra-cellular activation of fatty acids, were up regulated with Butterfat (47.87% and 
62.66%, respectively) but were not affected by other treatments (Figure 6.5). The 
expression of FABP3, a gene regulating intra-cellular FA transport was significantly 
(44%, P < 0.05) up-regulated with Butterfat, but was down-regulated with LCFA 
(-47%, Figure 6.5).  The expression of FABP4 was down regulated (P<0.3) with 
LCFA and t10c12-CLA, but was not affected with Butterfat infusion when compared 
to Control. 
 Butterfat infusion increased the mRNA abundance of ACACA (35%, P < 0.12) 
and FASN (40%, P < 0.13), genes related to FA synthesis; SCD (40%, P < 0.27, 
Figure 6.3), a gene related to desaturation; AGPAT6 (43%, P < 0.12, Figure 6.4), 
DGAT1 (13%, P < 0.13) and GPAM (43%, P < 0.05), genes related to triacylglycerol 
synthesis (Figure 6.3 and Figure 6.4). LCFA infusion decreased the expression of 
FASN (-101%, P < 0.07) while CLA infusion did not affect the expression of any 
genes related to FA and TAG synthesis or desaturation (Figure 6.3 and Figure 6.4). 
 The mRNA abundance of the transcriptional regulators SREBF1, SREBF2, 
THRSP, ChREBP and LPIN1, the nuclear receptor PPARG, and the transcriptional 
co-activators INSIG1 and SCAP were measured to elucidate the mechanisms involved 
in regulation of lipogenic genes (Figure 6.6). Butterfat infusion tended to increase the 
expression of SREBF1 (30%), SREBF2 (25%), THRSP (23%), LPIN1 (46%) and 
INSIG1 (30%) but tended to decrease SCAP (-84%, P<0.2). However, LCFA 
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infusions tended to decrease the expression of PPARG (-109%, P < 0.2), SREBF1 (-
47%), THRSP (-52%) and SCAP (-77%). The infusion of CLA tended to decrease the 
expression of SREBF1 (-36%) and SCAP (-77%).  
DISCUSSION 
 The studies on the regulation of milk fat synthesis due to dietary FA in 
lactating dairy cows have largely focused on the effects of feeding or abomasal 
infusions of CLA, particularly t10c12-CLA (Piperova et al., 2000; Harvatine and 
Bauman, 2006), and/or LCFA (Banks et al., 1990; Drackley et al., 1992; Enjalbert et 
al., 2000). Some of the studies with CLA have examined the changes in mammary 
lipogenic gene expression or activity, in addition to changes in the milk FA profile 
(Piperova et al., 2000; Baumgard et al., 2002; Peterson et al., 2003; Harvatine and 
Bauman, 2006).  Effects of LCFA on mammary lipogenesis have focused on changes 
in milk FA profile (Enjalbert et al., 2000) and not gene expression. To my knowledge 
other data describing the effect of SCFA and MCFA in regulation of mammary lipid 
synthesis in dairy cows are not available. 
 Abomasal infusion of butterfat, a source of short- and medium-chain FA 
increased the mRNA abundance of LPL and CD36, while an opposite effect was 
observed with the LCFA treatment. The differences in responses could be attributed 
to the short- and medium-chain FA as both Butterfat and LCFA treatments contained 
equal amounts of LCFA.  The enzyme LPL plays a role in the hydrolysis of plasma 
triacylglycerols and is critical for the delivery of dietary FA to the mammary gland 
(Fielding and Frayn, 1998). In turn, CD36 is a plasma membrane-bound protein 
involved in cellular FA entry. Butterfat treatment increased LPL and CD36 
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expression most likely due to increased availability of substrates (TAG), which 
determines their utilization by the mammary gland (Annison et al., 1968). Abomasal 
(Enjelbert et al., 2000) or duodenal (Gangliostro et al., 1991) infusion of lipid 
supplements could trigger increased apparent mammary FA uptake.  Mammary 
uptake of LCFA could also be affected by the type and means of lipid 
supplementation. Ahnadi et al. (2002) reported decreased milk 18:0 and 18:1 
concentrations and decreased LPL expression in lactating cows due to dietary fish oil 
supplementation compared to un-supplemented control.  In this study, LCFA infusion 
decreased LPL and CD36 expression but increased milk LCFA concentration and 
yield (Kadegowda et al., 2008) suggesting that some of the infused FA were taken up 
by the mammary gland.   
 Mammary FA uptake is driven by intra-cellular FA activation, FA binding to 
intracellular fatty acid binding proteins (FABP) and intracellular metabolism (TAG 
synthesis) (Mashek and Coleman, 2006). Fatty acid activation is important to prevent 
the FA efflux out of the mammary cells (Mashek and Coleman, 2006) and would aid 
FA binding to FABP. The genes ACSL1 and FABP3 are the dominant genes related to 
FA activation and transport in lactating dairy cows (Bionaz and Loor, 2008).  The 
protein ACSLI is located on the plasma membrane (Doege and Stahl, 2006) while 
FABP is shown to interact with CD36 (Spitsberg et al., 1995). The location of these 
proteins enables the mammary cells to trap the FA inside the cells. In this study, 
Butterfat infusion increased the expression of ACSL1, ACSS2, FABP3 and FABP4, 
suggesting that the FA were immediately activated and transported for TAG synthesis 
in the mammary cells.  Increased ACSL1 expression could have enhanced the uptake 
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of infused FA in this treatment. Marszalek et al. (2004) reported that over-expression 
of ACSL1 and ACSL2 isoforms in differentiated neurons increased uptake rates of 
oleic, arachidonic and docosahexaenoic acids by 25 to 115%. The increased 
expression of ACSS2, a gene related to activation of acetate to acetyl CoA, could be a 
consequence of higher palmitic acid provided with the Butterfat treatment. It was 
observed significant increase in ACSS2 expression when MAC-T cells were exposed 
to 100 µM of 16:0 but not to 18:0, 18:1, t10-18:1, t10c12-CLA or 20:5 (Kadegowda 
et al., 2008). In this study, the LCFA treatment did not affect ACSS2 expression.  
However, the LCFA mixture contained only 50% of  the palmitic acid provided with 
the Butterfat treatment suggesting that concentration of palmitic acid could be a factor 
in regulation. LCFA treatment decreased the expression of FABP3 and FABP4, which 
correlated with the decreased expression of genes related to FA uptake.  
 Butterfat infusion up regulated the expression of genes related to FA synthesis 
(ACACA, FASN), FA desaturation (SCD) and TAG synthesis (GPAM, DGAT1, 
AGPAT6). These changes were correlated with increase in milk FA yield and 
significantly higher concentrations of MCFA (14:0, 14:1, 15:0), c9-18:1 and 18:2 
(Kadegowda et al., 2008).  This suggested that the incorporation of SCFA and MCFA 
provided with the infused butterfat into milk fat could have activated the mammary 
FA-synthesizing machinery. The increased availability of acetyl CoA due to up 
regulation of ACSS2 expression could have increased expression of ACACA, the gene 
responsible for conversion of acetyl CoA to malonyl CoA. The increased availability 
of malonyl CoA in addition to other substrates (SCFA and MCFA) provided by the 
butterfat correlated with up-regulated FASN gene expression.   In ruminants, FASN 
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contains a loading acyltransferase with wider substrate specificity and is capable of 
loading and releasing short- and medium-chain FA (Barber et al., 1997). Therefore, 
the increase in milk c9-18:1 in the Butterfat treatment could be a consequence of 
increased FASN which would elongate the short and medium chain FA and SCD 
expression which would desaturate the elongated FA.  
 Butterfat infusion significantly increased the expression of GPAM gene that 
catalyzes the first step in TAG formation, and AGPAT and DGAT genes involved in 
the subsequent steps of TAG synthesis. Butterfat contains substantial amounts of 
palmitic acid, an important FA for TAG synthesis in the mammary gland (Hansen and 
Knudsen, 1987). Initiation of acylation of sn-1 position is prerequisite for TAG  
synthesis and palmitic acid is the preferred substrate for the initial acylation of L-α 
glycerol phosphate by GPAM to form sn-1-lysophasphatidic acid (Kinsella and Gross, 
1973). We can speculate that the increase observed in GPAM expression coupled with 
greater availability of palmitic acid could have stimulated the synthesis of 
phosphatidic acid. Again, increased AGPAT6 expression and the availability of 
MCFA would increase the diacylglycerol synthesis. Kinsella and Gross (1973) have 
showed that  myrystyl, stearyl and oleyl CoA were used in the second step of TAG 
synthesis and are  rapidly acylated when sn-1-lysophasphatidic acid was used as 
substrate. Finally, an increase in DGAT1 with the higher availability of SCFA, the 
preferred substrates for the sn-3 position would increase milk TAG output. 
 In contrast to Butterfat, the LCFA treatment decreased FASN expression 
which was reflected in the reduced concentrations of <16:0 FA in milk. Long-chain 
FA (Drackley et al., 2007; Palmquist et al., 1993) and PUFA (Ahnadi et al., 2002) are 
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known to decrease concentrations of  FA synthesized de novo suggesting down-
regulation of lipogenic  genes or decreased enzyme activity. Ahnadi et al. (2002) 
reported decreased expression of ACACA and FASN leading to 60% reduction in de 
novo-synthesized FA in dairy cows supplemented with fish oil.  
Possible Molecular Mechanisms Involved In Regulation Of  Lipid Synthesis. 
  The coordinated increase in all genes related to FA synthesis, uptake, 
transport and TAG synthesis due to Butterfat infusion and the opposite effect 
observed with LCFA treatment suggested that the FA effects could be mediated 
through a common regulatory mechanism at the transcriptional level. Although, 
molecular mechanisms regulating lipid synthesis in lactating dairy cows are not well 
established (Bernard et al., 2006; Shingfield and Griinari, 2007), a role for SREBP1 in 
regulation of mammary FA synthesis has been suggested (Peterson et al., 2004; 
Harvatine and Bauman, 2006).  
 The transcription factor SREBP1 is synthesized as a precursor protein, is 
associated with SCAP and is anchored to the endoplasmic reticulum membrane 
through INSIG proteins (Horton et al., 2002; Yang et al., 2002). Upon detaching from 
INSIG proteins, SREBP1 is escorted by SCAP to golgi and is processed to an active 
fragment, before translocation to the nucleus to activate the lipogenic genes (Rawson, 
2003).   The tendency of SREBP1 to increase with Butterfat infusion but to decrease 
with LCFA suggested that at least part of the effects of the infused FA could have 
been mediated through this transcriptional regulator. In addition, the co-activators 
INSIG1 and SCAP involved in the formation of SREBP1 nuclear active fragment, 
could play a role in the differences observed. The decreased SCAP expression with 
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LCFA suggested reduced synthesis of active nuclear fragment, which in turn would 
decrease the overall lipogenic gene expression. On the other hand, Butterfat treatment 
up regulated INSIG1 and down regulated SCAP expression, both negatively 
correlated to SREBF1 activity, in contrast to the overall (increased) lipogenic gene 
expression.  Bionaz and Loor (2008b) have suggested an important role for INSIG1 in 
milk fat synthesis in bovine mammary gland. The expression of INSIG1 and SREBF1 
increased during peak lactation and the mRNA abundance of INSIG1 was higher than 
that of SREBF1 (Bionaz and Loor 2008b). Similar results for INSIG1 mRNA 
abundance were observed in this study (Figure 1.). Bionaz and Loor (2008b) have 
suggested that the increased INSIG1 expression could be due to increased SREBF1 
and SREBF2 expression or a consequence of its short half-life.   
It is possible that the amounts of active nuclear SREBP produced with 
Butterfat treatment could have been enough to increase the overall lipogenic gene 
expression. Butterfat infusate contained a mixture of FA which could have also 
expressed individual effects on different transcriptional regulators. It was 
demonstrated (Kadegowda et al., 2008) that feeding t10c12-CLA decreased the 
mRNA abundance of SREBP1, ChREBP and PPARG while PHVO containing a 
mixture of trans-18:1 FA affected only SREBP1 expression in lactating mice.   
 PPARG is a nuclear receptor involved in regulation of genes related to FA 
uptake and transport (Desvergne, 2006). Bionaz and Loor (2008b) reported up 
regulation of PPARG expression in lactating mammary tissue of dairy cows and have 
suggested a key role of this gene in milk fat synthesis. In this study, infusion of LCFA 
 
 182
decreased PPARG expression (-109%) which correlated with reduced expression of 
genes related to FA uptake and transport. 
The LCFA treatment decreased the expression of THRSP, a nuclear protein 
associated with regulation of de novo lipid synthesis in lipogenic tissues (Kinlaw et 
al., 1995). Although, the exact function of THRSP is unknown, it was speculated that 
it functions as an allosteric regulator of lipogenic genes (LaFave et al., 2006). Zhu et 
al. (2005) demonstrated that milk TAG content in THRSP-null mice was significantly 
reduced due to a decrease in de novo lipid synthesis. Similarly, Harvatine and 
Bauman (2006) reported that diet-induced MFD and t10c12-CLA treatment down 
regulated the expression of THRSP in mammary gland of lactating cows. Kadegowda 
et al (20008) observed a decrease in THRSP mRNA expression, proportional to the 
degree of MFD in mice fed t10c12-CLA, PHVO and t7-18:1.  
  The LPIN1, a gene related to diacylglycerol synthesis is expressed in the 
bovine mammary tissue (Bionaz and Loor, 2008b). Bionaz and Loor (2008b) have 
reported an increase in LPIN1 expression during lactation and have suggested a 
possible regulatory role in milk fat synthesis.  In this study, the LPIN1 gene 
expression was up regulated by three folds with the fat infusions suggesting possible 
association between the availability of FA substrates and gene expression.   
 Data from this study reported earlier (Kadegowda et al., 2008) showed that the 
CLA infusion decreased milk fat percentage and yield up to 45%. However, the CLA 




The role of t10c12-CLA in decreasing de novo FA synthesis is established in 
lactating dairy cows (Baumgard et al., 2000). The degree of MFD depends on the 
quantity of t10c12-CLA (Peterson et al., 2003). Infusion of t10c12-CLA around 10g/d 
has decreased milk fat up to 45% in addition to decreased mRNA expression of genes 
related to FA uptake, synthesis, desaturation and TAG synthesis (Baumgard et al., 
2002; Harvatine and Bauman, 2006). Although, it was observed that the degree of 
MFD was similar to these studies, the mRNA expression of lipogenic genes was not 
affected. The major difference between the studies was the duration of infusion 3 to 5 
days in earlier studies vs. 14 days in the present experiment. This could be due to a 
possible effect of time on the lipogenic gene response to t10c12-CLA infusion, where 
the animal would try to maintain physiological (lactational) homeostasis. However, 
dietary supplementation of Ca-salts of t1012-CLA consistently reduced milk fat yield 
for 20 wks (Perfield et al., 2002; Bernal-Santos et al., 2003), but the lipogenic gene 
response was not examined in these studies. 
 Lack of lipogenic response to lipid supplementation have been reported earlier 
in lactating beef cows (Murrieta et al., 2006) and lactating goats (Bernard et al., 
2005). Dietary high linoleate safflower seed supplementation in lactating beef cows 
significantly decreased the MCFA but did not affect the levels of ACACA, FASN and 
SCD mRNA(Murrieta et al., 2006). Similarly, Bernard et al., (2005) reported 
decreased C10:0- C17:0 FA without any effects on the ACC and FAS expression in 
lactating goats supplemented with oleic sunflower oil.  
 In conclusion, the differences observed in the lipogenic gene response 
between the Butterfat and LCFA treatments suggest that milk fat synthesis is 
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regulated differently when SCFA and MCFA are provided. Availability of FA 
substrates coupled with increased lipogenic gene expression lead to increased milk fat 
synthesis in lactating dairy cows infused with butterfat. Although, LCFA infusion 
decreased lipogenic gene expression, milk fat content was maintained due to an 
increase in milk yield.  Infusion of CLA decreased milk fat but did not affect 
mammary lipogenic gene expression, suggesting possible  involvement of other 





Ahnadi, C. E, N. Beswick, L. Delbecchi, J. J. Kennelly and P. Lacasse. 2002. 
Addition of fish oil to diets for dairy cows. II. Effects on milk fat and gene 
expression of mammary lipogenic enzymes. J Dairy Res. 69:521-31. 
Annison, E. F., J. L. Linzell and C. E. West. 1968. Mammary and whole animal  
metabolism of glucose and fatty acids in fasting lactating goats. J Physiol. 
197: 445-459.  
Banks, W., J. L. Clapperton, and A. K. Girdler. 1990. Effect of dietary unsaturated  
fatty acids in various forms on the de novo synthesis of fatty acid in the 
bovine mammary gland. J. Dairy Res. 57:179–185. 
Barber, M. C., R. A. Clegg, M. T. Travers and R. G. Vernon. 1997. Lipid metabolism  
 in the lactating mammary gland. 1347: 101-126.  
Baumgard, L. H, E. Matitashvili, B. A. Corl, D. A. Dwyer and D. E.  Bauman. 2002.  
Trans-10, cis-12 conjugated linoleic acid decreases lipogenic rates and 
expression of genes involved in milk lipid synthesis in dairy cows.J Dairy 
Sci.85:2155-63. 
Baumgard, L. H., B. A. Corl, D. A. Dwyer, A. Saebo, and D. E. Bauman. 2000.  
 Identification  of the conjugated linoleic acid isomer that inhibits milk fat 
 synthesis. Am. J. Physiol. 278:R179-R184. 
Bernal-Santos, G., J. W. Perfield, II, D. M. Barbano, D. E. Bauman, and T. R.  
 Overton. 2003. Production responses of dairy cows to dietary supplementation 
 with conjugated linoleic acid (CLA) during the transition period and early 




Bernard, L., C. Leroux, Y. Chilliard. 2008. Expression and nutritional regulation of 
lipogenic genes in the ruminant lactating mammary gland. Adv Exp Med 
Biol.606:67 -108. 
Bernard, L., J. Rouel, C. Leroux, A. Ferlay, Y. Faulconnier, P. Legrand and Y. 
Chilliard. 2005.  Mammary Lipid Metabolism and Milk Fatty Acid Secretion 
in Alpine Goats Fed Vegetable Lipids. J. Dairy Sci. 88:1478-1489. 
Bionaz, M and J.J. Loor. 2008b. Gene network driving bovine milk fat synthesis  
 during the lactation cycle. BMC Genomics. 9:366. 
Bionaz, M. and J. J. Loor. 2007. Identification of reference genes for quantitative  
 real-time PCR in the bovine mammary gland during the lactation cycle. 
 Physiol Genomics 29(3):312-319. 
Bionaz, M. and J. J. Loor. 2008a. ACSL1, AGPAT6, FABP3, LPIN1, and 
 SLC27A6are the most abundant isoforms in bovine mammary tissue and their  
 expression isaffected by stage of lactation. J. Nutr. 138: 1019–1024. 
Desvergne, B. A., L. Michalik, and W. Wahli. 2006. Transcriptional regulation of  
 metabolism. Physiol. Rev. 86:465–514. 
Doege, H.  and A. Stahl. 2006. Protein-mediated fatty acid uptake: Novel insights  
 from in vivo models. Physiology 21: 259-268. 
Drackley, J. K., T. H. Klusmeyer, A. M. Trusk, and J. H. Clark. 1992. Infusion of 
 long-chain fatty acids varying in saturation and chain length into the  




Drackley, J. K., T. R. Overton, G. Ortiz-Gonzalez, A. D. Beaulieu, D. M. Barbano, J.  
 M. Lynch and E. G. Perkins. 2007. Responses to increasing amounts of high- 
oleic sunflower fatty acids infused into the abomasum of lactating dairy cows. 
J. Dairy Sci. 90:5165-5175. 
Enjalbert, F. M. C. Nicot, C. Bayourthe, and R. Moncoulon. 2000. Effects of  
duodenal infusions of palmitic, stearic and oleic acids on milk composition 
and physical properties of butter.  J. Dairy Sci. 83:1428-1433. 
Erdman, R.A. 2008. Feeding for and the cost of producing milk components: milk fat.  
 Proc. 6th Mid-Atlantic Nutr. Conf. Timonium, MD. 113-121. 
Farr, V. C., K. Stelwagen., L. R. Cate, A. J. Molenaar., T. B. McFadden, S. R. Davis.  
1996.  An improved method for the routine biopsy of bovine mammary tissue. 
J. Dairy Sci.. 79:543-559. 
Fieldinga, B. A.  and K. N. Frayna. 1998. Lipoprotein lipase and the disposition of  
 dietary fatty acids. British J. Nutr. 80:495-502. 
Gagliostro, G and Y. Chilliard. 1991. Duodenal rapeseed oil infusion in early and  
midlactation cows. 2. Voluntary intake, milk production, and composition. J. 
Dairy Sci. 74: 499-509.  
Genome Browser Gateway. 2008 http://genome.ucsc.edu/  
 
geNorm. 2008 http://medgen.ugent.be/~jvdesomp/genorm/  
 
Hansen, H.O. and J. Knudsen. 1987. Effect of exogenous long chain fatty acids on  
 individual fatty acid synthesis by dispersed ruminant mammary gland cells. J. 
 Dairy Sci.70:1350-1354. 
Harrison, J. H., R. L. Kincaid, J. P. McNamara, S. Waltner, K. A. Loney, R. E. Riley,  
 
 188
and J. D. Cronrath. 1995. Effect of whole cottonseeds and calcium salts of 
long-chain fatty acids on performance of lactating dairy cows. J. Dairy Sci. 
78: 181-193.  
Harvatine, K. J and D.E. Bauman. 2006. SREBP1 and Thyroid Hormone 
ResponsiveSpot 14 (S14) are involved in the regulation of bovine mammary 
lipid synthesis during diet-induced milk fat depression and treatment with 
CLA. J Nutr. 136:2468-74. 
Horton, J. D.,  J.  L. Goldstein, and M. S. Brown. 2002. SREBPs: activators of the  
complete program of cholesterol and fatty acid synthesis in the liver. J Clin 
Invest. 109: 1125–1131. 
Kadegowda, A. K. G., L. S. Piperova and R. A. Erdman. 2008. Principal component  
and multivariate analysis of milk long-chain fatty acid composition during 
diet-induced milk fat depression.  J. Dairy Sci. 91:749-759. 
Kadegowda, A. K. G., L. S. Piperova, P. Delmonte and R. A. Erdman. 2008.  
Abomasal infusion of butterfat increases milk fat in lactating dairy cows.  J. 
Dairy Sci. 91:2370-2379. 
Kadegowda, A.K. G., E. E. Connor, L.S. Piperova, R. A. Erdman. 2008. Mammary  
and liver lipogenic gene expression in lactating mice fed trans-18:1 FA and 
t10c12-CLA. J. Dairy Sci (Suppl 1). 
Kadegowda, A.K. G., M. Bionaz, L.S. Piperova, R. A. Erdman, J. J. Loor. 2008. 
Lipogenic gene expression in MAC-T cells is affected differently by fatty 




Kinlaw, W. B, J. L. Church , J. Harmon , C. N. Mariash. 1995.  Direct evidence for a 
role of the Spot 14  protein in the regulation of lipid synthesis. J. Biol. Chem. 
270:16615-16618. 
Kinsella, J.E. and M, Gross. 1973. Palmitic acid and initiation of mammary glyceride 
 synthesis via phospatidic acid. Biochim. Biophy. Acta. 316:109-113.  
LaFave, L.T., L. B. Augustin and C. N. Mariash. 2006. S14: Insights from knockout 
 mice. Endocrinology. 147:4044-4047.  
Mashek, D. G., and Coleman, R.A. 2006. Cellular fatty acid uptake: the contribution 
 of metabolism. Current Opinion in Lipidology. 17:274-278. 
Murrieta, C. M., B. W. Hess, E. J. Scholljegerdes, T. E. Engle, K. L. Hossner, G. E. 
Moss and D. C. Rule. 2006. Evaluation of milk somatic cells as a source of 
mRNA for study of lipogenesis in the mammary gland of lactating beef cows 
supplemented with dietary high-linoleate safflower seeds. J. Anim Sci. 
84:2399-2405. 
National Center of Biotechnology Information (NCBI) [homepage onthe Internet].  
Bethesda, MD; 2008 [cited 2008 Jan 13]. Nucleotide BLAST. Available from: 
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi. 
Palmquist, D. L., Beaulieu, A. D., Barbano, D.M. 1993. Feed and animal factors 
 influencing milk fat composition. J. Dairy Sci. 76, 1753-1771. 
Perfield, II, J. W., G. Bernal-Santos, T. R. Overton and D. E. Bauman. 2002. Effects 
of dietary supplementation of rumen-protected conjugated linoleic acid in 
dairy cows during established lactation.  J. Dairy Sci. 85:2609-2617. 
Peterson, D. G, E. A.  Matitashvili, and D.E.  Bauman. 2004. The inhibitory effect of  
 
 190
trans-10, cis-12 CLA on lipid synthesis in bovine mammary epithelial cells 
involves reduced proteolytic activation of the transcription factor SREBP-1. J 
Nutr.  134:2523-2527. 
Peterson, D. G., E. A. Matitashvili, and D. E. Bauman. 2003. Diet induced milk fat 
 epression in dairy cows results in increased trans-10, cis-12 CLA in milk fat 
 and coordinate suppression of mRNA abundance for mammary enzymes 
 involved in milk fat synthesis. J. Nutr. 133:3098-3102. 
Piperova, L. S., B. B. Teter, I. Bruckental, J. Sampugna, S. E. Mills, M. P. Yurawecz, 
 . Fritsche, K. Ku and R. A. Erdman. 2000. Mammary lipogenic enzyme  
activity, trans fatty acids and conjugated linoleic acids are altered in lactating 
dairy cows fed a milk fat depressing diet. J. Nutr.130:2568-2574.  
Rawson, R. B. 2003. The SREBP pathway: Insights from Insigs and insects. Nature 
 Reviews. Mol. Cell Biol.4: 631-640.  
Rudolph, M. C., J.L.  McManaman, T, Phang, T. Russell, D. J. Kominsky, N. J.  
Serkova, T. Stein, S.M. Anderson, M. C. Neville. 2007. Metabolic regulation 
in the lactating mammary gland: a lipid synthesizing machine. Physiol 
Genomics. 28:323–36. 
Schingfield, K. J., C. K. Reynilds, G. Hervas, J. M. Griinari, A. S. Grandison, and D.  
E. Beever. 2006. Examination of the persistency of milk fatty acid 
composition responses to fish oil and sunflower oil in the diet of dairy cows. J. 
Dairy Sci. 89: 714-732. 
Shingfield, K. J and J. M.  Griinari. 2007. Role of biohydrogenation intermediates in  




Spitsberg, V. L, E. Matitashvili, R. C. Gorewit. 1995.  Association and coexpression 
of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary 
gland. Eur J Biochem. 230:872–878. 
Sutton, J. A., 1989. Altering milk composition by feeding. J. Dairy Sci 72:2801.  
Yang, T., P . Espenshade , M . Wright , D . Yabe , Y . Gong , R . Aebersold , J 
Goldstein , M . Brown. 2002.Crucial step in cholesterol homeostasis sterols 
promote binding of SCAP to INSIG-1, a membrane protein that facilitates 
retention of SREBPs in ER .  Cell ,  110 ,  489 – 500.  
UCSC Genome Bioinformatics [homepage on the Internet]. Santa Cruz,CA; 2008  
[cited 2008 Jan 13]. Cow (Bos taurus) Genome Browser Gateway. Available 
from: http://genome.ucsc.edu/. 
Zhu, O, W. G. Anderson, G. T. Mucha, E. J. Parks, J. K. Metkowski and C. N.  
Mariash. 2005. The spot 14 protein is required for de novo lipid synthesis in 






Table 6.1. Slope, coefficient of determination of standard curve (R2), efficiency (E), 











ACACA 21.5 -0.3 -2.99 0.998 2.16 0.94
ACSL1 20.4 -1.3 -3.30 0.997 2.01 1.80
ACSS2 21.3 -0.3 -3.37 0.997 1.98 0.90
AGPAT6 21.0 -0.7 -3.27 0.996 2.02 1.21
CD36 18.6 -3.4 -3.02 0.998 2.14 10.18
ChREBP 32.5 11.0 -2.83 0.997 2.26 0.00
DGAT1 24.6 3.1 -3.15 0.999 2.08 0.08
FABP3 16.9 -4.7 -3.40 0.996 1.97 18.22
FABP4 20.3 -1.3 -3.09 0.998 2.11 1.99
FASN 17.0 -4.9 -3.24 0.998 2.04 23.56
GPAM 19.8 -2.2 -3.31 0.997 2.01 3.35
INSIG1 21.5 -0.1 -3.11 0.998 2.10 0.79
LPIN1 22.2 0.6 -3.22 0.996 2.04 0.47
LPL 19.5 -2.6 -3.17 0.997 2.07 4.74
PPARG 24.7 3.0 -3.18 0.998 2.06 0.08
SCAP 24.8 3.2 -3.40 0.997 1.97 0.09
SCD 16.9 -5.2 -3.24 0.995 2.03 29.98
SREBF1 22.4 0.9 -3.31 0.997 2.00 0.39
SREBF2 23.2 -0.6 -2.91 0.995 2.21 1.22
THRSP 27.3 5.5 -3.67 0.998 1.87 0.02
1 The median is calculated considering all time points and all cows. 
2 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal controls] for each time 
point and each cow. 
3 R2 stands for the coefficient of determination of the standard curve. 
4 Efficiency is calculated as [10(-1 / Slope)]. 
5 mRNA abundance = 1/E(Median∆ Ct). 
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 Table 6.2. Abundance of genes measured.  Percent relative mRNA abundance and 
median Ct of genes measured by qPCR. 
 
Gene Cellular Location Type mRNA abundance Median Ct 
ACACA Cytoplasm enzyme 1.2741 21.5 
ACSL1 Cytoplasm enzyme 2.4404 20.4 
ACSS2 Cytoplasm enzyme 1.2287 21.3 
AGPAT6 Cytoplasm enzyme 1.6469 21.0 
CD36 Plasma Membrane other 13.8382 18.6 
DGAT1 Cytoplasm enzyme 0.1024 24.6 
FABP3 Cytoplasm transporter 24.7526 16.9 
FABP4 Cytoplasm transporter 2.6973 20.3 
FASN Cytoplasm enzyme 32.0157 17.0 
GPAM Cytoplasm enzyme 4.5521 19.8 
INSIG1 Cytoplasm other 1.0710 21.5 
LPIN1 Nucleus other 0.6424 22.2 
LPL Cytoplasm enzyme 6.4355 19.5 
MLXIPL Nucleus transcription regulator 0.0001 32.5 
PPARG Nucleus ligand-dependent nuclear receptor 0.1107 24.7 
SCAP Cytoplasm other 0.1164 24.8 
SCD Cytoplasm enzyme 40.7415 16.9 
SREBF1 Nucleus transcription regulator 0.5265 22.4 
SREBF2 Nucleus transcription regulator 1.0117 23.2 
THRSP Nucleus other 0.0322 27.3 
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Figure 6.1. Percent relative mRNA abundance of measured lipogenic genes in bovine 








































































































































































Figure 6.3. Treatment effects on genes related to fatty acid synthesis, desaturationa 
and fatty acid uptake in bovine mammary samples (n=24).    
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Figure 6.4. Treatment effects on genes related to triacylglycerol synthesis in bovine 
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Figure 6.5. Treatment effects on genes related to fatty acid transport and activation in 
bovine mammary samples (n=24). 
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 Figure 6.7.  Gene networks developed using IPA showing potential regulatory 






Chapter 7:  EXPERIMENT 5 
 
 
Lipogenic gene expression in MAC-T cells is affected differently by 














1Preseneted in part at the Annual ADSA-ASAS meeting, 2008. 
A.K.G. Kadegowda, M. Bionaz, L. S. Piperova, R. A. Erdman and J. J. Loor. 




Recent work has focused on trans10,cis12-CLA (t10c12CLA) and its effect on 
mammary lipogenic gene expression, while the effects of other fatty acids (FA) 
remain ill-defined.  Objectives were to test individual FA effects on mRNA 
expression via qPCR of 19 genes with roles in de novo synthesis (ACACA, FASN), 
FA uptake (LPL, CD36), intracellular FA transport (FABP3, FABP4), desaturation 
(SCD), triacylglycerol (TAG) synthesis (AGPAT6, DGAT1, GPAM, LPIN1), 
transcriptional regulation (SREBF1, SREBF2, INSIG1, THRSP), and nuclear receptor 
signaling (PPARγ). A PPARγ-specific agonist (Rosiglitazone, ROSI) was used to 
assess the role of this nuclear receptor on mammary lipogenesis.  Lipid droplet (LD) 
formation was quantified with Oil Red O staining.  MAC-T cells were cultured in 
triplicate for 12 h with 50 µM ROSI or 100 µM t10-18:1, t10c12CLA, 16:0, 18:0, c9-
18:1, 20:5, or ethanol (control). Except for 16:0 and 18:0, all other FA increased (P < 
0.05) CD36 expression (~770%) and, decreased LPL (~150%) and FABP3 (~200%) 
relative to control. 16:0 and 18:0 elicited greater mRNA of FABP3 (+500%) and 
FABP4 (+160%) over control.  Responses common to 16:0 and 18:0 included greater 
THRSP (~90%), INSIG1 (~200%), AGPAT6 (~150%), DGAT1 (~60%), and LPIN1 
(~90%), coupled with greater LD formation with 16:0.  Trans10-18:1 and t10c12CLA 
reduced expression of ACACA (~60%), FASN (~50%), SCD (~240%), and LPIN1 
(~30%). SREBF1 was lower with t10c12-CLA (~200%), c9-18:1 (150%), and EPA 
(~140%) over control.  Cis9-18:1 and EPA also decreased ACACA (~40%) and SCD 
(~300%). No effects were observed for PPARγ but ROSI up regulated by >40% 
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ACACA, FASN, SCD, LPIN1, AGPAT6, DGAT1, SREBF1, SREBF2, and INSIG1 
without changes in LD formation over control.  Results showed that FA regulate 
mammary lipogenic gene expression to different extents. Further, PPAR-gamma 
activation of de novo lipogenesis coupled with exogenous FA availability might play 
a role in regulating milk fat synthesis. 




 Lactating mammary tissue synthesizes short and medium chain fatty acids 
while  long chain FA (LCFA) are supplied from the plasma (Dils, 1983). Plasma non-
esterified fatty acids (NEFA) originate mainly from the diet and also from adipose 
tissue mobilization (Dils, 1983). Mammary uptake of LCFA depends on the plasma 
NEFA concentrations (McArthur et al., 1999). Once taken up by the mammary cells, 
LCFA are incorporated into triacylglycerols (TAG). It is known that LCFA affect  de 
novo syntheses of  short and medium chain FA (Hansen and Knudsen, 1987) and they 
also have been shown to regulate gene transcription in bovine kidney epithelial cells 
(MDBK) (Thering et al., 2007; Bionaz et al., 2008).  
 In non-ruminants, most LCFA, and specifically polyunsaturated fatty acid 
(PUFA) are known to affect lipogenic gene expression through peroxisomal 
proliferator activator receptors (PPARs). However, data showing similar effects in 
bovine mammary epithelial cells are lacking. Recently, Bionaz and Loor (2008b) 
demonstrated that PPARγ nuclear receptor was up-regulated by more than three-fold 
at the onset of lactation and maintained throughout lactation in dairy cows.  
Simultaneously, increases  in genes related to FA uptake, transport, synthesis and 
desaturation (Bionaz and Loor, 2008a) were also observed suggesting that part of the 
LCFA effects could be mediated through PPARγ. It has been reported (Harvatine and 
Bauman, 2006), , FA could regulate lipogenic gene expression through SREBP-1c 
and THRSP in mammary cells.  However, these are most likely indirect effects as FA 
can not bind directly to these transcriptional regulators.  On the other hand, FA are 
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natural ligands of  PPARγ  and can directly bind  to the nuclear receptor and affect its 
target genes (Berger and Moller,2002).  
We hypothesized that FA regulate mammary lipogenic gene expression 
through multiple transcriptional regulators, where in addition to SREBF1 and THRSP, 
PPARγ could play an important role. The objective of this experiment was to 
determine the effects of individual FA on mammary lipogenic gene expression and to 
ascertain the role of PPARγ in lipogenic gene regulation. 
 
MATERIALS AND METHODS 
Cell Culture and Treatments   
Bovine  mammary epithelial cells  (MAC-T) (Provided by Dr. Dan Peterson, 
Cal Poly San Luis Obispo)  were cultured in minimum essential medium/Earle’s 
Balanced Salts HyQ (MEM/EBSS, HyClone, Logan, UT) with insulin (5mg/L, 
Sigma, I6634, St Lois, MO), hydrocortisone (1mg/L, Sigma, H0888), transferrin (5 
mg/L, Sigma, T1428), ascorbic acid (5µM/L, Sigma,A4544), sodium acetate(5mM/L, 
Sigma, S5636, St Lois, MO), fetal bovine serum (10%, GIBCO®, Invitrogen, 
Carlsbad, CA), progesterone(1mg/L, Sigma P8783), lactalbumin (0.05%, Sigma,
 L5385), α-lactose (0.05% ,Sigma,47287-U,) and Penicillin/Streptomycin 
(10ml/L, HyClone, sv30010, Logan, UT) in  sterile cell culture flasks. Cell cultures 
were maintained in a water-jacketed incubator (Forma Scientific, Model 3158, 
Marietta, OH) with 5% CO2 at 37 °C.   The medium was changed every 24 h. The 
cells were transferred to a lactogenic medium consisting of a high glucose 
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Dulebecco’s Modified Eagle’s Medium (HG-DMEM, HyClone, Logan, UT) with 
bovine serum albumin (1g/L), prolactin (2.5 mg/L) when the cells were ~70% 
confluent. The cells were cultured for 24h (~100% confluent) before initiating the 
treatments.  
Treatments were Control (NaOH +EtOH), palmitic acid (16:0; N-16-A, Nu-
Chek Prep, Inc., Elysian, MN), stearic acid (18:0; N-18-A, Nu-Chek Prep, Inc., 
Elysian, MN), oleic acid (cis9-18:1; 1022, Matreya, Pleasant Gap, PA), trans10-18:1 
(kindly provided by Dr. M. Pete Yurawecz, FDA), trans10, cis12 CLA (#1249, 
Matreya, Pleasant Gap, PA), eicosapentaenoic acid (20:5n-3, EPA; #N-20-A, NuChek 
Prep, Inc., Elysian, MN), and Rosiglitazone (Cayman Chemical, Ann Harbor, MI).   
In the FA treatments, treatment FA were saponified with 95:5 ethanol:NaOH 
solution to obtain a stock concentration of 30 mM fatty acid/L that was used to 
provide a final cell culture concentration of 100uM.  Cells were treated for a period of 
12h and the treatments were done in triplicate. Total cell counts (concentration/ml) 
were recorded with Coulter Particulate Counter (Beckman Coulter). The intra-
cytoplasmic lipid droplets in cells were visualized with Oil O Red staining.  Amounts 
of intra-cytoplasmic triglyceride content were determined by extracting and 
quantifying Oil O Red stain at 510 nm as suggested by Ramriez-Zacarias et al.(1992). 
Cells were harvested in 1 mL TRIzol® reagent (Invitrogen, Carlsbad, CA) and stored 
at -80 °C until RNA extraction. 
RNA Extraction and Quantitative RT-PCR 
Total RNA was extracted from the cells using ice-cold TRIZOL reagent 
(Invitrogen, Carlsbad, CA, USA) as explained by Loor et al.,(2005). The RNA 
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concentrations were quantified with a NanoDrop ND-1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, DE). Genomic DNA was removed with 
DNase using RNeasy Mini Kit columns (Qiagen, Valencia, CA). A portion of the 
assessed RNA was diluted to 100 mg/L using DNase-RNase free water prior to RT.  
Sufficient cDNA was prepared to run all selected genes. Each cDNA was 
synthesized by RT-PCR and cDNA was used for qPCR as previously described 
(Bionaz and Loor, 2007).  Briefly, each cDNA was synthesized by RT using 100 ng 
RNA, 1 µL dT18 (Operon Biotechnologies, AL), 1 µL 10 mM dNTP mix (Invitrogen 
Corp., CA), 1 µL Random Primers (Invitrogen Corp., CA), and 7 µL DNase/RNase 
free water.  The mixture was incubated at 65 °C for 5 min and kept on ice for 3 min.  
A total of 9 µL of Master Mix composed of 4.5 µL 5X First-Strand Buffer, 1 µL 0.1 
M DDT, 0.25 µL (100 U) of SuperScriptTM III RT (Invitrogen Corp., CA), and 0.25 
µL of RNase Inhibitor (Promega, WI) and 3 mL DNase/RNase free water was added.  
The reaction was performed in an Eppendorf Mastercycler® Gradient using the 
following temperature program: 25 °C for 5 min, 50 °C for 60 min and 70 °C for 15 
min.  cDNA was then diluted 1:3 with DNase/RNase free water.   
For qPCR analysis, 4 µL of diluted cDNA were combined with 6 µL of a 
mixture composed of 5 µL 1x SYBR Green master mix (Applied Biosystems, CA), 
0.4 µL each of 10 µM forward and reverse primers, and 0.2 µL DNase/RNase free 
water in a MicroAmp™ Optical 384-Well Reaction Plate (Applied Biosystems, CA).  
Each sample was run in triplicate and a 4 point relative standard curve (4-fold 
dilution) plus the non-template control were used (User Bulletin #2, Applied 
Biosystems, CA).  The reactions were performed in an ABI Prism 7900 HT SDS 
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instrument (Applied Biosystems, CA) using the following conditions: 2 min at 50 °C, 
10 min at 95 °C, 40 cycles of 15 s at 95 °C, and 1 min at 60 °C.  The presence of a 
single PCR product was verified by the dissociation protocol using incremental 
temperatures to 95 °C for 15 s plus 65 °C for 15 s.  Complete details regarding qPCR 
protocol can be found at http://docs.appliedbiosystems.com/pebiodocs/04364014.pdf.  
Data were analyzed with the 7900 HT Sequence Detection Systems Software (version 
2.2.3, Applied Biosystems, CA). 
Primer Designing and testing Primer Express 3.0 software (Applied Biosystems, 
Foster City, CA), optimized for use with Applied Biosystems qPCR Systems, was 
used for primer design using default features, except for the amplicon length, which 
was fixed at a mininum of 100 bp . Primers were designed across exon junctions 
when possible to avoid amplification of genomic DNA. The exon junctions were 
uncovered blasting the sequence against bovine genome (Genome Browser Gateway, 
2008). Primers were aligned against publicly available sequences in NCBI(National 
Center of Biotechnology Information, 2008) and UCSC(Genome Browser Gateway, 
2008). Prior qPCR, primers were tested using the same protocol as for qPCR without 
the dissociation step in a 20 µL reaction. Part of the PCR product was run in a 2% 
agarose gel stained with ethidium bromide to assess presence of the product to a 
expected size and presence of primer-dimer, the rest was purified using Qiaquick 
PCR purification kit (Qiagen, Valencia, CA) and sent to sequence at the Core DNA 
Sequencing Facility of the Roy J. Carver Biotechnology Center at the University of 
Illinois, Urbana. Only primers with high specificity evaluated by a single band on 
agarose gel, absence of primer-dimer, amplification of the right cDNA verified by 
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sequencing, and a unique peak in the dissociation curve after qPCR reaction were 
used. 
Statistical Analysis 
A normalization factor calculated as a geometric mean of 3 internal control 
genes (MRPL39, RP9 and UXT) using geNorm was used to normalize the qPCR data. 
The Mixed procedure in the Statistical Analysis System (Version 8.2, 2004, SAS 
Institute, Cary, NC) was used to evaluate the treatment effects on the normalized 
mRNA abundance. Fixed effects were  treatment while the random portion of the 
model included the sample/replicates (cell culture flasks). Probability of (P ≤ 0.05) 
was considered as statistically significant. 
The qPCR data is presented as percentage change relative to Control. The 
standard error for each treatment was estimated as described by Bionaz and Loor 
(2008a). Briefly, normalized data were transformed to obtain a perfect mean of 1.0 
for Control, leaving the proportional difference between the biological replicates. The 
same proportional change was calculated in all the treatments to obtain a fold change 
relative to Control. 
Networks Development by Ingenuity Pathway Analysis  
Networks among measured genes were developed by using Ingenuity Pathway 
Analysis® (IPA, www.ingenuity.com; Redwood City, CA, USA). This allows for the 
examination of gene networks within large gene expression datasets based on 
published relationships across several organisms.  The gene expression data set 
comprising of gene identifiers, corresponding expression values (logarithm 
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transformed percentage of expression relative to ethanol control), and pair-wise 
comparison P-values were uploaded into IPA. Each gene identifier was mapped to its 
corresponding gene object in the Ingenuity Pathways Knowledge Base. A cutoff of (P 
≤ 0.05) was set to identify genes whose expression was significantly and 
differentially regulated by treatments. The intensity of the node color indicates the 
degree of up- (red) or down- (green) regulation. A network is a graphical 
representation of the molecular relationships between gene products. Gene products 
are represented as nodes, and the biological relationship between two nodes is 
represented as an edge (line). All edges generated by IPA are supported by at least 
one reference from published literature, or from canonical information stored in the 
Ingenuity Pathways Knowledge Base. To summarize results from our data, we 
generated networks where custom edges were added to account for new findings and 
edges not demonstrated by our data were removed. Nodes are displayed using various 
shapes that represent the functional class of the gene product. Edges are displayed 
with various labels that describe the nature of the relationship between the nodes 
(e.g., A for activation, E for effect on expression). 
 
RESULTS 
The MAC-T cells showed increased accumulation of TAG with palmitic acid 
(240%), stearic acid (180%), oleic acid (190%) and t10c12-CLA (350%), compared 
to control (Figure 7.1).  The maximum accumulation of lipid droplets, visualized by 
the Oil- O-red staining was observed in the presence of  t10c12-CLA followed by 
oleic acid (Figure 7.2 ). 
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 The relative mRNA abundance of lipogenic genes related to FA uptake, 
activation, transport, TAG synthesis and transcriptional regulators is presented in 
Table 7.1 and Figure 7.3. the qPCR assay conditions and results of lipogenic genes 
are presented in tables 7.2 and 7.3, respectively. Maximum mRNA abundance was 
observed for SCD (36%) and FASN (18%) which constituted 54% of the overall 
mRNA of the examined lipogenic genes. The relative abundance of the transcriptional 
regulators, SREBF1 (9%) and SREBF2 (8%) represented 17% of the total mRNA 
abundance. The lowest mRNA abundance (< 0.1%) was observed for CD36 (0.02%), 
LPL (0.02%) and THRSP (0.04%) and which was reflected with higher median 
threshold (Ct) values, the cycle number at which the sequence detector amplifies the 
product (Figure 7.4). The Ct value of ChREBP transcriptional regulator was over 37 
and therefore was not detectable. 
 The expression of LPL and CD36, genes regulating FA uptake (Figure 7.5) 
were affected to different extents by individual treatment. Compared to the Control, 
LPL expression was significantly (P < 0.01) down regulated with the unsaturated FA, 
18:1(-123%), 20:5 (-172%), t10-18:1(-93%) and t10c12 CLA (-125%). Conversely, 
the expression of CD36, the membrane bound protein involved in FA uptake into 
mammary cells was increased with all  treatments compared to Control. Maximum 
CD36 response was observed with 18:0 (1400%, P < 0.001), 20:5 (1450%, P < 
0.001), and t10c12-CLA (1330%, P < 0.002).  Expression of ACSS2, one of the genes 
associated with activation of FA, was up regulated with 16:0 (168%, P < 0.001) but 
was not affected by the other treatments. Similarly, expression of ACSL1 was also not 
affected by the FA (Fig. 7.6).  
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 FABP genes are involved in regulation of intra-cellular FA transport. The 
mRNA abundance of FABP3 and FABP4 was significantly increased with the 
saturated FA, 16:0 (755%, P < 0.001 and 170 %, P < 0.001) and 18:0 (338%, P < 
0.001and 157, P < 0.001). 18:1 increased the expression of FABP4 (69%, P < 0.001) 
but tended to decrease the FABP3 (-161%, P < 0.17) expression. Trans10c12-CLA (-
162%) and t10-18:1(-92%) also tended to decrease FABP3 expression.  
 ROSI increased the expression of genes related to FA synthesis (ACACA, 
85%, P < 0.001 and FASN, 54%, P < 0.003) and desaturation  (SCD, 54%, P < 
0.001) (Figure 7.7). The expression of ACACA and FASN was significantly (P < 
0.001) reduced by 18:0 (-55 and -66%), t10-18:1 (-38 and -61%) and t10c12-CLA (-
82 and -23%), compared to Control. While 18:1 and 20:5 reduced the ACACA 
expression by -36% (P < 0.05) and -42% (P < 0.01), FASN  expression was not 
affected.  The mRNA abundance of SCD, gene related to desaturation of FA was 
significantly (P < 0.001) up-regulated with 16:0 (93%, P < 0.001) but was down-
regulated by the presence of FA containing one or more double bonds: 18:1(-422%), 
t10-18:1(-98%), t10c12-CLA (-355%) and 20:5 (-206%).  
 The mRNA abundance of GPAM, AGPAT6 and DGAT1 (Figure 7.8) were 
measured to test the effect of treatments on the different steps  of  TAG synthesis 
from FA and glycerol substrates. While none of the treatments affected GPAM 
expression, DGAT1 was increased with 18:0 (87%, P < 0.001) and ROSI (74%, P < 
0.001).  AGPAT6 expression was significantly (P < 0.05) increased by all the 
treatments (except t10-18:1) - 16:0 (131%), 18:0 (162%), 18:1 (153%), t10c12-CLA 
(98%), 20:5 (184%) and ROSI (263%).  
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 The mRNA abundance of transcriptional regulators SREBF1, SREBF2, 
THRSP, LPIN1; nuclear receptor PPARG and transcriptional co-activators INSIG1 
and SCAP were measured to elucidate the mechanisms involved in regulation of 
lipogenic genes due to individual FA treatments (Figures 7.9 and 7.10). SREBF1 
expression was significantly (P < 0.001) decreased with 18:1 (-138%), t10c12-CLA 
(-187%) and 20:5 (-120%) but was increased with ROSI (100%).  Similarly, SREBF2 
expression was significantly (P < 0.05) decreased with 18:1 (-82%), t10-18:1 (-19%), 
t10c12CLA (-71%) and 20:5 (-30%) but was increased with 16:0 (53%) and ROSI 
(74%). Of the Co-activators SCAP and INSIG1 that are known to regulate the SREBP 
activity, the SCAP expression was decreased with 20:5 (-57%, P < 0.02) but was 
increased with ROSI (32%, P < 0.05).  INSIG1 expression was increased with 16:0 
(297%, P < 0.001), 18:0 (91%, P < 0.001), 20:5 (83%, P < 0.001) and ROSI (142%, 
P < 0.001) but was decreased with 18:1 (-89%, P < 0.05) and t10c12-CLA (-89%, P 
< 0.05).   
 The 16:0 and 18:0 saturated FA significantly (P < 0.05) increased THRSP 
expression (Figure 7.10) by 88% and 98%, respectively. None of the treatments 
affected PPARG expression (Figure 7.10). Conversely, the expression of LPIN1 
(Figure 7.10) was affected by all the treatments. LPIN1 expression was increased with 
saturated FA (16:0, 140%, P < 0.001; 18:0, 29%, P < 0.05) and ROSI (117%, P < 
0.001) but decreased with unsaturated FA (18:1, -58%, P < 0.01; t10-18:1, -30%, P < 





 The molecular mechanisms regulating milk fat synthesis in lactating 
ruminants have not been completely elucidated (Bernard et al., 2008). A coordinated 
suppression of lipogenic genes during milk fat depression lead to the speculation that 
the mechanism of milk fat synthesis could be controlled at a common regulatory 
point. Studies have largely focused on the role of SREBP1 and THRSP in regulating 
milk fat synthesis (Peterson et al., 2004; Harvatine and Bauman, 2006). Recently, 
Bionaz and Loor (2008b) reported up-regulation of PPARγ during lactation in dairy 
cows suggesting its pivotal role in regulation of milk fat synthesis. The results from 
our study support the view of Bionaz and Loor (2008b) on possible role for PPARγ in 
milk fat synthesis. We observed that treatment of MACT cells with ROSI, a specific 
PPARγ agonist increased the expression of genes related to FA uptake (CD36), FA 
synthesis (ACACA, FASN), desaturation (SCD), TAG synthesis (AGPAT6, DGAT1, 
LPIN1), transcriptional regulators  of fat synthesis (SREBF1, SREBF2, THRSP) and 
co-activators (SCAP, INSIG1).   
 Genes related to FA uptake (CD36, LPL) and activation (ACSL1) are known 
PPARγ target genes (Desvergne et al., 2006).  In addition, genes related to FA 
synthesis (ACACA, FASN), desaturation (SCD), and TAG synthesis (AGPAT) were 
up- regulated with PPARγ agonist (GW1929) treatment in the adipose tissues of male 
ZDF rats (Way et al., 2001). In ruminants, a coordinated increase in the expression of 
LPL, ACACA, FASN and PPARγ expression in ovine adipose tissue due to propionate 
infusion suggested a possible regulatory role for PPARγ (Lee and Hossner, 2002). In 
the present study, ROSI did not affect the expression of LPL and ACSL1, which are 
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known PPARγ target genes in adipose. This indicated that the regulation of lipogenic 
gene expression through PPARγ could be different between adipose tissue and 
mammary epithelial cells.  In addition to the established target genes, PPARγ affected 
the mRNA abundance of other transcriptional regulators (SREBF1, SREBF2, LPIN1, 
THRSP) and co-activators (SCAP and INSIG1). Based on these observations, we 
could speculate that increased SREBF expression could increase the expression of 
other down-stream lipogenic genes. Nevertheless, increased INSIG1 expression 
would decrease the formation of active nuclear SREBF protein and INSIG1 is 
regulated by PPARγ (Kast-Woelbern et al., 2004). This suggests that many of the 
lipogenic genes could be directly regulated by PPARγ. 
 We tested the effects of saturated (16:0, 18:0), unsaturated FA (18:1, 20:5) 
and rumen biohydrogenation intermediates (t10-18:1, t10c12-CLA) on mammary 
lipogenic genes to determine if some of their effects were regulated through PPARγ 
as reflected in the expression of PPARγ target genes.  Compared to Control, the 
treatments with saturated FA (16:0 and 18:0) increased intra cytoplasmic TAG 
contents (Figure 7.1) but did not form visible lipid droplets (Figure 7.2). However, 
increased TAG content was correlated with lipid droplet formation with oleic acid 
(18:1) treatment. Similar observations were reported by Yonezawa et al., (2004) in 
bovine mammary epithelial cells (bMEC) treated with palmitic acid, stearic acid and 
oleic acid. The increased intra cellular TAG content due to 16:0, 18:0 and 18:1 
correlated with increased expression of CD36, gene related to FA translocation, in 
both this study and the study of Yonezawa et al., (2004). In this study CD36 
expression increased from 2.5 (ROSI) to 15 fold (18:0, 20:5 and t10c12 CLA).  
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Increased CD36 with all treatments suggests that the exogenous FA concentrations 
could play a role in FA uptake by the mammary cells.  
 Mammary FA uptake is also driven by intra-cellular FA activation, FA 
binding to intracellular proteins (FABP) and intracellular metabolism (TAG 
synthesis) (Mashek and Coleman, 2006).  ACSL1, one of the predominant genes 
related to FA activation, (Bionaz and Loor, 2008a) is present on the plasma 
membrane (Doege and Stahl, 2006). In this study, none of the treatments affected 
ACSL1 expression but palmitic acid increased ACSS2 expression, the gene related to 
acetate activation. Hansen and Knudsen (1987) have reported increased synthesis and 
incorporation of butyrate (C4:0) in TAG when bovine and ovine dispersed mammary 
epithelial cells were incubated with palmitic acid. Their observations correspond to 
the increased ACSS2 expression observed in our study.   
FABPs are proteins involved in intra cellular transport and are shown to 
directly interact with CD36 (Spitsberg et al., 1995).  The proteins FABP3 and FABP4 
are the predominantly expressed FABP isoforms in bovine mammary epithelial cells 
(Bionaz and Loor, 2008a). In this study, the saturated FA (16:0 and 18:0) 
significantly increased the expression of FABP3 and FABP4 while oleic acid (18:1) 
increased FABP4 expression suggesting the involvement of different FABP isoforms 
for transport of different FA.    
 Long-chain FA are known to affect mammary FA synthesis in lactating dairy 
cows (Chilliard et al., 2001) as feeding or infusion of LCFA supplements is known to 
decreases de novo FA synthesis in the mammary cells. However, these effects depend 
on the type of LCFA where unsaturated FA supplements result in greater decreases 
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(Drackley et al., 1992). In this study, oleic acid and EPA decreased the mRNA 
expression of ACACA but not FASN. ACACA is reported to control 63% of FA 
synthesis while FASN controls the remaining 37%, as measured by metabolic flux 
control in bovine mammary homogenates (Wright et al., 2006). The biohydrogenation 
intermediates, t10-18:1 and t10c12-CLA decreased expression of both genes related 
to FA synthesis. The role of t10c12-CLA in decreasing the expression of lipogenic 
genes is well established (Peterson et al., 2003). However, to our knowledge this is 
the first report showing a direct effect of t10-18:1 on mammary lipogenic gene 
expression. Recently, Lock et al (2007) reported a lack of effect of trans-10-18:1 on 
milk fat synthesis in lactating cows. However, milk t10-18:1 was only 1.11%, well 
below the concentration of 2.5% required for maximal MFD suggested by 
(Kadegowda et al., 2008).  This study suggests that a higher concentration of t10-18:1 
could potentially induce milk fat depression by decreasing lipogenic gene expression.  
 Of the saturated FA, stearic acid is known to decrease de novo FA synthesis 
FA while palmitic acid (16:0) stimulates TAG formation (Hansen and Knudsen, 
1987). Expression of ACACA and FASN were reduced with stearic acid but were not 
affected by palmitic acid in the present study. Nevertheless, increased TAG synthesis 
due to palmitic acid could be possibly due to the fact that palmitic acid is the most 
preferred substrate for the initial acylation of L-α glycerolphosphate by 
acyltransferase to form sn-1-lysophasphatidic acid.  Initiation of acylation of the sn-1 
position is a prerequisite for TAG  synthesis in the mammary gland (Kinsella and 
Gross, 1973).   
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 The mRNA abundance of SCD was increased with palmitic acid but was not 
affected with stearic acid. Both, palmitic acid and stearic acids are the preferred 
substrates for desaturation by SCD. Nevertheless, increased SCD expression with 
palmitic acid suggests involvement of other regulatory mechanisms. Expression of 
SCD was decreased with the presence of unsaturated FA possibly due to a feed back 
inhibition. Of the genes related to TAG synthesis, AGPAT6 expression was 
significantly increased with all treatments (except trans-10-18:1), indicating that most 
of the FA were diverted towards TAG synthesis in the mammary epithelial cells. 
 Mammary lipogenic gene expression is regulated through transcriptional 
regulators SREBF1, SREBF2, INSIG1, PPARγ, THRSP and LPIN1 (Bionaz and Loor, 
2008b). In this study, the unsaturated FA decreased the expression of SREBF1 and 
SREBF2, the transcriptional regulators known to control the lipogenic gene 
expression. All the unsaturated FA except EPA decreased INSIG1 expression. INSIG1 
is shown to be under the control of SREBP1 (Kast-Woelbern et al., 2004). Therefore, 
reduced SREBP1 expression could have reduced INSIG1 expression with these 
treatments. Decreased mRNA abundance of SCAP and increased abundance of 
INSIG1 indicated that EPA could regulate the synthesis of active nuclear SREBP 
through both transcriptional and post-translational mechanisms.  Similarly, increased 
mRNA abundance of INSIG1 due to saturated FA suggested a post-translational 
decrease in SREBP proteins which in turn could potentially down regulate the 
mammary lipogenic genes. However, palmitic and stearic acid increased LIPN1 and 
THRSP expression; the transcriptional regulators involved in TAG (Coleman and 
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Lee, 2004) and de novo FA (LaFave et al., 2006) synthesis, respectively. This could 
explain the increased TAG synthesis by these treatments.  
 Summarizing the results (Figure 7.12), ROSI, a PPARγ agonist identified that 
the down-stream genes controlled by PPARγ in mammary epithelial cells, were genes 
related to FA synthesis, FA desaturation, TAG synthesis and mammary 
transcriptional regulators. The results from the study suggested that part of the effects 
due to palmitic acid could be mediated through PPARγ activation. However, SREBF 
could also play a major role in lipogenic gene regulation when  unsaturated FA- 18:1, 
20:5, t10-18:1 and t10c12-CLA were present. We demonstrated that the effects of 
t10-18:1 were similar to that of t10c12-CLA in decreasing mammary lipogenic gene 
expression at the levels of FA used in this study. However, keeping in view the 
limitations of cell culture work, in vivo studies with lactating dairy cows would be 
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Table 7.1. Percent relative mRNA abundance and median threshold cycle (Ct) of 









 ACACA Cytoplasm enzyme 0.06 24.61 
 ACSL1 Cytoplasm enzyme 0.11 23.84 
 ACSS2 Cytoplasm enzyme 0.23 22.68 
 AGPAT6 Cytoplasm enzyme 0.23 22.50 
 CD36 
Plasma 
Membrane other 0.00 30.93 
 DGAT1 Cytoplasm enzyme 0.09 23.76 
 FABP3 Cytoplasm transporter 0.21 22.54 
 FABP4 Cytoplasm transporter 0.01 27.53 
 FASN Cytoplasm enzyme 0.87 20.48 
 GPAM Cytoplasm enzyme 0.01 27.06 
 INSIG1 Cytoplasm other 0.13 23.51 
 LPIN1 Nucleus other 0.13 23.21 
 LPL Cytoplasm  enzyme 0.00 32.24 
 MLXIPL Nucleus transcription regulator  39.06 
 PPARG Nucleus ligand-dependent nuclear receptor 0.01 26.18 
 SCAP Cytoplasm other 0.20 22.55 
 SCD Cytoplasm enzyme 1.78 19.07 
 SREBF1 Nucleus transcription regulator 0.44 21.64 
 SREBF2 Nucleus transcription regulator 0.42 21.61 




Table 7.2. Slope, coefficient of determination of standard curve (R2), efficiency (E), 
median threshold cycle (Ct), and mRNA abundance of measured transcripts. 
 








ACACA -3.45 0.997 1.95 24.6 4.3 1.12 
ACSL1 -3.73 0.998 1.85 23.8 3.6 2.16 
ACSS2 -3.77 0.997 1.84 22.7 2.4 4.59 
AGPAT6 -3.54 0.999 1.92 22.5 2.2 4.71 
CD36 -3.63 0.998 1.89 30.9 10.6 0.02 
ChREBP -2.56 0.959 2.46 39.1  0.00 
DGAT1 -3.38 0.996 1.98 23.8 3.5 1.91 
FABP3 -3.48 0.997 1.94 22.5 2.4 4.28 
FABP4 -3.99 0.998 1.78 27.5 7.5 0.26 
FASN -3.56 0.998 1.91 20.5 0.2 17.65 
GPAM -3.57 0.999 1.91 27.1 6.9 0.23 
INSIG1 -3.69 0.998 1.87 23.5 3.3 2.54 
LPIN1 -3.49 0.999 1.94 23.2 3.1 2.69 
LPL -3.85 0.994 1.82 32.2 12.0 0.02 
PPARG -3.15 0.999 2.08 26.2 6.0 0.26 
SCAP -3.33 0.997 1.99 22.5 2.3 4.01 
SCD -3.58 0.998 1.90 19.1 -0.9 36.13 
SREBF1 -3.81 0.993 1.83 21.6 1.3 8.96 
SREBF2 -3.56 0.998 1.91 21.6 1.3 8.46 
THRSP -3.60 0.996 1.90 30.1 9.8 0.04 
 
1 R2 stands for the coefficient of determination of the standard curve. 
2 Efficiency is calculated as [10(-1 / Slope)]. 
3 The median is calculated considering all time points and all cows. 
4 The median of ∆Ct is calculated as [Ct gene – geometrical mean of Ct internal 
controls] for each time point and each cow. 
5 mRNA abundance = 1/E(Median∆ Ct). 
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Table 7.3. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on lipogenic gene expression relative to the Control treatment.  
 
Gene Control C16:0 C18:0 C18:1 t10-18:1 
t10c12-
CLA EPA ROSI P value 
  ------------------------------ % Change, relative to Control1------------------------------  
ACACA 0b -4.94bc -55.46cd -35.84bc -38.08bc -81.84d -42.12bcd 84.73a 0.001
ACSL1 0 -7.47  24.12 9.41 -2.67 3.47 15.17 15.85 0.41
ACSS2 0bcd 167.54a 3.46bc -25.90cd -16.64cde -31.05e 3.14bc 18.26b 0.001
AGPAT6 0d 130.99bc 162.14b 152.84b 40.26cd 97.75bc 184.36ab 262.82a 0.001
CD36 0b 539.10b 1407.09a 315.65b 477.25b 1331.13a 1453.46a 140.00b 0.003
DGAT1 0cd 41.02abc 86.91a 42.19abc 24.78bc 38.50abc -17.03d 73.86ab 0.01
FABP3 0cd 754.65a 338.40e -162.07e -92.08de -161.31e 12.81c 39.53c 0.001
FABP4 0c 170.90a 157.19a 68.97b 0.40c 0.77c -1.88c 36.32bc 0.001
FASN 0b 29.84bc -68.26e 57.77bc -61.13de 22.75cd -3.77bc 53.73a 0.001
GPAM 0 -74.45 -0.99 -0.63 -0.37 14.67 -30.13 -25.40 0.36
INSIG1 0d 297.49a 90.95bc -89.29e -13.14d -89.18e 83.39c 141.56b 0.001
LPIN1 0bc 140.03a 29.21b -57.55d -29.70cd -32.58cd -37.12cd 116.67a 0.001
LPL 0 -27.02 1.55 -122.63 -93.40 -124.97 -172.31 -48.34 0.157
PPARG 0 24.10 19.26 -12.96 -15.28 10.72 0.33 5.67 0.56
SCAP 0a -13.82a -8.92a 17.02a 8.97a 12.42a -56.77b 31.54a 0.01
SCD 0b 93.30a 3.25b -421.89f -97.63c -354.95e -205.53d 53.77ab 0.001
SREBF1 0b 6.27b -4.95b -137.66d -46.79c -186.82e -119.70d 99.71a 0.001
SREBF2 0b 52.90a 2.45b -82.30d -18.66bc -71.43d -29.94c 35.33a 0.001
THRSP 0abc 88.48ab 96.80a -19.34abc -31.36bc -58.53c -19.39c 43.52abc 0.07
1Superscripts with unlike letters differ. 
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Figure 7.1. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on 




















































































Figure 7.2. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on lipid 







Figure 7.3. Percent relative mRNA abundance of measured lipogenic genes. 
 
































































































Figure 7.4. Median threshold cycle (Ct) values of measured lipogenic genes. 
          






































































Figure 7.5. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on mRNA 







































* P < 0.05
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
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Figure 7.6.  Effect of long-chain fatty acids and Rosiglitazone (ROSI)on mRNA 















































* P < 0.05
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
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Figure 7.7. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on mRNA 
























































* P < 0.05
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
 
 235
Figure 7.8. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on mRNA 






















































* P < 0.05
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
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Figure 7.9. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on mRNA 



































































* P < 0.05
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
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Figure 7.10. Effect of long-chain fatty acids and Rosiglitazone (ROSI) on mRNA 
























































* P < 0.05 
 
Control C16:0 C18:0 C18:1 t10-18:1 t10c12-CLA EPA ROSI
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Figure 7.12. Networks developed using IPA showing potential regulatory 


















































Identification of internal controls for quantitative PCR in mammary 




























1Presented in part at the annual ADSA-ASAS meeting, 2008. 
 
Kadegowda. A. K. G., M. Bionaz, B. Thering, L. Piperova, R. A. Erdman, and J. 




Dietary lipid supplements affect mammary lipid metabolism through changes in 
lipogenic gene expression. Quantitative PCR (qPCR) is one of the most sensitive, 
reliable, and accurate techniques available to date for gene expression analysis. 
However, variation introduced in qPCR data by analytical/technical errors needs to be 
accounted for via normalization using appropriate internal control genes (ICG). 
Objectives were to mine individual bovine mammary micro array data on >13,000 
genes across 66 cows from two independent studies to identify the most suitable ICG 
for normalization of qPCR. In addition to unsupplemented control diets, cows were 
fed saturated or unsaturated lipids (fish oil, Energy Booster) for 21 d, or were infused 
with supplements (Butterfat, CLA mixture, long-chain fatty acids) into the abomasum 
to modify milk fat synthesis and fatty acid profiles. GeneSpring® GX identified 49 
genes that did not vary in expression across the 66 samples.  Subsequent gene 
network analysis revealed that 22 of those genes were not co-regulated.  Among 
those, COPS7A, CORO1B, DNAJC19, EIF3K, EMD, GOLGA5, MTG1, UXT, 
MRPL39, GPR175, and MARVELD1 (sample/reference expression ratio = 1 ± 0.1) 
were selected for qPCR analysis upon verification of goodness of BLAT/BLAST 
sequence and primer design.  Relative expression of B2M, GAPDH, and ACTB, 
previously used as ICG in bovine mammary, was highly unstable (0.9 ± 0.6) across 
studies.  Gene stability analysis, via geNorm software, uncovered EMD, MARVELD1, 
MRPL39, GPR175, UXT, and EIF3K as the most stable genes and, thus, suitable as 
ICG.  geNorm also indicated that use of 3 to 5 ICG was most appropriate for 
calculating a normalization factor.  Overall, results showed that the geometrical 
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average of at least three among EMD, MARVELD1, MRPL39, GPR175, UXT, and 
EIF3K is ideal for normalization of mammary qPCR data in studies involving lipid 
supplementation of dairy cows. 




 Regulation of bovine mammary lipid synthesis remains a very active field of 
investigation (Bauman et al., 2006). Large-scale transcript analysis of lipogenic genes 
in lactating mice has shown that regulation of mammary lipid synthesis occurs at the 
level of mRNA expression (Rudolph et al., 2007). While, the molecular mechanisms 
by which dietary fatty acids regulate bovine mammary lipogenic gene expression are 
not completely established,  there is evidence of a role for transcriptional regulators 
(Peterson et al., 2004; Harvatine and Bauman, 2006). 
  The advent of bovine microarray tools (Loor et al., 2007), has enabled 
comprehensive large-scale evaluation of mRNA expression in tissues due to nutrition 
and/or physiological state (Loor et al., 2006; 2007).  Use of this technology promises 
to substantially increase our knowledge of transcriptional adaptations in bovine 
tissues.  Despite the advantages of microarrays, however, quantitative RT-PCR 
(qPCR) remains the method of choice for evaluation of mRNA expression. 
Quantitative  RT-PCR is one of the most sensitive, reliable, and accurate techniques 
available for gene expression analysis. Central to the applicability of qPCR is the fact 
that variation introduced due to sampling, analytical, and technical errors during the 
procedure should be accounted for via normalization. Use of appropriate internal 
control genes (ICG) is the most reliable method currently used for data normalization 
(Vandesompele et al., 2002). Use of ICG allows normalization of differences due to 
initial quantity of RNA, RNA handling and variation in kinetics of reverse-
transcription reaction. The selected ICG should not vary due to the type of 
cells/tissues or respond differently to treatments (Vandesompele et al., 2002). Thus, 
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proper selection and evaluation of ICG is critical to avoid additional variation in the 
data.  
 Most recent studies assessing the effects of lipid supplements on bovine 
mammary lipid synthesis regulation at the level of mRNA expression have relied on 
commonly-used ”housekeeping genes” such as actin-β (Peterson et al., 2003; 
Peterson et al., 2004; Harvatine and Bauman, 2006), GAPDH (Baumgard et al., 
2002), B2M (Harvatine and Bauman, 2006), and/or 18S rRNA (Harvatine and 
Bauman, 2006). Among these, actin-β and GAPDH have been shown to be 
inappropriate as ICG in bovine mammary due to the presence of co-regulation 
(Bionaz and Loor, 2007; Piantoni et al., 2008).  Further, due to its high abundance, 
the use of 18S rRNA for normalization is questionable (Vandesompele et al., 2002). 
In the present study, we mined individual cow microarray data from two independent 
studies with lactating dairy cows supplemented with different lipids to identify 
potential ICG.  The specific objective of the study was to use pair-wise analysis of 
expression ratios (Vandesompele et al., 2002) among several genes to identify 
potential ICG for qPCR normalization from mammary tissue of lactating dairy cows 
supplemented with lipids. 
 
MATERIALS AND METHODS 
RNA extraction, qPCR, and Primer Design and Testing 
Mammary tissue samples (n = 66) from lactating dairy cows fed saturated or 
unsaturated lipid supplements for 21 days (Thering et al., 2007) or infused with  
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Butterfat [source of short and long-chain fatty acids (LCFA)], LCFA or a CLA 
mixture for 14 days (Kadegowda et al., 2008) in addition to unsupplemented controls 
were used in this study.   Mammary tissue was collected via percutaneous biopsy, 
immediately frozen in liquid N2, and preserved at -80° C for RNA extraction as 
described by Bionaz and Loor (2007).   
Total RNA was extracted from ~0.5 g tissue using ice-cold TRIZOL reagent 
(Invitrogen, Carlsbad, CA, USA). The RNA concentrations were quantified with a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE) 
and the quality was evaluated using 2100 Bioanalyzer (Agilent Technologies, Santa 
Clara, CA, USA).  Only samples (n=66) with an RNA integrity number of 6 to 9 were 
used for further analysis. Genomic DNA was removed with DNase using RNeasy 
Mini Kit columns (Qiagen, Valencia, CA). A portion of the assessed RNA was 
diluted to 100 mg/L using DNase-RNase free water prior to RT. Sufficient cDNA was 
prepared to run all selected genes. Each cDNA was synthesized by RT-PCR and 
cDNA used for qPCR previously described (Bionaz and Loor, 2007). Each sample 
was run in triplicate and a six-point relative standard curve plus the non-template 
control were used. The 4-fold-dilution standard curve was made using cDNA from a 
pool RNA of all the samples. The reactions were performed in an ABI Prism 7900 
HT SDS instrument (Applied Biosystems, Foster City, CA) using the following 
conditions: 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at 
60°C.  
The presence of a single PCR product was verified by the dissociation protocol 
using incremental temperatures to 95°C for 15 s plus 65°C for 15 s. Data were 
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calculated with the 7900 HT Sequence Detection Systems Software (version 2.2.1, 
Applied Biosystems, Foster City, CA). Primer Express 3.0 software (Applied 
Biosystems, Foster City, CA), optimized for use with Applied Biosystems qPCR 
Systems, was used for primers design using default features, except for the amplicon 
length, that was fixed at min of 100 bp (Table 8.2). Primers were designed across 
exon junctions when possible to avoid amplification of genomic DNA. The exon 
junctions were uncovered blasting the sequence against bovine genome (Genome 
Browser Gateway, 2008). Primers were aligned against publicly available sequences 
in NCBI(National Center of Biotechnology Information, 2008) and UCSC (Genome 
Browser Gateway, 2008). Prior qPCR, primers were tested using the same protocol as 
for qPCR without the dissociation step in a 20 µL reaction. Part of the PCR product 
was run in a 2% agarose gel stained with ethidium bromide to assess presence of the 
product to a expected size and presence of primer-dimer, the rest was purified using 
Qiaquick PCR purification kit (Qiagen, Valencia, CA) and sent to sequence at the 
Core DNA Sequencing Facility of the Roy J. Carver Biotechnology Center at the 
University of Illinois, Urbana. Only primers with high specificity evaluated by a 
single band on agarose gel, absence of primer-dimer, amplification of the right cDNA 
verified by sequencing, and a unique peak in the dissociation curve after qPCR 
reaction were used. 
Selection and Evaluation of ICG 
Sixty-six bovine microarrays from Thering et al. (2007) and Kadegowda et al. 
(2008) were used to identify potential ICG. The selection criterion was as described 
by Piantoni et al. (2008) and Tramontana et al. (2008) with modifications. Briefly, 
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genes with 3 SD above background were uploaded to GeneSpring GX software 
(Agilent Technologies, Santa Clara, CA) and normalized using Lowess.  Only genes 
with medium-to-large mRNA abundance (≥100 relative florescent units) and 
expression ratio ~1.0 ± 0.2 between sample and reference in at least 60 of 66 samples 
were evaluated as potential ICG.  In addition to the genes meeting these criteria (n = 
39), 9 previously-tested ICG (ACTB, GAPDH, RPS23, RPS9, MTG1, ITGB4BP, 
MRPL39, RPS15A, and UXT) in bovine mammary tissue (Bionaz and Loor, 2007) 
were  used to assess co-regulation using Ingenuity Pathway Analysis® (IPA, 
Redwood City, CA).  Subsequently, the selected genes were verified for goodness of 
BLAT and BLAST sequences and primers were designed. The mRNA expression of 
the selected genes was assessed via qPCR as described by Bionaz and Loor (2007).  
Analysis of expression ratio stability and optimal number of ICG was conducted with 
geNorm software (Vandesompele et al., 2002).  The applicability of the most stable 
ICG was tested by conducting qPCR on genes associated with fatty acid metabolism, 
e.g. acetyl-CoA carboxylase-α (ACACA), fatty acid synthetase (FAS), stearoyl-CoA 
desaturase (SCD), fatty acid binding protein 3 (FABP3), and glycerol-3-phosphate 
acyl-transfrease, mitochondrial (GPAM).  
Statistical Analysis  
Normalized data of ICG and lipid-metabolism genes were analyzed using the 
MIXED procedure of SAS (SAS Inst., Cary, NC). For the latter, separate statistical 
analysis were conducted for each experiment.  Fixed effects were treatments while 




RESULTS AND DISCUSSION 
Selection of Potential ICG   
The first criterion for selecting ICG that we applied was identification of 
genes with stable expression across all 66 microarrays encompassing 6 different lipid 
supplements and two controls.  Among >13,000 annotated transcripts using this initial 
filtering step we identified 49 transcripts with expression ratio of ~1.0 ± 0.2. Of these, 
10 were excluded from the subsequent steps as the identity and function of the 
transcripts could not be verified. The genes ACTB, GAPDH, and B2M are among the 
most commonly used ICG in studies of bovine mammary lipid synthesis regulation 
(Peterson et al., 2003; Harvatine and Bauman, 2006), were not evaluated further 
because they were highly unstable across the entire set of microarrays, i.e. expression 
ratio averaged ~0.9 ± 0.6 (Fig. 8.1) confirming earlier observations in non-ruminant 
tissues (Glare et al., 2002; Vandesompele et al., 2002). 
 Co-Regulation Analysis 
  The second criterion  applied was testing for absence of co-regulation, i.e., the 
selected genes should not be regulated through common upstream effectors (e.g., 
transcription factors).  The co-regulation among potential ICG was assessed by using 
Ingenuity Pathway Analysis® (IPA, www.ingenuity.com; Redwood City, CA, USA). 
The IPA allows the examination of gene networks within large gene expression 
datasets based on published relationships across several organisms. Network analysis 
of the 39 transcripts selected in the first step plus 9 ICG previously tested (Bionaz and 
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Loor, 2007) identified 21 with no known co-regulation (Figure 8.2).  IPA revealed co-
regulation between commonly used ICG such as GAPDH, B2M, and ACTB through 
the transcription factors MYC, MYCN, TP53, EPO, and KITLG (Figure 2).  Among 
the relationships uncovered, the expression of GAPDH, ACTB, RPS9, and UXT is 
regulated by MYC (Grandori et al., 2005), while expression of GAPDH, ACTB, 
B2M, RPS9, and RPS29 is regulated by MYCN (Boon et al., 2001; Valentijn et al, 
2005).  In addition, ACTB and B2M also are regulated by EPO (Kolbus et al., 2003) 
and KITLG (Kolbus et al., 2003). TP53 also regulates GAPDH and ACTB (Ginsberg 
et al., 1991).  
 The 21 transcripts with no known co-regulation, in addition to UXT, were 
used for further analysis. Despite the apparent co-regulation of UXT by MYC, this 
gene was previously found as a suitable ICG for use in bovine mammary tissue 
(Bionaz and Loor, 2007; Piantoni et al., 2008). We verified the annotation of 
sequences on the microarray (Loor et al., 2007) for all the selected genes through 
BLAST and BLAT searches, and excluded SLC35E2 from further analysis. In 
addition, we were unable to design appropriate primers for DND1, FAM57A, PCF11, 
PPFIA3, and SMUG1. Highly-specific primers were designed for the remaining 
transcripts and these were subsequently tested by sequencing (data not shown). 
Among these, 11 were selected for qPCR analysis: COPS7A, CORO1B, DNAJC19, 
EIF3K, EMD, GOLGA5, GPR175, MARVELD1, MTG1, MRPL39, and UXT (Table 
8.1).   
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ICG Expression Profile and Stability Evaluation 
Bionaz and Loor (2007) suggested that changes in mRNA expression of ICG 
could be due to a potential dilution effect on constantly expressed genes driven by 
increased expression of milk component synthesis genes as a consequence of equal 
amounts of RNA used for qPCR analysis.  In essence, a simple statistical analysis on 
the expression of ICG as selection criteria would not take this dilution effect into 
account.  Dilution effects, in our experience, are most evident in experiments where 
changes in physiological state of the tissue are of interest [e.g., non-lactating vs. 
lactating; Bionaz and Loor (2007); Tramontana et al. (2008)].  However, in the case 
of lipid supplementation it is well-known that the nature of dietary fat can elicit 
changes in mRNA of lipogenic genes (Shingifeld and Griinari, 2007).  Thus, to 
examine potential dilution effects on selected ICG we evaluated relative mRNA 
abundance as % change from MRPL39 (Table 8.2).  The relative percentage 
abundance was calculated as 1/E(Ct) (where E = efficiency [10-1/slope] and Ct = cycle 
determined by the threshold applied to the maximum amplification of the standard 
curve). Among the ICG, the mRNA abundance varied from 0.91 (UXT) to 47.62 
(EIF3K). However, the mRNA abundance of most of the transcripts was closer (<2.5 
fold differences). Only, MARVELD1 (16.23), EIF3K (47.62), EMD (4.91) and 
DNAJC19 (3.54) had higher expression (>2.5 folds) compared with MRPL39.  On 
the contrary, the relative mRNA abundance of most the genes related to lipid 
synthesis were substantially higher than measured ICG. Thus, it could be possible that 
decreased mRNA expression of ICG occur due to a dilution effect.  This was 
overcome, however, by use of pair wise comparison method (Bionaz and Loor, 2007), 
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which determines the expression ratio across samples.  The ratios would remain 
constant when all genes with stable expression are affected to a similar extent by 
errors during the steps from RNA extraction through qPCR analysis (Vandesompele 
et al., 2002).  The pairwise comparison of ICG was conducted using the geNorm 
software (http://medgen.ugent.be/~jvdesomp/geNorm/).  Briefly, stability (M = gene-
stability measure) refers to the constancy of the expression ratio between two non-co-
regulated genes among all samples tested.  The more stable the expression ratio 
among two genes, the more likely that the genes are appropriate internal controls, i.e. 
two ideal control genes should have an identical expression ratio in all samples 
regardless of experimental conditions, cell, and/or tissue type.  The lower the M 
value, the higher the stability.  geNorm also performs an analysis to determine the 
utility of including more than 2 genes for normalization by calculating the pairwise 
variation (V) between the normalization factor (NF) obtained using n genes (best 
references) (NFn) and the NF obtained using n+1 genes (addition of an extra less 
stable reference gene) (NFn+1).  A large decrease in the pairwise variation indicates 
that addition of the subsequent more stable gene (i.e. with lowest M value) has a 
significant effect and should be included for calculation of the NF.  Once the most 
stable internal reference genes are selected, the NF is calculated using the geometrical 
average between them to normalize qPCR data. 
 The genes EIF3K, UXT, GPR175, MRPL39, MARVELD1, and EMD were the 
most stable while MTG1 and COPS7A were the least stable transcripts (Figure 8.4). 
The largest change in pairwise expression ratio stability, from 0.20 (Figure 8.4, Panel 
1) to 0.077 (Figure 8.4, Panel 2), would occur if GPR175 was selected as a third ICG 
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in combination with EIF3K and UXT, shown to be the most stable genes.  The second 
largest change in variation, from 0.059 (V3/4) to 0.039 (V5/6), would be observed 
when using 5 ICG instead of 3.  There were smaller changes in the variation due to 
subsequent addition of genes. These results suggested that use of 3 to 5 genes as ICG 
would be appropriate to normalize gene expression data from bovine mammary tissue 
in lipid-supplementation studies.  An important result from our analysis is the fact 
that ICG selected for one physiological or experimental condition may or may not be 
suitable for a widely-different condition.  For example, Bionaz and Loor (2007) found 
UXT as a suitable ICG for studies with bovine mammary gland during lactation cycle, 
which we confirmed. In contrast, MTG1, which was one of the most stable ICG in 
studies of prepubertal bovine mammary development (Piantoni et al., 2008) had 
lower stability value in the present study.  Our analysis uncovered novel ICG that 
could be used in similar studies as alternatives to the less-reliable ACTB, GAPDH, 
18S, or B2M for normalization.   
mRNA Expression of ICG and Lipid Metabolism Genes   
The mRNA expression of selected ICG in mammary tissue of lactating cows fed 
different lipid supplements are presented in Figure 8.3.  Compared with controls, ICG 
expression in response to lipid supplements did not differ significantly and had 
similar patterns across all treatments from both experiments.  Vandesompele et al. 
(2002) originally suggested the use of at least 3 appropriate ICG for normalization.  
On practical grounds, it is important to establish an optimum number of ICG for 
normalization.  To assess this, we studied mRNA expression patterns of ACACA, 
FASN, SCD, GPAM, and FABP3 independently in both experiments prior to and after 
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normalization using NF calculated with the geometrical mean of 3 or 6 most stable 
genes (Figure 8.5).  Changes due to use of 6 vs. 3 ICG were minimal and, thus, not 
justified.  Therefore, we propose that the geometric mean of EIF3K, UXT, and 
GPR175 is appropriate to normalize data arising from lipid-supplementation studies 
of could be optimum for normalizing the data from mammary tissue in lactating 
cows.   
CONCLUSIONS 
The results from the study showed that the relative expression of B2M, 
GAPDH, and ACTB, previously used as ICG in bovine mammary tissue from lipid-
supplemented cows, was highly unstable across two studies representing 66 
individual cow observations and 6 different lipid supplements.  Gene stability 
analysis, via geNorm software, uncovered EMD, MARVELD1, MRPL39, GPR175, 
UXT, and EIF3K as the most stable genes and, thus, suitable as ICG.  Analysis also 
indicated that use of 3-to-5 ICG was most appropriate for calculating a normalization 
factor.  Overall, geometrical average of at least three among EMD, MARVELD1, 
MRPL39, GPR175, UXT, and EIF3K is ideal for normalization of mammary qPCR 
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Table 8.1.  Accession number, symbol, sequence, amplicon size and molecular functions of genes tested with qPCR. 
 
Accession  # 
Gene 
Symbol Primer Primers (5' --3') 
Amplicon 
Size (bp) Molecular Function 
NM_001105331 COPS7A F.267 AGGCCCCTGGTGTCTACGT 143 protein binding 
  R.407 CCGGGCTTCGGCTAAGTAGT   
NM_001024510  CORO1B F.1043 GAGATTGCCCGGTTCTACAAACT 100 actin binding 
  R.1142 CGGGATACAGATCATCCTGGAA   
NM_001034458  DNAJC19 F.124 GTGGTAGCAGTTGGACTGACCAT 125 heat shock protein binding 
  R.248 CTGAAGGCAGTTTTTGGTAGACTTT   
NM_001034489  EIF3K F.345 CCAGGCCCACCAAGAAGAA 125 translation initiation factor activity 
  R.469 TTATACCTTCCAGGAGGTCCATGT   
NM_203361 EMD F.490 GCCCTCAGCTTCACTCTCAGA 100 protein binding 
  R.589 GAGGCGTTCCCGATCCTT   
NM_001098007  GOLGA5 F.1370 GAGCTACAGCAGCAAGTCAAAGTG 103 protein-tyrosine kinase activity;protein binding;ATP binding; 
  R.1472 CTTTAGACTGGAGTATTCGAGTAGCTTTT  Rab GTPase binding;protein homodimerization activity 
NM_001102314  GPR175 F.388 TGCTGCTCATCCCCAATGT 125 G-protein coupled receptor activity 
  R.512 CACCACGAACACCAGGATATAAAA   
NM_001101262  MARVELD1 F.2262 GGCCAGCTGTAAGATCATCACA 100  
  R.2361 TCTGATCACAGACAGAGCACCAT   
 NM_001025327 MTG1 F.277 GATCTGAAGGAGCAGCAGAAAATT 110  
  R.386 GTTGGGATGACCTGCTTGACA   
NM017446 MRPL39 F.493 AGGTTCTCTTTTGTTGGCATCC 101  
  R.593 TTGGTCAGAGCCCCAGAAGT   
NM_001037471  UXT F.134 CAGCTGGCCAAATACCTTCAA 125 protein binding;microtubule binding;beta-tubulin binding;  





Table 8. 2. Slope, coefficient of determination of standard curve (R2), efficiency (E), 
median Ct, and mRNA abundance of measured transcripts. 
 
 





MRPL39 -3.137 0.993 2.08 23.49 1.00 
UXT -3.179 0.998 2.06 23.94 0.91 
CORO1B -3.154 0.997 2.08 22.75 1.88 
DNAJC19 -3.323 0.989 2.00 23.06 3.54 
COPS7A -3.137 0.998 2.08 23.22 1.22 
EMD -3.157 0.994 2.07 21.46 4.91 
GOLGA5 -3.202 0.995 2.05 22.73 2.46 
MARVELD1 -3.431 0.995 1.96 21.54 16.23 
MTG1 -3.302 0.996 2.01 23.56 2.25 
EIF3K -3.396 0.996 1.97 19.73 47.62 
GPR175 -3.106 0.998 2.10 23.32 0.95 
ACACA -2.993 0.998 2.16 21.48 2.05 
FASN -3.239 0.998 2.04 17.01 172.91 
FABP3 -3.397 0.996 1.97 16.90 326.17 
GPAM -3.309 0.997 2.01 19.81 31.72 




Figure 8.1. Expression pattern of potential ICG in addition to commonly-used ICG 




































































































       
       
           
           
           
           
            
Figure 8.3.  Mammary tissue mRNA expression patterns (mean ± SEM) of potential 
ICG tested in cows receiving control, lipid supplements into the abomasum 
(experiment A; control A, CLA, butter, and oil mix), or lipid supplements in a TMR 
(experiment B; control B, EB100, and fish oil).  Data shown are from transformed Ct 
values with a standard curve.  There were no statistically significant effects due to 
treatments.  





























































































































































































Figure 8.4.  geNorm results from the average expression stability of potential ICG 
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Figure 8.5.  Patterns of mammary tissue ACACA, FASN, SCD, GPAM, and FABP3 
prior to and after normalization using NF calculated with the geometrical mean of 3 
or 6 most stable genes from geNorm analysis. All data from experiment A (control A, 
CLA, butter, and oil mix) tended (P < 0.15) to be significant only when not 
normalized.  In experiment B (control B, EB100, and fish oil) ACACA, FASN, and 
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GenBank accession number, hybridization position, sequence, amplicon size, and source of 
primers for Bos taurus used to analyze gene expression by qPCR. 
Accession # Gene Primers1 Primers (5’-3’)2 bp3 Source 
AJ132890 ACACA  F. 3709 CATCTTGTCCGAAACGTCGAT 101 Bionaz and Loor, 2008b 
  R. 3809 CCCTTCGAACATACACCTCCA   
BC119914 ACSL1  F. 1929 GTGGGCTCCTTTGAAGAACTGT 120 Bionaz and Loor, 2008a 
  R. 2047 ATAGATGCCTTTGACCTGTTCAAAT   
BC134532 ACSS2 F. 1881 GGCGAATGCCTCTACTGCTT 100 Bionaz and Loor, 2008b 
  R. 1970 GGCCAATCTTTTCTCTAATCTGCTT   
DY208485 AGPAT6  F. 171  AAGCAAGTTGCCCATCCTCA 101 Bionaz and Loor, 2008a 
  R. 271  AAACTGTGGCTCCAATTTCGA   
X91503 CD36  F. 743  GTACAGATGCAGCCTCATTTCC 81 Bionaz and Loor, 2008b 
  R. 823  TGGACCTGCAAATATCAGAGGA   
NM_174693 DGAT1  F. 177  CCACTGGGACCTGAGGTGTC 101 Bionaz and Loor, 2008b 
  R. 277  GCATCACCACACACCAATTCA   
DN518905 FABP3  F. 458  GAACTCGACTCCCAGCTTGAA 102 Bionaz and Loor, 2008a 
  R. 559  AAGCCTACCACAATCATCGAAG   
DV778074 FABP4       F. 402  TGGTGCTGGAATGTGTCATGA 101 Bionaz and Loor, 2008a 
       R. 502  TGGAGTTCGATGCAAACGTC   
CR552737 FASN F. 6383 ACCTCGTGAAGGCTGTGACTCA 92 Bionaz and Loor, 2008b 
  R. 6474 TGAGTCGAGGCCAAGGTCTGAA   
AY515690 GPAM F. 1963 GCAGGTTTATCCAGTATGGCATT 63 Bionaz and Loor, 2008b 
  R. 2026 GGACTGATATCTTCCTGATCATCTTG   
XM_589325 INSIG1  F. 438  AAAGTTAGCAGTCGCGTCGTC 120 Bionaz and Loor, 2008b 
  R. 557  TTGTGTGGCTCTCCAAGGTGA   
DV797268 LPIN1  F. 147  TGGCCACCAGAATAAAGCATG 101 Bionaz and Loor, 2008a 
  R. 247  GCTGACGCTGGACAACAGG   
BC118091   LPL  F. 327  ACACAGCTGAGGACACTTGCC 101 Bionaz and Loor, 2008b 
  R. 427  GCCATGGATCACCACAAAGG   
NM_181024 PPARG  F. 135  CCAAATATCGGTGGGAGTCG 101 Bionaz and Loor, 2008b 
  R. 235  ACAGCGAAGGGCTCACTCTC   
DV935188 SCAP  F. 990  CCATGTGCACTTCAAGGAGGA 108 Bionaz and Loor, 2008b 
  R. 1097 ATGTCGATCTTGCGTGTGGAG   
AY241933 SCD  F. 665  TCCTGTTGTTGTGCTTCATCC 101 Bionaz and Loor, 2008b 
  R. 765  GGCATAACGGAATAAGGTGGC   
TC263657 SREBF1  F. 143  CCAGCTGACAGCTCCATTGA 67 Bionaz and Loor, 2008b 
  R. 209  TGCGCGCCACAAGGA   
DV921555 SREBF2  F. 4134 AGGTCTCTGGGCACCATGC 101 Bionaz and Loor, 2008b 
  R. 4234 CATCACCGCAACCCCAAG   
AY656814 THRSP F. 631  CTACCTTCCTCTGAGCACCAGTTC 151 Bionaz and Loor, 2008b 
  R. 781  ACACACTGACCAGGTGACAGACA   
1 Primer direction (F – forward; R – reverse) and hybridization position on the 
sequence 
2 Exon-exon junctions are underlined 





Sequencing results of genes using BLASTN from NCBI against nucleotide collection. 






































Appendix 1C  
Sequencing results obtained from PCR product of Bos taurus specific primers for 
isoforms under investigation. 
( Bionaz and Loor, 2008a, b) 
 
 
Gene  Best hit in NCBI Score 
ACACA Bos taurus acetyl-coenzyme A carboxylase alpha (ACACA) 93.7 
ACSL1 Bos taurus similar to acyl-CoA synthetase long-chain family member 1 153 
ACSS2 Bos taurus acetyl-CoA synthetase 2  134.0 
AGPAT6 Bos taurus 1-acylglycerol-3-phosphate O-acyltransferase 6 (AGPAT6) 81.8 
CD36 Bos taurus CD36 molecule (thrombospondin receptor) 86.0 
DGAT1 Bos taurus diacylglycerol O-acyltransferase homolog 1 (mouse) 122.0 
FABP3 Bos taurus heart fatty acid-binding protein (FABP-3) 95.6 
FABP4 Bos taurus fatty acid binding protein 4, adipocyte (FABP4) 86 
FASN Bos taurus fatty acid synthase (FASN) 71.9 
INSIG1 PREDICTED: Bos taurus similar to insulin induced gene 1, transcript variant 2 123.0 
LPIN1 PREDICTED: Bos taurus similar to KIAA0188, transcript variant 4 (alias of LPIN1) 113 
LPL Bos taurus lipoprotein lipase, mRNA 123.0 
PPARG Bos taurus peroxisome proliferator-activated receptor gamma 107.0 
SCAP Predicted: Similar to sterol response element binding protein cleavage-activating protein  83.8 
SCD Bos taurus stearoyl-CoA desaturase (delta-9-desaturase) 79.8 
SREBF2 Predicted: Bos taurus similar to sterol regulatory element-binding transcription factor 2 136.0 
THRSP Bos taurus thyroid hormone-responsive protein 187.0 
 
GPAM and SREBF1 were not sequenced due to the short PCR product (<70 bp), 








































Temporal pattern of lipogenic genes subjected to treatments: Control, Palmitate 
(16:0), t10c12-CLA, ROSIGLITAZONE  (Time Points studied: 0, 3, 6, 12, 24 h). The 
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